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Background and Introduction  
Despite significant declines in maternal mortality rates, sub-Saharan Africa continues to face the burden of 
maternal deaths due to pregnancy related complications. Nigeria is one of the ten most dangerous countries for 
a woman giving birth and is reportedly responsible for 14% of the world’s maternal deaths (National Population 
Commission [Nigeria] & ICF International, 2014). Nigeria’s MMR is estimated to be 576 deaths per 100,000 live 
births; one in 30 women in Nigeria will die from a cause related to pregnancy or childbirth (NPC & ICF 
International, 2014). Poor health systems, lack of trained staff and quality of care, low levels of education, 
poverty, patriarchal societies and women's lack of agency to make decisions about their own healthcare needs 
are some of the factors contributing to the high maternal mortality and morbidity (NPC & ICF International, 2014) 
Pre-eclampsia and eclampsia (PE/E), pregnancy-related hypertensive disorders, are consistently cited as a 
leading cause of maternal morbidity and mortality Nigeria. In addition to maternal morbidity and mortality, PE/E 
can increase the likelihood of preterm or stillbirth (Onyearugha, & Ugboma, 2012; Olusanya & Solanke, 2012b; 
Owolabi et al., 2008). Both PE/E are preventable and the deaths due to PE/E can be avoided through timely 
detection and management of complications during and after pregnancy (The World Health Organization, 2011).  
To fully appreciate the enormity of the problem at country level, we conducted a systematic review of published 
papers on PE/E in Nigeria from 2000-2015 in order to understand the key challenges, gaps and interventions 
related to the prevention and treatment of pre-eclampsia and eclampsia. 
WHAT IS PRE-ECLAMPSIA AND ECLAMPSIA? 
While the medical cause of eclampsia is unknown and definitions of the condition vary, there are some generally-
accepted signs and symptoms that are used to diagnose pre-eclampsia and eclampsia in pregnant women. Pre-
eclampsia is a condition where a woman experiences a rapid elevation of blood pressure to > 140/90 mmHg 
(hypertension) and high levels of protein in the urine (significant proteinuria >0.3g/day or >30mg/mmol of 
urinary creatinine in random sample) after 20 weeks gestation (Magee et al., 2015). If untreated, it can progress 
to eclampsia, characterized by seizures, and other complications such as kidney or liver damage and ultimately 
death of the mother and/or fetus.  
Diagnosing pre-eclampsia and managing it before it progresses to severe pre-eclampsia or eclampsia is a critical 
strategy to promote maternal and newborn health. Pre-eclampsia can be managed and eclampsia can be 
prevented by routine screening of blood pressure and protein levels in urine for pregnant women during 
antenatal care (ANC) visits. Health care providers can manage high BP in pregnant women using antihypertensive 
drugs that are safe during pregnancy, prevent and control eclamptic convulsions with injectable magnesium 
sulphate (MgSO4) and, if at PHC facility, should refer the woman for follow-up monitoring and management of 
PE/E. 
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FIGURE 1   Diagnosing pre-eclampsia and eclampsia 
 
Adapted from: Wagner, L.K. (2004) 
 
 
The World Health Organization (WHO) recommends three main evidence-based approaches to prevent maternal 
mortality due to PE/E (The World Health Organization, 2011): 
1) Preventing the incidence of PE/E by screening all pregnant women for signs and symptoms during 
antenatal care (ANC) check-ups. Preventative interventions include: calcium supplementation during 
pregnancy, low-dose aspirin prophylaxis and family planning methods to delay pregnancies. 
2) Detecting early signs of PE by measuring blood pressure and protein levels in the urine during ANC visits 
to monitor and manage pre-eclampsia. 
3) Managing severe cases of PE/E by administering anti-convulsant therapy―magnesium sulphate 
(MgSO4) ―to stop seizures followed by careful monitoring of the pregnant mother and her fetus and plan 
timed delivery of the baby. 
The World Health Organization recommends use of MgSO4 as the standard method of preventing eclampsia in 
women with severe pre-eclampsia and of treating eclampsia (The World Health Organization, 2011). Women 
treated with MgSO4 have a 67% lowered risk of recurrent seizures compared to women who were treated with 
diazepam and phenytoin (Euser & Cipolla, 2009). Despite its proven efficacy, this inexpensive drug is often 
underutilized for various reasons including lack of awareness and continued use of outdated methods (like 
diazepam and phenytoin), poor access to supplies, and insufficient number of trained personnel to administer 
MgSO4 (Yeager & Patel, 2012). 
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PRE-ECLAMPSIA AND ECLAMPSIA IN NIGERIA 
In Nigeria, approximately 34% of pregnant women receive no antenatal care, putting them at higher risk of 
maternal mortality (NPC & ICF International, 2014). A recent, nationwide cross-sectional survey found that pre-
eclampsia and eclampsia is the leading cause of maternal mortality in Nigeria and is responsible for 28.2% of 
maternal deaths; the other main contributors to maternal mortality are hemorrhage (24.4%) and pregnancy-
related infection/sepsis (14.2%) (Oladapo et al., 2015). 
This systematic review of peer-reviewed literature published after 2000 aims to identify the interventions 
adopted to treat and manage pre-eclampsia and eclampsia. It specifically looks at issues around the quality of 
care, gaps in the evidence, and barriers to accessing services for PE/E in Nigeria. 
NIGERIAN HEALTH SYSTEM AND MATERNAL HEALTH POLICIES 
Nigeria is Africa’s most populous nation of 162.5 million people. The Nigerian health system divides hospitals 
into primary, secondary, and tertiary hospitals with referral linkages between them (Tukur et al, 2009). In 
addition, Nigeria divides levels of governance into three distinct and independent entities, which are: federal, 
state, and local governments. The tertiary healthcare systems are managed by the federal government, the 
secondary institutions by the state government and the primary health care by the local government authorities, 
with no formal connection between these levels of care (Tukur et al, 2009). Patients with Pre-eclampsia and 
eclampsia are often referred from primary to secondary and tertiary health facilities for management. Delays in 
care are common due to lack of knowledge from the patient and poor understanding of the seriousness of the 
condition, as well as differing governance structures in the healthcare system. 
Some of the key national policies and strategies adopted in Nigeria to address the high MMR include: Safe 
Motherhood Initiative launched in Nairobi in 1987, the road map for accelerating the attainment of MDG 4 and 
MDG 5 in 2005, FIGO's Safe Motherhood and Newborn Health Committee Initiative (2006-2011), the Integrated 
Maternal Newborn and Child Health (MNCH) Strategy in 2007, the Midwives Services Scheme (2009) which was 
launched by the National Primary Healthcare Development agency, USAID’s Saving Mothers, Giving Life initiative 
(2012) and their Maternal and Child Survival Program (MCSP) and DFID’s Maternal and Newborn Child Health 
Programme. The Federal Ministry of Health has included all of the necessary drugs for the management of 
hypertensive disorders of pregnancy (Labetalol, Hydralazine, Methyldopa, Nifedipine, magnesium sulphate, and 
calcium gluconate), on the national Essential Medicines List (EML) which was last updated in 2010 (Federal 
Ministry of Health Nigeria, 2010). The inclusion of these drugs on the EML means that every facility should 
maintain a regular supply of these medications; though this is not always the case. While some of these efforts 
have put a focus on the high maternal mortality rate in Nigeria, much remains to be done to address some of 
the challenges in the delivery of services for the prevention and treatment of pre-eclampsia/eclampsia. It will be 
necessary to re-visit some of the policies and on-going programs and explore how we may improve some of the 
gaps in health management to achieve better maternal health.  
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Methods 
This systematic literature review was conducted in three phases to collect, organize and analyze the published 
literature on pre-eclampsia and eclampsia in Nigeria.  
IDENTIFYING ARTICLES FOR REVIEW 
Search of Databases 
The research team developed two sets of key terms related to pre-eclampsia and eclampsia that captured 
citations for peer-reviewed papers related to detection, management, and prevention of PE/E (Appendix I). The 
first search was designed to capture results that do not mention PE/E explicitly and the second search included 
the MeSH terms for PE/E and the rare complication known as, HELLP syndrome. The two searches were run in 
bibliographic databases including: PubMed, ScienceDirect, World of Science, Cochrane, POPLINE, and Wiley 
Online Library. These searches used a combination of terms linking various aspects of the diagnosis, treatment, 
and prevention of pre-eclampsia, eclampsia and hypertensive disorders of pregnancy. Searches were limited to 
articles published from 2000 to 2015 (April).  
To accommodate the large number of key terms included in the second search, the terms were divided into three 
sub-searches to avoid any inadvertent omissions. The exact combinations of search terms used can also be 
found in Appendix I. The three sub-searches resulted in a high volume of duplicate citations. 
Google Search 
In an effort to identify any articles that may have been missed during the database searches, a simple google 
search was done using the following search terms:  
"eclampsia" or "pre eclampsia" or "preeclampsia" or "pre-eclampsia" AND Nigeria  
From the articles identified, the same search was run on the website or database hosting those articles. These 
sites included: Hindawi.com, African Journals Online (AJOL), Journal of Obstetrics and Gynaecology Canada 
(JOGC), Journal of Family and Reproductive Health (JFRH), Guttmacher Institute, International Federation of 
Gynecology and Obstetrics (FIGO). A final effort was made to ensure capture of any relevant articles by running 
two simplified searches in PubMed, results were duplicates with articles that had already been identified, and 
the searches were: 
[“task shifting” AND Nigeria AND (“Magnesium sulfate” OR “magnesium sulphate”)]  
and  
[(“magnesium sulfate” OR “magnesium sulphate”) AND Nigeria]. 
Articles were excluded prior to phase I review if they were duplicate citations, if they pertained to non-human 
subjects, or if it was evident from the title that the article was not related to Nigeria (e.g. specifically identified 
the location of the study as somewhere other than Nigeria). 
Titles and abstracts for the articles were imported into an excel spreadsheet adapted from “Excel Workbook for 
2 Screeners” by Helena VonVille, licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 
Unported License, available online at http://libguides.sph. uth.tmc.edu /excel_SR_workbook.  
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PHASE I: EXCLUSION CRITERIA 
During Phase I of the systematic review two independent reviewers KK and IC conducted title and abstract 
screening to determine if the abstracts should be included or excluded in the next phase of the review. Abstracts 
were excluded if they were:  
1) Not about Nigeria,  
2) Not related to pregnancy; (for example: abstracts about male subjects and abstracts that discussed 
hypertension but not in pregnancy were excluded), 
3) Not related to PE/E or associated risk factors, symptoms, or complications.  
The two screeners then reconciled their reviews and in cases where it was unclear from the abstract if an article 
would provide relevant information, the screeners consulted the full text of the article.  
PHASE II: INCLUSION AND EXCLUSION 
In the second phase, the two reviewers read the full texts of the remaining articles to determine their relevance 
and eliminated any papers that were not related to PE/E, did not focused enough on Nigeria or did not provide 
any substantive data or observations specific to Nigeria, and any papers for which a full text could not be 
acquired.  
PHASE III: CATEGORIZATION 
Finally, the remaining articles were sorted into five types of papers—based on the main topic of each—that were 
found during the systematic review. 
1) Intervention: papers that explore questions related to prevention and treatment of PE/E 
2) Potential risk factors for pre-eclampsia and eclampsia 
3) Other health outcomes associated with pre-eclampsia and eclampsia 
4) Descriptive papers: including program descriptions/summaries and literature reviews 
5) Reviews of hospital case files summarizing maternal mortality rates, causes of maternal mortality and 
the proportion of maternal mortality attributable to PE/E (and other hypertensive disorders in 
pregnancy). 
The goal was to identify articles that presented evidence on interventions that addressed the diagnosis, 
treatment, or prevention of pre-eclampsia or eclampsia.  
6 
Results 
After removing duplicate citations and those that were obviously unrelated to this review, the initial database 
searches identified 520 abstracts which were included in Phase I review. The two reviewers removed 338 articles 
that were deemed to not fulfill the inclusion requirements for Phase I. During Phase II, 37 articles were removed 
because they did not provide enough, relevant information specific to Nigeria or a full text document could not 
be located (details in Appendix II). A total of 145 articles were included in the systematic review. 
FIGURE 2   Flow diagram of systematic review methods and results 
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SUMMARY OF TOPICS FROM THE LITERATURE 
Strategies for prevention and treatment of PE/E 
Nineteen studies relating to strategies for the prevention and/or treatment of PE/E were identified in this 
systematic review. Key data was extracted from these papers and compiled in a summary table (see Appendix 
III). These articles look at possible strategies for reducing mortality due to pre-eclampsia and eclampsia in 
Nigeria. 
There were six major topics that emerged from these nineteen papers looking at best practices for preventing 
and treating PE/E including: confirming MgSO4 is safe and effective, testing different dosing mechanisms, 
determining different methods for delivering patients with PE/E, improving case monitoring, creating and 
incorporating policy and management guidelines, and re-training of providers/task-shifting to lower cadres. 
MgSO4 is safe and effective  
Two papers confirm that magnesium sulphate is a safe and effective treatment for eclampsia and is a better 
option than other anticonvulsants like diazepam. Altman et al. performed a randomized placebo-controlled trial 
(known as the Magpie Trial) that showed that in 33 countries (including Nigeria) which demonstrated that MgSO4 
is safer and more effective for controlling fits in eclamptic women than diazepam (Altman et al., 2002). The 
Magpie Trial was the first large, multi-country, randomized trial to generate evidence on the safety and efficacy 
of MgSO4 in women with eclampsia; this study lead to the determination that MgSO4 is the drug of choice and 
should be used over other anticonvulsants to control eclamptic fits. 
The second paper, Ugwu et al. involved a before-and-after comparison of health outcomes based on 
retrospective case review from hospital records (Ugwu et al., 2011). During the three year study period, the 
University of Nigeria Teaching Hospital, Enugu, saw 77 cases of severe PE; 47 of whom were treated with 
diazepam and 30 of whom received MgSO4. Only one woman experienced recurrent seizures, and she had been 
treated with diazepam. During the study, no maternal deaths occurred due to severe PE, however, women in the 
diazepam group were more likely to experience prolonged hospital stay.  
MgSO4 dosage 
There are currently two predominant regimens for administering MgSO4 to women with severe PE, impending 
eclampsia, or eclampsia: the Pritchard regimen and Zuspan regimen. The Pritchard regimen has been 
considered the ‘gold standard’ treatment method in low resource settings since 1925, but there is no evidence 
to show that this is best and most efficient mode of treating convulsions associated with PE/E. The Zuspan 
regimen requires more medical skills and equipment (involves setting up an infusion pump). 
Four papers identified in this review looked at the question of dosage and tested alternate regimens. One was a 
descriptive comparative study conducted at the Federal Medical Centre in Katsina where women presenting with 
severe PE during the two study periods received a different dosage of MgSO4 (Okusanya et al., 2012). The 54 
women who were enrolled during the first study phase received a 10g dose of MgSO4 and 49 women in the 
second study phase received the 14g associated with the standard Pritchard regimen. Overall, the health 
outcomes from both groups were comparable: similar rates of vaginal delivery, onset of convulsion/recurrent 
convulsion, maternal death, and neonatal Apgar score were not significantly different between the two groups.  
Ekele and Ahmed conducted an experimental pilot in 2002-2003 that used the same loading dose of MgSO4 but 
limited the maintenance doses for 12 hours following the loading dose (compared to the 24 hours stipulated in 
the Pritchard regimen)(Ekele & Ahmed, 2004). Thirty-three women participated in this study and the results seem 
to indicate that the primary outcome of interest—rate of recurrent convulsion—in these women (6.0%) is 
comparable to the rate documented in the large MgSO4 Collaborative Eclampsia Trial (Magpie Trial) that followed 
the standard, Pritchard regimen (4.7%).  
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The other two papers looking at the dosage question were randomized control trials. Chama and Geidam 
randomized 112 patients into standard treatment group (Pritchard) and a shortened postpartum course which 
involved administering only two IM injections four hours apart (Chama & Geidam, 2013). The findings indicated 
that the shortened postpartum course was as effective as the Pritchard regimen to manage eclampsia. While 
Chama and Geidam shortened the postpartum maintenance in their study, Abdul et al. instead modified the 
antepartum loading and maintenance doses (Abdul, et al., 2013). During their study, Abdul et al. randomized 72 
patients into standard dose (n=33) and low dose (n=39) groups. The low dose regimen reduced the amount of 
MgSO4 required in the standard, Pritchard. The women in the low dose group received a 9g loading dose (4g IV, 
2.5g in each buttock) followed by 2.5g in alternate buttocks every four hours. Though the sample size was small, 
this study found no significantly different rates in maternal or perinatal mortality or in Cesarean section (CS) rate.  
Delivery methods for PE/E cases 
The only definitive treatment for eclampsia is to end the pregnancy by delivering the baby and placenta. It is, 
therefore, understandable that PE/E leads to increased rates of cesarean section (CS) deliveries in populations 
with high rates of PE/E. Afolayan and Tukur explore two different aspects of labor and delivery in order to 
determine which methods have the best outcomes for mother and baby.  
Afolayan et al. conducted a retrospective case review that compared complication rates between using general 
anesthesia or spinal anesthesia during caesarean section deliveries among eclamptic women (Afolayan et al., 
2014). The study showed that maternal and perinatal survival among eclamptics are better among those who 
received spinal anesthesia during their caesarean section procedure.  
Tukur examines the outcomes for eclamptic mothers and their babies who underwent caesarean section versus 
those who had labor induced using misoprostol (Tukur et al., 2007). Their study found that although both 
methods were effective, misoprostol requires more time to fully induce labor and should therefore only be used 
when prompt and safe caesarean section is not available.  
Improved case management and monitoring 
Case management and monitoring can be modified and improved and at different stages throughout the 
development of the condition; three papers looked at strategies to improve case management for women with 
PE/E. One looks at a strategy to manage early PE, one incorporates a tool for streamlining monitoring and 
treatment, and the third tests the role of serum magnesium levels in eclamptic patients as a way to prevent and 
detect MgSO4 toxicity. 
In a prospective, case-control study conducted in Enugu, 749 consecutive cases of pre-eclampsia admitted to 
the University Teaching Hospital were recruited; 175 cases were deemed to be ‘early onset’ (before 30 weeks 
gestation) and made up the study group and 574 served as controls (Onah & Iloabachie, 2002). All participants 
were tested for blood count, serum electrolytes, urea and creatinine, liver function, clotting profile, urinalysis and 
ultrasonography. When necessary, they were treated with antihypertensives (alpha-methyldopa used antepartum 
and hydralazine used in the event of a hypertensive crisis) and diazepam (to control convulsions). The women in 
the early onset group were conservatively managed using antihypertensives and diazepam until maternal and/or 
fetal risks meant that continued conservative management was considered dangerous; 80% gained more than 
two weeks gestation using this method of management. Women in the late onset group were delivered promptly, 
especially if the woman was beyond 34 weeks gestation. While conservative management may improve fetal 
outcomes, this study saw an increase in maternal morbidity and mortality among the study group participants 
which was likely due in part to facility delays and the unavailability of MgSO4. The authors suggest that 
conservative management has potential to improve fetal outcomes but in order to improve maternal outcomes, 
institutional delays need to be reduced and MgSO4 needs to be available. 
Ameh et al. developed a monitoring chart that simplified the paperwork and compiled all relevant details onto 
one sheet (Ameh et al., 2012). The improved chart, the LIVKAN chart allows for the patient’s blood pressure to 
be tracked over time as well as the number and timing of convulsions, patient’s level of consciousness, 
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proteinuria, respiratory rate, deep tendon reflex. Furthermore, any drugs needed to manage high BP (hydralazine, 
nifedipine, labetolol), eclamptic fits (MgSO4), or MgSO4 toxicity (calcium gluconate) are also recorded in the chart. 
Missing from the chart, however, is methyldopa, another antihypertensive that is usually affordable and 
available. In order to assess the effectiveness and acceptability of the LIVKAN chart, Ameh et al. trained 118 
skilled birth attendants on its use and followed up with questionnaires. The study found that 98% of the 
participants thought that the LIVKAN chart was an improvement over the existing monitoring system and would 
be useful at their level and at lower levels to improve care and documentation of referral. The challenges cited 
include: low availability of blank charts and high workload due to paperwork. Overall, the chart appears to 
improve monitoring of PE/E by combining monitoring and treatment guidelines and allowing for 24 hour 
surveillance of a patient experiencing PE/E in one single page.  
Finally, whenever a patient is treated with MgSO4, she must be monitored for indications of toxicity from MgSO4. 
Ekele and Badung quesiton the role of serum magnesium levels in patients receiving MgSO4 as an indicator of 
possible toxicity. During their prospective study, they recruited 19 patients who presented with eclampstic 
convulsions and were treated using MgSO4; blood samples were taken from patients prior to administration of 
MgSO4  to assess whether there was a significant change in serum magnesium levels (Ekele & Badung, 2005). 
This small study found that serum magnesium levels in eclamptic patients do not change drastically and they 
remain within therapeutic levels and conclude, therefore, that serum magnesium level estimation is not 
necessary in patients with eclampsia being treated with MgSO4. 
Policy and management guidelines 
Establishing policies and institutionalizing guidelines support clinical efforts to manage cases of PE/E. Three 
papers included in this review examined the impact of guidelines and policies on maternal mortality related to 
PE/E. Nkwocha et al. looked at the impact of a global call to action—the Safe Motherhood Initiative—that was 
adopted in Nigeria in 1990 and called for a reduction in maternal mortality by 50% by 2000. Igwegbe et al. 
assessed the impact of a facility-specific policy and Ezugwu et al. looked at guidelines within a specific facility to 
assess the effect on maternal mortality due to PE/E.  
Nigeria launched the Safe Motherhood Programme in 1990 with the express purpose of reducing maternal 
mortality by half in ten years (Nkwocha et al., 2006). Nkwocha et al. reviewed hospital cases from eight years 
before (1981-1989) and eight years after (1990-1998) the introduction of this initiative in Nigeria. The study 
found that while the overall MMR decreased by 8% between the two study periods, maternal deaths due to PE/E 
increased after 1990. Prior to 1990, PE caused 4.4% and eclampsia caused 10.5% of maternal deaths, after 
1990 these rates increased to 13.9% and 17.9%, respectively. These findings indicate that PE/E represents a 
priority area that requires more focus in order to reduce the associated maternal death. 
In 2005, the Nnamdi Azikiwe University Teaching Hospital (NAUTH) introduced a “Service Compact” (SERVICOM) 
contract in response to a federal proclamation to provide all Nigerians with “basic services to which each citizen 
is entitled in a timely, fair, honest, effective and transparent manner” (Igwegbe, Eleje, Ugboaja, & Ofiaeli, 2012). 
The SERVICOM charter at NAUTH included mandates including: elimination of fee-for-service for all emergency 
services (which included emergency obstetric services), prompt and appropriate treatment, and monitoring of 
services and record keeping. Igwegbe et al. reviewed hospital records from before and after the introduction of 
the SERVICOM charter at NAUTH to determine if the policy had any effect on maternal mortality. Overall, the 
maternal mortality rate at the facility from 2004-2010 was 1,098 per 100,000 live births and eclampsia 
contrubuted 25% of the maternal deaths. Before SERVICOM, the 2004 maternal moratily rate was 1,567 per 
100,000 live births compared to 691 per 100,000 in 2010. Igwegbe et al. showed that introducing a policy like 
the SERVICOM charter can improve quality of care, timeliness of treatment and maternal health outcomes which 
may have implications for maternal outcomes related to PE/E. 
In 2008, the Enugu State University Teaching Hospital adopted evidence-based guidelines aimed at reducing 
maternal mortality (Ezugwu et al. 2014). This study reviewed hospital records from three years before the 
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institutionalization of the guidelines and three years after in order to compare the maternal outcomes at the 
facility and to determine if the guidelines had an impact. The guidelines were identified through PubMed and 
Google scholar; they were adapted to the local context and included guidelines on the management of severe 
PE using the Pritchard regimen. The three years after the introduction of the guidelines at the facility showed a 
43.5% reduction in MMR when compared with the three years prior to the guidelines. The case fatality rate fell 
by 80% (from 15.8% to 2.7%) after introducing the guidelines and training providers on them. This study by 
Ezugwu et al indicates that institutionalization and training on guidelines related to management of PE/E can 
reduce maternal mortality. 
Re-training and task-shifting 
The final major theme that emerged from the literature on strategies for improving prevention and management 
of PE/E is focused on increasing access through provider knowledge and skills. Five studies were on training, re-
training and task-shifting as a way of improving access and quality of care for patients with severe PE/E. 
In a multi-state study, Okonofua et al. conducted a before-and-after trial in six health facilities that sought to test 
the impact of training various professionals (Ob/Gyns, doctors in training, nurses, midwives and others) on the 
proper treatment of PE/E cases using the Pritchard regimen, antihypertensives, and monitoring the patient 
(Okonofua et al., 2013). To establish a baseline and identify gaps in knowledge, the researchers reviewed 
hospital records from January to May 2008 and conducted in-depth interviews (IDIs) with providers to inform 
development of the training materials.  The endline data was prospectively collected for one year after the 
intervention. Incidence of eclampsia was comparable at baseline and endline but the case fatality rate 
decreased from 15.1% at baseline to 3.2% at endline. This study found that the trainings successfully built the 
capacity of the healthcare providers to safely use MgSO4 and effectively reduced deaths due to eclampsia. 
Ishaku et al. conducted a case-control study where they assessed whether lower-cadre health workers could 
detect severe PE/E and safely administer the loading dose of MgSO4. In their study, ten primary health care 
facilities in Kano state were included, 5 made up the experimental arm and 5 were controls (Ishaku et al., 2013). 
At the experimental facilities, health workers received training on how to recognize cases of severe PE/E and 
learned how to administer the loading dose of MgSO4 (10g IM) and refer women for follow up care. In addition 
to recognizing and initiating treatment for severe PE/E, the PHC providers also received instruction for detecting 
MgSO4 toxicity and treating it with calcium gluconate. The PHC providers at the control facilities did not give 
MgSO4 or diazepam. During this study, a higher proportion of women defaulted from experimental facilities than 
in the control facilities; this was potentially due to the immediate, yet temporary, effect of MgSO4. This study 
demonstrated that PHC providers can safely and effectively administer the loading dose of MgSO4 in patients 
with severe PE/E, however referral mechanisms need to be strengthened to reduce the 75% default rate seen 
in this study.  
The remaining three papers are reporting on data collected during the same or complementary studies that were 
implemented in ten facilities in Kano state from February 2008 to December/January 2009 (Okereke, Ahonsi, 
Tukur, Ishaku, & Oginni, 2012; Tukur et al., 2011; Tukur et al., 2013).  
The intervention trained twenty-five individuals on evidence-based management of hypertensive disorders of 
pregnancy and use of MgSO4 (five hospital board officials and one midwife and one doctor from each of the ten 
facilities). These 25 people were considered “Master Trainers” and together trained another 160 health workers. 
These papers report a baseline case fatality rate of 20.9% compared to 2.3% after the intervention.  
This evidence-based intervention was successful because it engaged with stakeholders and it is replicable (Tukur 
et al., 2011). Training providers on protocols for the treatment of severe PE/E using MgSO4 was determined to 
be an effective strategy to reduce case fatality due to eclampsia without incurring any significant increase in cost 
(Okereke et al., 2012). This effective, low-cost, replicable intervention has a positive effect on maternal and fetal 
mortality and morbidity and should be implemented on a wider scale (Tukur et al., 2013). 
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Demonstrated and Potential Risk Factors 
While the biological mechanism for developing eclampsia remains unknown, many studies look at various 
attributes or conditions in an effort to identify risk factors for developing PE/E. Among the potential risk factors 
explored in the literature are: maternal ethnicity, adolescent mothers, sickle cell anemia, parity, and history of 
hypertension or prior pre-eclampsia. Thirty-six papers looked at demonstrated or potential risk factors for PE/E 
that had the potential to improve early detection (Appendix IV). 
Previously demonstrated risk factors for PE/E that appear in the literature from Nigeria and include: low parity, 
young age, multiple gestation, history of chronic high blood pressure, previous pre-eclampsia, and not registering 
or booking at a health facility for ANC (Adokiye & Isreal, 2015; Anorlu et al., 2005; Olusanya, 2011; Osungbade 
et al., 2008; Owolabi et al., 2008). Three papers looked specifically at young age and determined that 
adolescence is a risk factor for PE/E, though the papers did not look at explanations for this fact (Adeyinka et 
al., 2010; Airede & Ekele, 2003; E. I. Nwobodo & Panti, 2012).  
While rise in blood pressure is known to be associated with PE/E, one paper investigated whether or not a relative 
rise versus absolute rise in BP would be better to predict maternal and fetal outcome. After following a cohort of 
478 women and tracking blood pressure levels throughout the study period, Onah concluded that fetomaternal 
outcomes were not significantly affected by relative rise in diastolic BP and concluded that absolute BP is a 
better predictor of fetomaternal outcome (Onah, 2002).  
Twenty-one other papers looked at potential risk factors relating to biomarkers in pregnancy. Each looked at a 
specific set of biological measures to determine if there were any observable trends or associations between the 
biomarker and the development of PE/E. These included: various antioxidant vitamins, magnesium or 
magnesium serum levels, trace element levels, lysosomal enzymes or enzymic antioxidants, among others 
(Appendix IV). Based on these studies, elevated levels of haptoglobin, malondialdehyde, phenylalanine 
concentration, blood lead and homocysteine levels were observed in pre-eclamptic women and may contribute 
to the development of PE/E. Low serum concentrations in zinc, copper, manganese and magnesium, and low 
plasma calcium, vitamin C and E levels could indicate PE/E or risk of PE/E in pregnant women. 
The remaining papers tested the effect of maternal ethnicity, seasonality, past abortion and change in paternity, 
socioeconomic status and polygamy on a woman’s risk of developing PE/E (Abubakar et al., 2009; Attahir, et al., 
2010; Chigbu et al., 2009; Familoni et al., 2008; Okafor & Ezegwui, 2010; Olayemi et al., 2010; Olayemi, et al., 
2010). All of these studies were specific and small but their findings indicate the potential need for further 
research into risk factors for PE/E. Abubakar et al. found that the Fulani ethnic group was more likely to progress 
from PE to eclampsia when compared to Hausa and Kanuri women. Attahir et al. learned that seclusion and 
polygamy did not have an effect on rates of PE. Okafor reported from a retrospective review of hospital records 
that women with PE were more likely to undergo CS during the rainy season.  
While these findings are certainly interesting, they are looking only at a relatively small number of women and 
are not sufficient to consider these aspects as risk factors for PE/E.   
Other Health Outcomes associated with PE/E 
In addition to the common, known health outcomes of PE/E (edema, headache, seizure, and death), other health 
outcomes are associated with PE/E. Twenty-three papers identified during this review reveal other health 
outcomes that can affect mother and/or fetus including: fetal malnutrition, poor Apgar scores increased chance 
of cesarean section (CS), cardiac complications and persistent hypertension (Appendix V).  
Among the less-common outcomes associated with PE/E were: orofacial injuries, loss of vision, and paralysis. 
The orofacial injuries are not caused by PE/E, however, but are the result of objects being forced into the mouths 
of eclamptic women in a misguided effort to mitigate consequences of the seizures (Adeyemo & Rabiu, 2012; 
Ndukwe et al., 2004). While change in vision is a more common consequence of PE/E, total loss of vision occurs 
less often but one such case is reported in the literature (Waziri-Erameh et al., 2003). The literature also revealed 
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a rare case of a 26-year old woman who was brought into a facility with postpartum eclampsia and was left 
quadriplegic, a rare yet real consequence of her eclampsia (Okafor & Efetie, 2006).  
Since MgSO4 only allows for the temporary management of eclampsia, many women suffering from the condition 
must be delivered pre-term; this leads to an increase in the number of caesarean section (CS) deliveries that are 
performed which, in turn, increases the woman’s chance of suffering a morbidity or mortality from the procedure 
(Adeoye et al., 2013; Oladapo et al., 2004; Okafor & Ezegwui, 2010; Okafor, 2009; Ozumba & Anya, 2002). 
Further to the increase in caesarean sections and associated morbidities and mortality for the mother are the 
increased negative health outcomes for the fetus/baby. With an increase in pre-term deliveries, there is a 
heightened burden of low birthweight babies (Olusanya & Solanke, 2012a, 2012b; Onyearugha & Ugboma, 
2012a). 
Another health outcome of PE/E is HELLP syndrome, a dangerous condition that complicates eclampsia with 
hemolysis, elevated liver enzymes, and low platelets. HELLP syndrome causes the internal organs to shut down, 
and left untreated, the mother’s health, as well as the fetus’ health, will quickly deteriorate (Makinde, 2009). 
It is important to remember that PE/E has negative health effects on the fetus/newborn as well as the mother. 
Eight papers reviewed discuss the fetal/neonatal outcomes associated with PE/E including fetal malnutrition, 
low birth weight (LBW), preterm birth (PTB), low Apgar score and fetal death. For example, Onyearugha et al. 
conducted a study based on the hospital records for 48 babies delivered to eclamptic mothers in Abia state. The 
records showed that 13 babies were LBW <1500g, and 29 (60%) were stillborn and four were severely 
asphyxiated; the authors suggest that these poor Apgar scores could be impacted by ‘asphyxiogenic effect’ in 
utero during eclamptic convulsions (Onyearugha & Ugboma, 2012b).  
Program descriptions and literature reviews 
Thirteen of the papers reviewed were categorized as being descriptive articles and included: project summaries 
(three), literature reviews (five), purely cross-sectional studies (three), and editorial or correspondence articles 
(two). Some of the topics covered in these descriptive papers were: verbal autopsy to determine cause of 
pregnancy-related death in a population, assessment of nurse-midwife educators on causes of maternal 
mortality, determine whether brief summaries of these descriptive papers relating to PE/E in Nigeria can be 
found in Appendix VI. 
Summaries of hospital case notes and records for PE/E 
A majority of the papers collected for this review are a specific kind of a descriptive paper; they are summaries 
of hospital reports of eclampsia or, more broadly, maternal mortality. The 54 papers that fall into this category 
report maternal mortality ratios, the attributable proportion of MMR to PE/E, incidence of PE/E, and case fatality 
rate at a specific facility during a specific time period and do not provide any analysis or interpretation. The 
facilities are from across the country, with a greater concentration in the South West and South East (Figure 3).  
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FIGURE 3   Map of facilities where records were reviewed 
 
 
 
The MMRs reported in these papers cover specific periods of time over the last three decades; Olatunji et al. 
reviewed data from a facility in Sagamu in Ogun state that included cases from 1988-1997; their review found 
92 maternal deaths out of 5,423 deliveries making the MMR at that facility at that time, 1,696 per 100,000 
deliveries. The lowest MMRs reported include 463 per 100,000 live births (44 maternal deaths) at the Federal 
Medical Centre in Kogi state from 2005-2009 (Alabi et al., 2012) and 454 per 100,000 from Edo state in 1996-
2000 (Onakewhor & Gharoro, 2008). The highest MMRs reported among these summary papers include one 
from a rural referral hospital, Baptist Medical Centre, in Delta state. The cases reviewed were from 1994—2003 
and revealed 115 maternal deaths out of 5,153 deliveries making the MMR= 2,232 per 100,000 live births 
(Igberase & Ebeigbe, 2007). Another extraordinarily high MMR of 2,849 per 100,000 deliveries comes from a 
tertiary facility that experienced 112 maternal deaths out of 3,931 deliveries from 2003-2007 (Kullima et al., 
2009). The highest observed MMR comes from Olabisi Onabanjo University Teaching Hospital in Sagamu in Ogun 
state from 2000-2005 where 75 maternal deaths and 2,509 live births were recorded making the MMR= 
2.989.2 per 100,000 live births (Oladapo et al., 2006).  
In addition to reporting on MMRs at facilities, the authors also reported on the proportion of MMR that is 
attributable to PE/E. These proportions also varied, every paper that reported the proportion of maternal deaths 
caused by hypertensive disorders in pregnancy, PE/E, severe PE/E, eclampsia, was over ten percent (Figure 4). 
The proportions ranged from 12.4% of 97 maternal deaths (Nwagha et al., 2010) to 42.2% of 277 maternal 
deaths (Nwobodo & Ahmed, 2011).  
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FIGURE 4   Attributable proportion of maternal death due to PE/E as reported in the literature 
 
 
 
Two papers, examined ‘maternal near miss’ cases to get a larger sample size and a better idea of the causes of 
severe maternal outcomes even in cases where the woman survived. These also found that a large proportion 
of cases were due to PE/E. Adeoye et al. saw that hypertensive disorders in pregnancy (which they defined as 
severe PE/E) caused 37.3% of near miss cases at the maternity units of Obafemi Awolowo University Teaching 
Hospitals Complex in Ile-Ife from July 2006-June 2007. In a recent cross-sectional study of 91,724 live births, 
Oladapo et al. found 2,440 severe maternal outcomes (1,451 maternal near-miss and 998 maternal deaths). 
Of these 2,440 cases, hypertensive disorders (chronic hypertension and PE/E) were the most common cause 
and contributed 24% of the SMOs and eclampsia was found to be the most frequent complication and resulted 
in 20% of the maternal deaths (Oladapo et al., 2015). 
The papers already discussed in this section were looking at all causes of maternal mortality/maternal near 
misses and reported on overall MMR and attributable proportion of maternal death to PE/E among other health 
conditions; the remaining summaries of hospital records look at reports from cases of PE/E specifically and 
report on prevalence/incidence and case fatality rates. Incidence/prevalence of PE/E ranged from very low: 
0.42% (Onwuhafua et al., 2001) and 0.75% (Ikechebelu & Okoli, 2002) to very high: 9.42% (Tukur, Umar, & 
Rabi’u, 2007). For obstetric complications, the United Nations has set the maximum case fatality rate at 1% of 
cases; every paper reporting CFR in this literature review found CFR over 1%, most were over 10% and one study 
found CFR as high as 42.22% (out of 45 cases) (Onwuhafua et al., 2001).  
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Discussion  
GAPS IN PREVENTION OF PE/E 
Globally, aspirin and calcium are thought to have a protective effect for women at risk of developing PE/E. This 
potential prophylactic effect is only very briefly mentioned in a few papers and none of the studies test the effect 
of these two supplements on the incidence of PE/E. The effectiveness and impact of prophylactic aspirin and 
calcium are unknown in the Nigerian context.  
GAPS IN DETECTION OF PE/E  
Terminology and clinical definitions 
Throughout the 145 full text articles reviewed in this paper, there is no consistency in terminology used or in 
clinical definitions for those terms; each paper provides their own definitions with some overlapping criteria.  
Among the various terms used throughout the literature were: hypertensive disorders of pregnancy, mild 
pregnancy-induced hypertension (PIH), PIH, severe PIH, chronic hypertension with superimposed pre-eclampsia, 
pre-eclamptic toxaemia (PET), severe PET, toxemia of pregnancy, the toxaemia syndrome, mild pre-eclampsia, 
pre-eclampsia, severe pre-eclampsia, imminent eclampsia, impending eclampsia and eclampsia.  
Currently, with the plethora of accepted terms used to refer to varying degrees of PE/E severity, studies are 
forced to define the clinical parameters for each condition. While some of the definitions contain similarities or 
overlapping criteria, there are often specific differences between them. Below are a few examples of definitions 
from the literature 
Mild pre-eclampsia 
 “a blood pressure of 140/90 mmHg on two occasions 6 h or more apart, or a rise of 30 mmHg systolic 
or 15 mmHg diastolic from mid-trimester values; proteinuria above (+) on two consecutive urine 
specimens and significant non- dependent oedema” (Okafor & Okezie, 2005). 
 “Pregnancy-induced systole hypertension of 140 to <160 mmHg (or diastole hypertension of 90 to <110 
mmHg) with proteinuria of 2+ (100 mg/dL)” (Osinubi, Ajayi, & Adegbola, 2009) 
Pre-eclampsia 
 “Preeclampsia, a multisystem disorder unique to human pregnancy is defined as the association of 
pregnancy induced hypertension with proteinuria of greater than or equal to 300mg/24h after 20 weeks 
of gestation” (Okafor & Ezegwui, 2010) 
 “Hypertension after the 20th week of gestation, the diastolic blood pressure >110 mmHg on admission, 
proteinuria >30mg/dl in random urine specimen or > 300mg in a 24hr urine specimen” (Makinde, 
2011) 
 “Hypertension (?140/ 90mmHg on two occasions 4h apart) and proteinuria (>0.3g/dl) in the second 
half of pregnancy” (Adeyinka et al., 2010) 
 “Hypertension (systolic pressure = 169 ± 26.0 mmHg, diastolic pressure = 102 ± 11.0 mmHg), 
significant proteinuria (368 ± 39 mg/24 h), severe headache, abdominal pain and vomiting.” (Akiibinu, 
Kolawole, Ekun, & Akiibinu, 2013) 
 “Significant proteinuria (>100 mg/day) and high blood pressure (>130/90 mm Hg) irrespective of 
weight of the patients or the presence of edema. The blood pressure must have manifested on at least 
two occasions 6 hours or more apart.” (Arinola, Arowojolu, Bamgboye, Akinwale, & Adeniyi, 2006) 
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 ”Blood pressure of >140/90 mmHg on at least two occasions measured at least 6 h apart or a diastolic 
blood pressure of 110 mmHg at any time or an increase of 30 mmHg and 15 mmHg in the systolic and 
diastolic blood pressures, respectively from the booking values or a mean arterial pressure of greater 
than 105 mmHg” with “two midstream urine specimens more than 4 h apart with 2+ protein on dipstix 
testing or 1+ protein with measured specific gravity of 41.03 and < 8” (Chigbu et al., 2009) 
 “Cerebral or visual disturbances, epigastric pain, pulmonary edema or cyanosis, a systolic blood 
pressure >140 mm Hg or a diastolic blood pressure >90 mm Hg and proteinuria.”(Glew et al., 2004) 
Severe pre-eclampsia 
 “The blood pressure is persistently above 160/110 mmHg and proteinuria above 5 g/24 h (+++) and 
symptoms of headache, blurring of vision, epigastric pain and oliguria.” (UV Okafor & Okezie, 2005). 
 “New hypertension with blood pressure of 160 mmHg systolic or diastolic blood pressure of 110 mmHg, 
or greater, arising after 20 weeks of gestation in a woman who was normotensive before 20 weeks 
gestation, associated with proteinuria […] 2+ or more protein on urine dipstick.” (Guerrier, Oluyide, 
Keramarou, & Grais, 2013) 
 “If any two of the following signs were present: (1) systolic blood pressure >160 mmHg or diastolic blood 
pressure >110 mmHg; (2) proteinuria (>3+ on dipstick [500 mg/dL]); (3) facial oedema.” (Osinubi et 
al., 2009) 
Eclampsia 
 “…maternities that presented with fitting or fitted while on admission, had blood pressure equal to or 
greater than 140/90 mm Hg, at least 2 +proteinuria with or without edema, and had no past history of 
epilepsy.” (B. Ekele, Bello, & Adamu, 2007) 
 “hypertension after the 20th week of gestation, the diastolic blood pressure >110 mmHg on admission, 
proteinuria >30mg/dl in random urine specimen or > 300mg in a 24hr urine specimen […] plus 
headache, blurring of vision and upper abdominal pain […] and seizures” (O. N. Makinde, 2011) 
 “associated with convulsions, oliguria (4400ml/24h), increased tendon reflex, pain in the right 
hypochondriac region.” (Adeyinka et al., 2010) 
 “Occurrence of seizure and/or altered level of consciousness not caused by epilepsy or other convulsive 
disorders, with signs of severe preeclampsia.” (Guerrier et al., 2013) 
Creating specific and clear clinical definitions for these conditions is essential to ensuring that providers around 
the globe are able to appropriately diagnose and manage the symptoms related to PE/E. Generally speaking, 
“toxemia” is an outdated term that is not frequently used today to classify types of hypertensive disorders of 
pregnancy. Given the wide range of definitions related to hypertensive disorders in pregnancy, it is necessary to 
reduce the number of terms and simplify the definitions to move beyond the implication that interventions vary 
significantly between each classification, when in fact, the monitoring and management methods are not so 
different between mild PE and PE or severe PE and eclampsia.  
ANC attendance, content, and quality 
One message that comes through clearly in the literature is that “booked” patients are less likely to develop 
PE/E when compared to “unbooked” women. This trend is not surprising as women who attend ANC will be more 
likely to be screened for PE/E and receive preventative care and careful monitoring before the condition worsens. 
Women who do not attend ANC are unlikely to be aware of any problem until eclamptic seizures begin. What is 
not always clear from the literature are the details about which services the women attending ANC are receiving 
and whether or not they know what danger signs to look for in pregnancy. Attending ANC and receiving all 
essential ANC services is required for early detection of PE/E and to prevent the women with early signs of 
preeclampsia from worsening.  
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GAPS IN TREATMENT OF PE/E  
The literature very clearly supports the use of MgSO4 to manage eclamptic convulsions; MgSO4 is not the only 
weapon that we have against PE/E. If indicators of PE/E are detected early in pregnancy, these symptoms can 
be managed using antihypertensive drugs before the condition escalates.  
Antihypertensives 
There is nothing in the literature that specifically reports on the effectiveness and safety of antihypertensives for 
pregnant women with high blood pressure; a few mention that as part of their treatment procedure, women were 
receiving antihypertensives to manage their high BP. Using antihypertensive drugs (labetalol, nifedipine, 
methyldopa, hydralazine) to manage high blood pressure in pregnant women is an important strategy to reduce 
the number of PE cases that escalate to eclampsia. 
Use of MgSO4 
Despite the abundance of evidence demonstrating the safety and effectiveness of MgSO4, its use has remained 
low, especially in developing countries where it, incidentally, is most needed. Low availability of MgSO4, lack of 
guidelines on its use (or unawareness of these guidelines), misinformation regarding who can administer the 
drug, poor knowledge of health workers on its use, fear of toxicity, little incentive for pharmaceutical companies 
to commercialize the drug (no profit to be made), ready availability of pre-packaged forms of less effective drugs 
(like diazepam), and lack of support for policy change all contribute to the underutilization of this safe and 
effective life-saving drug. Even if providers are trained to use MgSO4 and know how and when to use it, 
sometimes providers choose to use diazepam instead because they are more familiar with it since it was the 
recommended drug for PE/E in Nigeria for decades before MgSO4 was introduced (Ekele, 2009). 
In addition to the relatively low use of MgSO4, there are no studies that demonstrate the lowest effective dose 
to manage PE/E. As described earlier in this paper, some researchers have started questioning and testing the 
dosage with preliminary results indicating that a reduced dose—either in amount delivered or timing of doses—
can be as effective as the generally-accepted Pritchard regimen.  
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Conclusion 
Throughout the development of a pregnancy, there are many opportunities when PE/E can be prevented, 
detected and managed; based on the literature, certain gaps exist along this continuum of care. In order to have 
the most impact, we recommend a multi-level set of interventions that increase community awareness of 
symptoms of PE/E and ANC health seeking behavior, improve and expand provider skills and knowledge at 
multiple levels (including PHC) for detecting and treating high BP in pregnancy and PE/E throughout the 
developmental stages of pregnancy. Figure 5 visualizes the cycle of pregnancy and specific strategies that are 
currently thought to be the best practices to reduce maternal mortality related to PE/E; the blue stars correspond 
to opportunities that hold the most potential for significant reduction of incidence of eclampsia and subsequent 
death. 
FIGURE 5   Opportunities and strategies for preventing, detecting and treating PE/E  
 
*orange text indicates adverse outcomes for which providers should monitor and be prepared to manage 
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RECOMMENDATIONS 
Develop common language and clear streamlined policies  
 Develop simple terminology and associated definitions for global use. 
 Continued advocacy to hospital administrators and relevant policymakers to ensure that protocols are 
followed over time and that the necessary drugs and equipment are procured.  
Clarify and define management strategies and dosage 
 Determine the minimum effective dose for MgSO4. 
 Create and distribute clear and concise guidelines and protocols for treating PE/E with 
antihypertensives and MgSO4. 
 Assess the effectiveness and need of aspirin and/or calcium prophylaxis in Nigeria. 
Increase access to quality services 
 There should be training and re-training of healthcare providers on recognizing PE/E, managing high BP 
with antihypertensives, when and how to administer MgSO4, and how to monitor for and treat toxicity. 
 Task-shifting can increase the workforce capable of providing life-saving services; PHC providers can 
and should be able to detect and provide initial treatment (antihypertensives and MgSO4 loading dose) 
for PE/E and monitor for toxicity. 
Engage Community 
 Increase community awareness of and access to antenatal care.  
 Educate community members on the signs and symptoms of PE/E and when and where to seek 
treatment. 
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beyond essential interventions for reduction of maternal mortality (the {WHO} Multicountry 
Survey on Maternal and Newborn Health): a cross-sectional study. The Lancet, 381(9879), 
1747–1755. 
Not Nigeria Not enough focus on Nigeria or Nigeria-specific data 
Tukur, J., & Muhammad, Z. (2010). Management of eclampsia at AKTH: before and after magnesium 
sulphate. Nigerian Journal of Medicine, 19(1), 104–7.  
No Full Text Journal not available online prior to 2011 
Tukur, J., Babatunde, A., Salisu, I., & Ayodeji, O. (2012). I369 EXPANDING THE USE OF MAGNESIUM 
SULPHATE IN NIGERIA. International Journal of Gynecology & Obstetrics, 119S3, S161–S260. 
No Full Text Abstract for oral presentation published in supplement 
Uzoigwe, S. A., & John, C. T. (2004). Maternal mortality in the University of Port Harcourt Teaching 
Hospital, Port Harcourt in the last year before the new millennium. Nigerian Journal of 
Medicine : Journal of the National Association of Resident Doctors of Nigeria, 13(1), 32–35. 
No Full Text Unable to acquire full text 
van Lonkhuijzen, L., Stekelenburg, J., & van Roosmalen, J. (2012). Maternity waiting facilities for 
improving maternal and neonatal outcome in low-resource countries. The Cochrane Database 
of Systematic Reviews, 10, CD006759. 
Not related to 
PE/E 
 
von Dadelszen, P., Sawchuck, D., Justus Hofmeyr, G., Magee, L. A., Bracken, H., Mathai, M., … Roberts, 
J. M. (2013). PRE-EMPT (PRE-eclampsia-Eclampsia Monitoring, Prevention and Treatment): A 
low and middle income country initiative to reduce the global burden of maternal, fetal and 
infant death and disease related to pre-eclampsia. Pregnancy Hypertension: An International 
Journal of Women’s Cardiovascular Health, 3(4), 199–202. 
Not Nigeria Not enough focus on Nigeria or Nigeria-specific data; Nigeria is part of the 
PRE-EMPT project, but this paper merely included Nigeria in a list of 
countries. 
Wahab, K. W., Sanya, E. O., Ademiluyi, B. A., & Bello, A. H. (2014). Posterior reversible encephalopathy 
syndrome complicating postpartum eclampsia in a Nigerian: case report. The Nigerian 
Postgraduate Medical Journal, 21(3), 266–268. 
No Full Text Unable to acquire full text 
Watila, M., Omeiza, B., & Kwari, S. (2015). Seizure occurrence, pregnancy outcome among women with 
active convulsive epilepsy; one year prospective study. Seizure. 
Not related to 
PE/E 
Related to seizure associated with epilepsy; eclamptic patients were 
excluded from the study 
Yakasai, I., Dikko, B., Sunday, A., & Tukur, J. (2009). O1018 Free maternity services in Kano State 
Nigeria–Use of magnesium sulphate as key to reduction of maternal mortality. International 
Journal of Gynecology 
No Full Text Abstract for oral presentation, published in supplement 
Yeager, B., & Patel, S. (2012). Medicines for Maternal Health; Key Data and Findings. Grey Literature  
  
 29 
 
Appendix III:  
SUMMARY TABLES OF 19 INTERVENTIONS TO IMPROVE PREVENTION/TREATMENT OF PE/E 
Citation Study Design 
Location, 
Timeframe, and 
Sample size 
Prevalence
/ 
Incidence/ 
CFR 
 
Brief summary of methods/intervention 
Main findings/ limitations 
Conclusions/ 
Recommendations 
Abdul, M., Nasir, U., Khan, 
N., & Yusuf, M. (2013). 
Low-dose magnesium 
sulphate in the control of 
eclamptic fits: a 
randomized controlled 
trial. Archives of 
Gynecology and Obstetrics, 
287(1), 43–6. 
Randomized 
Controlled 
Trial 
 
 
Labour Unit, 
Obstetrics and 
Gynecology Federal 
Medical Centre, 
Azare, north-eastern 
Nigeria 
 
January to August 
2008 
 
72 patients 
recruited, 39 
randomized into low-
dose group, 33 were 
in standard regimen 
group 
Prevalence 
rate of 
eclampsia 
= 4.2% 
 
CFR= 5.5% 
Standard dose: 14g loading dose of MgSO4 
(4g IV, 10g IM) followed by IM maintenance 
dose of 5g every four hours 
 
Low dose: 9g loading dose of Mg SO4 (4g IV, 
5g IM) followed by IM 2.5g every four hours 
 Primigravidas: 57% of cases. 
 44% intrapartum, 26% antepartum, and 15% postpartum 
eclampsia. 
 Recurrent convulsion rate did not differ between the study 
groups. 
 There were more cesarean deliveries and perinatal deaths in 
the low-dose group, but the difference was not statistically 
significant. 
 Other maternal complications, including mortality, were not 
significantly different between the groups.  
 Limitations: small sample size and the study was not 
blinded. 
 Conclusions: more studies needed to determine whether a 
low-dose regimen of MgSO4 should be standardized.  
Afolayan, J. M., 
Nwachukwu, C. E., 
Esangbedo, E. S., Omu, P. 
O., Amadasun, F. E., & 
Fadare, J. O. (2014). 
Evolving pattern of spinal 
anaesthesia in stable 
eclamptic patients 
undergoing caesarean 
section at University of 
Benin Teaching Hospital, 
Benin, Nigeria. Nigerian 
Retrospective 
case review 
University of Benin 
Teaching Hospital, 
Benin City, Nigeria 
 
January 1, 2011—
December 31, 2012 
 
99 cases of 
eclampsia 
Incidence 
of 
eclampsia: 
170 in 
10,000 = 
1.7% 
Patients’ case notes were reviewed; clinical 
and demographic data was extracted and 
analyzed. 
 58.59% antepartum, 29.29% intrapartum, 12.12% 
postpartum eclampsia 
 68.73% of cases were nulliparous and 84.1% did not receive 
ANC at the hospital 
 82 underwent caesarean section; 13.4% of whom were <20 
years old, 39% were between 25-29 years old, and 52.4% 
were 30+ years old 
 Of patients who underwent c/s, 65 (79.3%) had spinal 
anaesthesia and 17 (20.7%) had general anaesthesia.  
 This study concludes that maternal and perinatal survival is 
better when the patient undergoes spinal anaesthesia than 
those who had general anaesthesia. 
30 
Citation Study Design 
Location, 
Timeframe, and 
Sample size 
Prevalence
/ 
Incidence/ 
CFR 
 
Brief summary of methods/intervention 
Main findings/ limitations 
Conclusions/ 
Recommendations 
Journal of Medicine, 23(4), 
288–295. 
Altman, D., Carroli, G., 
Duley, L., Farrell, B., 
Moodley, J., Neilson, J., … 
Magpie Trial Collaboration 
Group. (2002). Do women 
with pre-eclampsia, and 
their babies, benefit from 
magnesium sulphate? The 
Magpie Trial: a randomised 
placebo-controlled trial. 
The Lancet, 359(9321), 
1877–90. 
Randomized 
placebo-
controlled 
trial 
 
Magpie Trial 
Was conducted in 
33 countries, 
including Nigeria. 
10, 141 women  
 
 
 
10, 141 women who had not given birth or 
were <24 h postpartum, blood pressure 
140/90 mmHg or more and proteinuria of 
1+ (30mg/dL) or more. 
 
Randomized to: 
Magnesium sulphate (n=5071) or placebo 
(n=5070)  
 
 While this study does not report findings specific to Nigeria, 
it is listed here as it was the Magpie Trial that definitively 
demonstrated the safety and effectiveness of MgSO4 for the 
management of severe PE/E. 
 This trial found that MgSO4 reduces the risk of eclampsia 
(and probably risk of maternal death) by half with no 
substantive harmful effects for mother or baby. 
 
Ameh, C. A., Ekechi, C. I., 
Tukur, J., & J, A. C. E. C. T. 
(2012). Monitoring severe 
pre-eclampsia and 
eclampsia treatment in 
resource poor countries: 
skilled birth attendant 
perception of a new 
treatment and monitoring 
chart (LIVKAN chart). 
Maternal and Child Health 
Journal, 16(5), 941–946.  
 
Cross-
sectional 
Katsina, Nigeria 
 
118 participants 
(skilled birth 
attendants) over five 
workshops in 2010 
N/A 
LIVKAN chart was developed and providers 
were trained on its use. Participating 
providers were interviewed using a semi-
structured questionnaire to assess the 
usefulness in the chart and assess the 
quality of care for severe PE/E.  
 The goal was to assess the usefulness of the treatment 
monitoring tool (LIVKAN chart) in improving quality of care 
for severe PE/E using questionnaires 
 98% reported that the LIVKAN chart was better than existing 
monitoring system and would be useful for improving care. 
73% said the chart would be useful at lower levels and 
improve documentation of referral.  
 Some challenges to using the LIVKAN chart were high 
workload (45%) and irregular supply of blank charts (53%). 
 The chart combines monitoring and treatment guidelines 
(anticonvulsant, anti-hypertensive, IV fluids, calcium 
gluconate and delivery) and allows for 24h of monitoring 
using fewer pages. 
Chama, C., & Geidam, A. 
(2013). A shortened versus 
standard matched 
postpartum magnesium 
sulphate regimen in the 
treatment of eclampsia: a 
randomised controlled 
trial: original article. African 
Journal of Reproductive 
Health, 17(3), 131–136.  
Randomised 
Controlled 
Trial 
Labour ward of 
University of 
Maiduguri Teaching 
Hospital 
January and June 
2011 
98 eclamptic 
mothers 
Incidence 
6.41% 
(141 out of 
2,201 
deliveries) 
Eclamptic mothers were randomized and 
received either the standard or shortened 
postpartum regimen. Fetomaternal 
outcomes were measured and compared. 
 21 of the 141 had previously received anticonvulsants 
(mainly diazepam) from referring health facilities and 8 had 
other complications and were excluded 
 The remaining 112 participants were randomized to receive 
either the standard Pritchard regimen of MgSO4 or a 
shortened postpartum course: two doses of IM MgSO4 are 
given four hours apart. (14 had incomplete information and 
98 were included in the analysis) 
 Primary outcome measure was recurrence of fits  
 The shortened course was found to be as effective as 
Pritchard for the management of eclampsia 
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Citation Study Design 
Location, 
Timeframe, and 
Sample size 
Prevalence
/ 
Incidence/ 
CFR 
 
Brief summary of methods/intervention 
Main findings/ limitations 
Conclusions/ 
Recommendations 
Ekele, B., & Ahmed, Y. 
(2004). Magnesium sulfate 
regimens for eclampsia. 
International Journal of 
Gynecology and Obstetrics, 
87(2), 149–150. 
Experimental 
pilot 
Usmanu Danfodiyo 
University Teaching 
Hospital 
 
January 2002—
December 2003 
 
33 women 
 
Patients were treated with a modified 
regimen that limited MgSO4 administration 
to 12 hours (vs. 24) and the authors’ 
primary outcome of interest was recurrent 
convulsions. 
 Pritchard regimen involves use of MgSO4 with a habitual 
24h administration of maintenance doses after initial 
loading dose 
 This small study tested an alternate regimen that is the 
same loading dose as in Pritchard (4g IV and 5g each 
buttock) and maintenance doses every four hours for 12 
hours. 
 Recurrent convulsion rate was 6.0% (comparable to 4.7% 
found in the Collaborative Eclampsia Trial 
 Since cost of magnesium sulfate has been underestimated, 
according to the authors, reducing the amount needed to 
manage PE/E is better. 
 Recommend a larger, multicenter randomized (12h vs 24h) 
trial is needed to validate these findings. 
Ekele, B. A., & Badung, S. 
L. H. (2005). Is serum 
magnesium estimate 
necessary in patients with 
eclampsia on magnesium 
sulphate? African Journal 
of Reproductive Health, 
9(1), 128–132. 
Prospective 
Usmanu Danfodiyo 
University Teaching 
Hospital, Sokoto 
January—December 
2002 
19 patients 
 
Blood samples were taken from consecutive 
patients treated for eclampsia with MgSO4 
prior to administration of the loading dose 
and subsequent maintenance doses serum 
magnesium levels were estimated  
Modified Pritchard regimen was used 
(loading dose of 4gIV over 10 mins followed 
by 10g of deep IM MgSO4; followed by 
maintenance doses of 5g every four hours. 
Patients were monitored for MgSO4 toxicity 
and calcium gluconate was available, 
 
Blood samples were taken before each 
maintenance dose 
 19 patients completed the study 
 One patient had recurrent convulsion within 30 mins of 
initiative treatment and was given an additional 2g IV to stop 
the seizure. 
 None of the patients experienced loss of deep tendon reflex 
or respiratory depression; no signs of MgSO4 toxicity 
 Mean serum magnesium level at baseline was 1.96mmol/L; 
subsequent serum levels (2.1mmol/L) remained within 
suggested therapeutic level of 2.0-3.5mmol/L.  
 Based on this small study, the authors conclude that serum 
magnesium levels in eclamptic patients receiving only 
MgSO4 to manage their seizures remained within 
therapeutic range; recommend more widespread use of 
magnesium sulphate without the need to estimate serum 
magnesium. 
Ezugwu, E. C., Agu, P. U., 
Nwoke, M. O., & Ezugwu, F. 
O. (2014). Reducing 
maternal deaths in a low 
resource setting in Nigeria. 
Nigerian Journal of Clinical 
Practice, 17(1), 62–66.  
Retrospective 
pre/post 
intervention 
study 
 
 
Enugu State 
University Teaching 
Hospital, Nigeria 
Jan. 2005—Dec. 
2007 & Jan 2008—
Dec.  2009 
59 maternal deaths 
 
Reviewed files of all maternal deaths over a 
six year period (three years before the 
adoption of guidelines aimed at maternal 
mortality reduction and three years after) 
 91% retrieval rate, MMR of 645 per 100,000 live births.  
 Evidence based guidelines were identified through PubMed 
and Google scholar and were adapted to the local context.  
 For this study, resident doctors and nurses were then 
trained on the guidelines, which included using the Pritchard 
regimen for the management of severe PE/E.  
 After adoption of the guidelines, there was a 43.5% 
reduction in MMR (488 vs 864 per 100,000 live births) 
 CFR for eclampsia fell by 80% (15.8% to 2.7%) 
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Citation Study Design 
Location, 
Timeframe, and 
Sample size 
Prevalence
/ 
Incidence/ 
CFR 
 
Brief summary of methods/intervention 
Main findings/ limitations 
Conclusions/ 
Recommendations 
Igwegbe. AO, Eleja, GU, 
Ugboaia, JO, & Ofiaeli, RO. 
(2012). Improving maternal 
mortality at a university 
teaching hospital Nnewi, 
Nigeria. International 
Journal of Gynecology & 
Obstetrics, 116(3), 197-
200. 
 
Retrospective 
evaluation 
study  
Nnamdi Azikiwe 
University Teaching 
Hospital (NAUTH), 
Nnewi 
January 1, 2004—
December 31, 2010 
4,916 live births 
 
This study compared maternal mortality at 
the facility during the pre-SERVICOM and 
post-SERVICOM periods. 
 
 As a result of Federal proclamation of a social contract with 
all Nigerians to provide “basic services to which each citizen 
is entitled in a timely, fair, honest, effective and transparent 
manner,” all government establishments were required to 
prepare a “Service Compact” (SERVICOM) contract with all 
Nigerians.  
 NAUTH launched a SERVICOM charter in May 2005 to 
improve service delivery to patients including: elimination of 
fee-for-service for all emergency services (including obstetric 
services); prompt and appropriate treatment, monitoring of 
services and record keeping and penalties for “errant staff” 
 Overall MMR 1098 per 100,000 livebirths over the six year 
period.  In 2004, MMR was 1,567 per 100,000 and in 
2010, the MMR 691 per 100,000. 
 PE/E was most common direct cause of maternal death 
(25%) 
 Introduction of SERVICOM reduced the delay at the facility to 
receive treatment (change in intake and waiver procedures 
led to reduction in presentation-intervention interval) 
 
Ishaku, S., Ahonsi, B., 
Tukur, J., & Ayodeji, O. 
(2013). Attrition from care 
after the critical phase of 
severe pre-eclampsia and 
eclampsia : Insights from 
an intervention with 
magnesium sulphate in a 
primary care setting in 
northern Nigeria. Health, 
5(9), 1461–1466. 
Case-control 
PHC facilities in 
Kano State, Nigeria 
September 2010—
August 2011 
10 PHCs, 150 
patients recruited 
 
10 PHCs were included, 5 were in an 
experimental arm and 5 were controls; all 
facilities received severe PE/E patients and 
performed stabilizing treatment (anti-
hypertensives) before sending patient to 
referral centers.  
The health workers at the experimental 
PHCs were trained to recognize patients with 
severe PE/E and were trained to administer 
loading dose of MgSO4 (10g IM) before 
referral. They also received training on 
detecting MgSO4 toxicity and how to 
administer the antidote, calcium gluconate. 
Health workers at control PHCs did not give 
MgSO4 and either gave diazepam or no 
anticonvulsant.  
 
 
 75% of the women referred to hospitals defaulted; default 
rate was higher among those who had been at experimental 
PHCs and received the loading dose of MgSO4 
 It is possible that the immediate, yet temporary, effect of 
MgSO4 gave the false idea that the patients were cured and 
that follow up was unnecessary; contributing somewhat to 
the higher attrition among the experimental group; the 
community needs to be educated about the continuing 
dangers of severe PE/E  
 “With appropriate training and supervision, lower-cadre 
health care professionals can safely administer MgSO4 to 
treat severe pre-eclampsia and eclampsia without significant 
toxic effects in primary care settings in developing 
countries.” 
Nkwocha, G. C., Anya, S. E., 
& Anya, A. E. (2006). 
Obstetric mortality in a 
Retrospective 
review of 
births and 
Federal Medical 
Centre, Umuahia, 
Abia State. 
 
This study used hospital records to compare 
mortality rates from the period before the 
1990 launch of the “Safe Motherhood 
 Overall, puerperal sepsis, hypertensive disorders of 
pregnancy (pre-eclampsia and eclampsia), hemorrhage and 
uterine rupture, together, accounted for 88% of maternal 
deaths. 
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Citation Study Design 
Location, 
Timeframe, and 
Sample size 
Prevalence
/ 
Incidence/ 
CFR 
 
Brief summary of methods/intervention 
Main findings/ limitations 
Conclusions/ 
Recommendations 
Nigerian general hospital. 
Nigerian Journal of 
Medicine : Journal of the 
National Association of 
Resident Doctors of 
Nigeria, 15(1), 75–76. 
maternal 
deaths 
 
‘before-and-
after’ study 
 
January 1, 1981—
December 31, 1998 
 
21,244 deliveries 
Programme” in Nigeria which aimed to 
reduce maternal mortality by 50% before 
2000.  
 
 MMR decreased 8% from 4942 per 100,000 before 1990 
and 4545 per 100,000 from 1990-1998 
 Deaths due to PE/E increased after the launch of the Safe 
Motherhood Programme: In 1981-1989, pre-eclampsia 
caused 4.4% of maternal deaths and eclampsia caused 
13.9%. From 1990-1998, PE caused 10.5% and eclampsia 
caused 17.9% 
Okereke, E., Ahonsi, B., 
Tukur, J., Ishaku, S. M., & 
Oginni, A. B. (2012). 
Benefits of using 
magnesium sulphate 
(MgSO(4)) for eclampsia 
management and maternal 
mortality reduction: 
lessons from Kano State in 
Northern Nigeria. BMC 
Research Notes, 5, 421.  
Retrospective 
study; before-
and-after 
 
Bayero 
University/Aminu 
Kano Teaching 
Hospital, Kano 
Baseline: 2006—
2007 
Intervention: 
February 2008—
January 2009 
Baseline: 1,233 
patients 
Intervention: 1045 
patients (49 severe 
PE, 996 eclampsia) 
 
Data for the study was obtained from 
obstetric records for eclamptic patients.  
For baseline: patients were treated using 
diazepam, which was commonly available 
Intervention: doctors and midwives were 
trained to use MgSO4 following protocol and 
detect and treat MgSO4 toxicity (using 
calcium gluconate) 
 52% of the patients were teenagers, 60.4% were 
primigravidae, 74.1% were illiterate, 71% were in 
monogamous relationships 
 This study found a reduction in case fatality among 
eclampsia patients from 20.9% (95% CI: 18.7, 23.2) at 
baseline to 2.3% (1.4, 3.2) during intervention period. 
 92.5% of patients treated with MgSO4 did not have 
recurrent convulsions 
 This study found that training providers on protocol for 
treating severe PE/E with MgSO4 is effective to reduce CFR 
due to eclampsia and there is no significant difference in 
cost of MgSO4 vs. diazepam. 
Okonofua, FE et al. 
“Training Health Workers 
for Magnesium Sulfate Use 
Reduces Case Fatality from 
Eclampsia: Results from a 
Multicenter Trial.” Acta 
obstetricia et gynecologica 
Scandinavica 92 (2013): 
716–720. 
Multicenter 
trial 
‘before-and-
after’ 
Kano, Lagos, 
Calabar, Jos, 
Maiduguri, Enugu 
Baseline: January—
May 2008 
Training: April-June 
2009 
 
Intervention: August 
2009 
Incidence 
of 
eclampsia 
baseline: 
1.5% 
interventio
n: 1.4% 
 
CFR 
Baseline: review of hospital records and in-
depth interviews with providers to inform 
development of training curriculum. 
Training: mandatory 3-day workshop on 
epidemiology of maternal mortality, clinical 
features of eclampsia, ways to overcome 
limitations in the healthcare system in 
managing eclampsia, protocols on MgSO4. 
Intervention: use of Pritchard regimen to 
treat MgSO4 and guidelines on use and 
timing of anti-hypertensives and monitoring 
patient. 
 Aminu Kano Teaching Hospital, Lagos State University 
Teaching Hospital, University of Calabar Teaching Hospital, 
University of Jos Teaching Hospital, University of Maiduguri 
Teaching Hospital, University of Nigeria Teaching Hospital 
 Multi-professional trainings included: Ob/Gyns, doctors in 
training, nurses, midwives, nurses/midwives in training, staff 
from related departments and senior management 
 The results from pre- and post-tests at the training sessions 
indicate a significant increase in knowledge related to 
eclampsia management 
 During one year after the intervention, 219 eclampsia cases 
were treated; compared to baseline, a similar incidence of 
eclampsia was seen but maternal mortality was significantly 
reduced 
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Timeframe, and 
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/ 
Incidence/ 
CFR 
 
Brief summary of methods/intervention 
Main findings/ limitations 
Conclusions/ 
Recommendations 
Six teaching 
hospitals in Nigeria 
 
Baseline: 
15.1% 
endline: 
3.2% 
Endline: clinical records of cases of 
eclampsia for one year after the intervention 
were reviewed and analyzed 
 Perinatal mortality rate reduced slightly, but the difference 
was not significant (141.5 per 1,000 at baseline, 129.8 per 
1,000 after intervention, p=0.32). 
 13.5% of newborns had low birthweight after the 
intervention 
 “Key message: building the capacity of healthcare providers 
to use magnesium sulfate for the treatment of eclampsia is 
an effective intervention for reducing the number of deaths 
due to eclampsia in low-income countries” 
Okusanya, B O, K D Garba, 
and H M Ibrahim. “The 
Efficacy of Intramuscular 
Loading Dose of MgSO4 in 
Severe Pre-Eclampsia/ 
Eclampsia at a Tertiary 
Referral Centre in 
Northwest Nigeria.” The 
Nigerian postgraduate 
medical journal 19.2 
(2012): 77–82. 
Descriptive 
comparative 
study 
Federal Medical 
Centre Katsina 
10g dose: 
April 1, 2008—April 
30, 2009 
14g dose: 
May 1, 2009—
October 25, 2009 
10g dose 54 women 
14g dose: 49 
women 
 
All women presenting with severe PE/E were 
prospectively enrolled during two periods; 
the first receiving a 10g loading dose of 
MgSO4 and the second period using a 14g 
loading dose.  
Severe PE: BP 116/110 mmHg and 
proteinuria of at least 2+ 
Eclampsia: occurrence of convulsions in 
women with severe PE 
 
 
 55 women had severe PE (25 were in 10g group. 30 in 14g 
group) 
 48 had eclampsia (29 in 10g group and 19 in 14g group) 
 Two (7%) of the women in the 10g group had recurrent 
convulsions and none who were in the 14g group 
experienced recurrent convulsions (difference is not 
significant). 
 Rates of vaginal delivery, onset of convulsion/recurrent 
convulsion, maternal death and neonatal Apgar score did 
not have statistically significant rates between the two 
groups. 
 10g IM loading dose prevented eclampsia in 80% of women 
with severe PE and prevented recurrent convulsions in 93% 
of women with eclampsia.  
 Using 10g did not increase chances of caesarean section or 
severe birth asphyxia at 5 minutes.  
 The six perinatal deaths observed were all in women in the 
10g groups, but these women were admitted with 
intrauterine fetal demise before treatment was delivered. 
 RCT is needed to confirm efficacy and safety of lower loading 
dose for potential use at lower level facilities. 
Onah, H., & Iloabachie, G. 
(2002). Conservative 
management of early-onset 
pre-eclampsia and 
fetomaternal outcome in 
Nigerians. Journal of 
Obstetrics and 
Gynaecology, 22(4), 357–
362. 
Prospective 
case control 
University of Nigeria 
Teaching Hospital, 
Enugu 
May 5, 2005—June 
30, 2000 
175 study group 
574 controls 
CFR 
among 
early 
onset: 
33.3% 
CFR 
among late 
onset: 
7.1% 
749 consecutive cases of PE were recruited. 
The early-onset cases (PE manifested before 
30 weeks gestation) formed the study group 
and the remaining cases were the controls. 
Demographic and obstetric details were 
recorded including gestational age at onset 
of disease as well as BP and urine test.  
After being admitted, patients were routinely 
tested for :full blood count, serum 
electrolytes, urea and creatinine, liver 
function tests, clotting profile, urinalysis and 
ultrasonography, they were put on bed rest, 
 ‘Pure’ PE: hypertension associated with proteinuria in 
previously normotensive women.  
 Superimposed PE: significant aggravation of preexisting 
hypertension associated with sustained proteinuria 
 Alpha-methyldopa and hydrallazine were used to control high 
BP above 160/110 mmHg (methyldopa was used 
antepartum and hydrallazine used to manage hypertensive 
crises, eclampsia and during peripartum).  
 Seizures were controlled using diazepam (MgSO4 was 
unavailable). 
 Early onset group experienced 14 maternal deaths (7 due to 
eclampsia, 3: renal failure, 2: HELLP syndrome, 1: 
anesthetic accident, 1: septicemia from AIDS) –80% of early 
onset group gained two weeks gestation. 
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given diazepam and anti-hypertensives as 
deemed necessary by the physician. 
 Causes of death in the late onset group were: eclampsia=7, 
renal failure=6, abruptio placentae=5, anesthesia-related 
causes=4, cerebrovascular accident=2, HELLP syndrome=2, 
associated diabetic ketoacidocis=1, septicaemia from 
AIDS=1 
 Based on the high CFR among early onset cases, the 
authors recommend that these cases be managed 
conservatively to improve fetal and maternal outcomes 
 
Tukur, J., Ahonsi, B., 
Ishaku, S. M., Araoyinbo, I., 
Okereke, E., & Babatunde, 
A. O. (2013). Maternal and 
fetal outcomes after 
introduction of magnesium 
sulphate for treatment of 
preeclampsia and 
eclampsia in selected 
secondary facilities: a low-
cost intervention. Maternal 
and Child Health Journal, 
17(7), 1191–1198. 
Before and 
after 
Kano, Bichi, Wudil, 
Gwarzo, Rano, 
Minjibir, Tudun 
Wada, Doguwa, 
Rano, Rogo 
February 1, 2008—
January 31, 2009 
 
 
baseline 
CFR: 
20.9% 
post 
interventio
n CFR: 
2.3% 
Five hospital officials from the Hospitals 
Management Board and one doctor and one 
midwife from each of the ten facilities were 
invited to participate in a training. The two-
day training provided didactic lectures on 
evidence-based management of 
hypertensive disorders of pregnancy and use 
of MgSO4. Participants were taught to 
administer 4g MgSO4 IV and 10g IM followed 
by 5g IM every 6 hours until 24 hours after 
delivery or the last seizure and also to 
monitor for toxicity by checking deep tendon 
knee reflex.   
Data was then collected on maternal 
sociodemographics, pattern of severe PE/E, 
and fetomaternal outcomes at the ten 
facilities and compared to baseline survey 
from three general hospitals 
 Baseline surveys showed that 1,233 patients with severe 
PE/E, 258 died : baseline CFR: 20.9% 
 25 master trainers participated in the training and 
subsequently trained 160 health workers (doctors, 
midwives, and community health extension workers) 
 During the project period, 49 cases of severe PE and 996 
cases of eclampsia were treated at the facilities out of a 
total of 22, 502 deliveries 
 322 cases of eclampsia manifested antepartum, 430 were 
intrapartum, and 244 developed postpartum 
 After the intervention, only 24 of the 1045 cases died, 
significantly reducing the CFR associated with severe PE/E. 
 Perinatal mortality was 12.3% (129 of 1045); perinatal 
mortality was significantly higher among patients who 
experienced three or more convulsions (there was no 
baseline perinatal mortality rate, but another facility that 
uses diazepam reported a 35.3% stillbirth rate). 
 Introducing MgSO4 for severe PE/E is a low-cost and 
replicable intervention that has a positive effect on maternal 
and fetal morbidity and mortality and should be scaled up. 
Tukur, J., Ogedengbe, C., 
Nwanchukwu, E., 
Araoyinbo, I. A., Yakasai, I. 
A., Adaji, S. E., & Ajala, B. 
(2011). Introduction of an 
innovation for the 
reduction of maternal 
mortality in Kano State, 
northern Nigeria: a case 
study of magnesium 
 
Kano State 
 
Feb—December 
2008 
 
1045 patients 
treated with MgSO4 
CFR: 2.3% 
MgSO4 was introduced to ten general 
hospitals and data was collected from the 
facilities to monitor the intervention. A 
workshop on MgSO4 use and monitoring was 
conducted and 25 master trainers took the 
knowledge they acquired and conducted 
step down trainings to 160 clinical 
providers.  
 
 60.4% of the patients treated with MgSO4 were primigravida 
and 44.1% had no form of ANC 
 23 women (2.2%) experienced toxic effects associated with 
MgSO4 but they were treated with calcium gluconate and no 
morbidity or mortality resulted 
 24 mothers died, and 129 (12.3%) of the babied were 
delivered dead 
 The 24 deaths in this study made up 4.9% of all maternal 
deaths during the 12 month period of the project 
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sulphate. Tropical Doctor, 
41(4), 197–200. 
Prior to these trainings, a pilot survey was 
conducted to assess the use of MgSO4 in 
general hospitals. Advocacy visits were then 
necessary to explain to health officials the 
evidence for the effectiveness of MgSO4.  
 Compared to maternal deaths due to eclampsia during the 
12 months prior to the intervention (268/567; 47.3%), the 
attributable deaths from eclampsia reduced by 42.4% 
 This project was successful because it was evidence-based, 
sustainable through stakeholder involvement, and 
replicable. 
Tukur, J., Umar, N. I., Khan, 
N., & Musa, D. (2007). 
Comparison of emergency 
caesarean section to 
misoprostol induction for 
the delivery of antepartum 
eclamptic patients: a pilot 
study. Nigerian Journal of 
Medicine : Journal of the 
National Association of 
Resident Doctors of 
Nigeria, 16(4), 364–367. 
 
Randomized 
pilot study 
 
Federal Medical 
Centre Azare, 
Bauchi  
 
 
50 eclamptic 
patients 
 
Primigravida patients with singleton 
pregnancies presenting with antepartum or 
imminent eclampsia and a closed cervical os 
were randomized for delivery by CS or by 
induced labor using misoprostol.  
 
 
 Misoprostol failure rate was 4 patients (16%); these four 
were subsequently delivered by CS. 
 The CS group spent an average 10.1 days in the center 
compared to 6.08 days spent on average in the center by 
the misoprostol group. 
 Maternal complications and admissions of babies were 
frequent in the CS group. 
 Maternal mortality in each group was 4%  
 Given the findings of this pilot study, the authors 
recommend using misoprostol (cheap, available, and safe 
for delivery of antepartum eclamptics) in the event of a delay 
for CS. A larger, multi-center study is also suggested.  
Ugwu, E. O. V, Dim, C. C., 
Okonkwo, C. D., & 
Nwankwo, T. O. (2011). 
Maternal and perinatal 
outcome of severe pre-
eclampsia in Enugu, 
Nigeria after introduction 
of Magnesium sulfate. 
Nigerian Journal of Clinical 
Practice, 14(4), 418–421. 
Retrospective 
case review 
Before-and-
after 
University of Nigeria 
Teaching Hospital 
Enugu  
January 1 2005—
December 31, 2008 
Diazepam: 47 
women 
MgSO4: 30 women 
Prevalence 
of severe 
PE: 3.3% 
 
CFR 
before: 
 
CFR after: 
This retrospective case review looked at 
cases of severe PE and the maternal and 
perinatal outcomes for two years before and 
two years after the introduction of MgSO4 as 
standard treatment for severe PE in 2007 
(previously diazepam). 
 77 cases of severe PE over the four year period; 49.4% were 
primigravidae 
 One woman from the diazepam group experienced tonic-
clonic seizures, none of the women in the MgSO4 group 
experienced seizures after the initiation of the treatment; no 
maternal death occurred in either group. 
 Women in the diazepam group were more likely to 
experience prolonged hospital stay compared to the MgSO4 
group. 
 25 of the 79 babies died within the perinatal period (2 sets 
of twins) giving a perinatal case fatality rate of 32.5%--but 
there was not a significant difference in perinatal mortality 
between the groups. 
 This study showed that MgSO4 is the most effective and 
safest drug to manage convulsions in severe PE and results 
in reduced maternal and perinatal morbidity when compared 
to diazepam. 
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Abubakar, A., Abdullahi, R., HZ, J., 
Dauda, M. H., & MA, P. (2009). 
Maternal Ethnicity and Severity of 
Pre-Eclampsia in Northern Nigeria. 
Asian Journal of Medical Sciences, 
1(3), 104–107. 
 
 
 
Primary Health 
Centers in Katsina, 
Adamawa and Borno 
States 
February—August 
2009 
61 cases of severe 
PE 
 
N/A 
Blood pressure measured and 
monitored. BMI calculated. Total serum 
cholesterol, triglyceride, high and low 
density lipoproteins were determined 
from a blood sample taken after 
overnight fasting. Urinalysis began. 
-22 in Group A (Hausa) 
-20 in Group B (Kanuri) 
-19 in Group C (Fulani) 
 No significant difference in the severity of 
pre-eclampsia between the Hausa and 
Kanuri, though they demonstrated 
elevated levels of triglyceride, serum 
cholesterol, pathological edema, increase 
in blood pressure, and higher levels of 
urine protein. 
 The Fulani group showed higher levels of 
the above and were more likely to 
progress to eclampsia than the other two 
tribes. 
Ademuyiwa, O., Odusoga, O. L., 
Adebawo, O. O., & Ugbaja, R. (2007). 
Endogenous antioxidant defences in 
plasma and erythrocytes of pregnant 
women during different trimesters of 
pregnancy. Acta Obstetricia et 
Gynecologica Scandinavica, 86(10), 
1175–1182.  
 
Case-Control 
Obstetrics 
Departments of 
Sacred Heart 
Hospital Abeokuta, 
Nigeria and Olabisi 
Onabanjo University 
Teaching Hospital, 
Sagamu Nigeria 
97 pregnant 
women, 7 with new 
onset of PE  
Controls (n=20) 
female students 
from University of 
Agriculture, 
Abeokuta, Nigeria 
and Olabisi 
 
Blood samples taken from all 
participants for exzymatic 
determinations. The study looked at: 
enzymic antioxidants (SOD, CAT, GST), 
non-enzymic antioxidant (GSH), and a 
heme biosynthetic enzyme, 
aminolevulinic acid dehydratase (ALAD) 
to determine characterize the profiles of 
antioxidant response in pregnant 
women. 
 This study showed an increased plasma 
activity of Mn-SOD and statistically 
significant low values of erythrocyte CAT, 
SOD and ALAD activities in PE compared 
to healthy pregnant women 
 Other antioxidants in plasma and 
erythrocytes remain unchanged 
 The data from this study supports 
hypothesis that ‘oxidative stress’ (OS) 
occurring secondary to impaired oxidant 
defenses, might be one mechanism 
underlying the pathophysiology of pre-
eclampsia (small sample size, needs 
further studies) 
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Onabanjo University, 
Ikenne, Nigeria. 
Adeyinka, D., Oladimeji, O., 
Adekanbi, T., Adeyinka, F., Falope, Y., 
& Aimakhu, C. (2010). Outcome of 
adolescent pregnancies in 
southwestern Nigeria: A case control 
study. Journal of Maternal-Fetal and 
Neonatal Medicine, 23(8), 785–
789.  
Retrospective 
case control 
University College 
Hospital, Ibadan, 
Nigeria 
January 2007—
November 2008 
45 cases, 
90 controls 
Incidence 
of PE/E 
among 
cases: 20% 
Incidence 
of PE/E 
among 
controls: 
3.33% 
Cases were women aged <18 years and 
controls were between 20 and 35 years 
 Defined pre-eclampsia as hypertension (> 
140/90mmHg on two occasions 4 hours 
apart) and proteinuria (>0.3g/dl) in the 
second half of pregnancy. Eclampsia = 
associated with convulsions, oliguria 
(>400ml/24h), increased tendon reflex, 
pain in the right hypochondriac region. 
 Adolescents were significantly more likely 
to develop PE/E than their non-adolescent 
counterparts. 
Adokiye, E., Isreal, J., C, H. T., & Levi, 
W. O. (2015). Factors influencing the 
prevalence of Preeclampsia-
eclampsia in booked and unbooked 
patients: 3 years retrospective study 
in NDUTH, Okolobiri. World Journal 
of Medicine and Medical Science, 
3(1), 1–14. 
Retrospective 
case review 
Department of 
Obstetrics and 
Gynaecology, Niger 
Delta University 
Teaching Hospital, 
Okolobiri, Nigeria 
January 1, 2011—
December 31, 2013 
1,667 deliveries 
Incidence 
of PE/E: 
5.69% 
Eclampsia 
only: 
2.16% 
Review of medical records for all 
pregnant women admitted and 
managed to delivery during the study 
period. 
 Seven (7.37%) of PE/E cases were 
teenagers, 48 (48.42%) were 20-29 
years, 40 (42.11%) were 30+ years old 
 89.5% live in rural areas 
 66.32% had either primary or post 
primary education 
 60% had more than two previous 
deliveries 
 Perinatal mortality was 36.84%; 41.05% 
were preterm deliveries (29-36 weeks) 
 77.68% were unbooked, 69.47% had 
visited TBAs 
 Proteinuria in PE/E patients: 3+ = 
30.53%; 2+= 40.00%; 1+ 27.37%; no 
proteinuria = 1.05% 
 85.79% treated with Pritchard regime for 
MgSO4 
 81.10% received Aldomet (Methyldopa); 
97.89% were given Hydralazine 
 21.05% were given diazepam 
Afolabi, B. B., Iwuala, N. C., Iwuala, I. 
C., & Ogedengbe, O. K. (2009). 
Morbidity and mortality in sickle cell 
pregnancies in Lagos, Nigeria: a 
case control study. Journal of 
Obstetrics and Gynaecology : The 
Journal of the Institute of Obstetrics 
and Gynaecology, 29(2), 104–106.  
Retrospective 
case control 
Department of 
Obstetrics and 
Gynaecology, Lagos 
University Teaching 
Hospital, Idi-Araba, 
Lagos, Nigeria 
 
 
Examination of delivery records for all 
pregnant HbSS women delivering during 
study period and the case notes of the 
next two delivering age-and parity-
matched HbAA women were retrieved. 
 Among HbAA women 5.6% developed PE 
and 1.3% developed eclampsia; among 
HbSS women, 6.7% developed PE and 
none developed eclampsia 
 This study did not find that HbSS women 
were at a higher risk of developing PE; the 
power of this study is not enough to make 
conclusions 
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January 1996—
December 2000 
 
75 women with 
HbSS and 150 
women with HbAA 
Airede, L., & Ekele, B. (2003). 
Adolescent maternal mortality in 
Sokoto, Nigeria. Journal of Obstetrics 
and Gynaecology, 23(2), 163–165. 
Retrospective, 
cross-sectional 
study 
Usmanu Danfodiyo 
University Teaching 
Hospital, Sokoto 
 
January 1990 to 
December 1999 
 
 
 
Information relating to age, parity, 
literacy level, booking status, duration 
and outcome of labour, mode of delivery 
and cause of death were obtained from 
casenotes and data were reviewed and 
analyzed 
 MMR 4863 per 100,000 livebirths 
 46 (23.4%) of all maternal deaths were 
adolescents (12-19 years old) 
 Eclampsia causes 21 (46%) of the 
adolescent maternal deaths 
Akerele, J., Abhulimen, P., & 
Okonofua, F. (2001). Prevalence of 
asymptomatic bacteriuria among 
pregnant women in Benin City, 
Nigeria. Journal of Obstetrics and 
Gynaecology, 21(2), 141–144. 
Semi-
quantitative 
screening 
ANC clinics in Benin 
City 
500 pregnant 
women 
N/A 
Semi-quantitative culture of midstream 
urine from pregnant women to screen 
for asymptomatic bacteriuria in first 
trimester. 
Samples with significant bacteriuria 
(105 or more bacteria per ml) were 
examined under the light microscope 
for: presence and number of red blood 
cells, white blood cells, epithelial cells, 
and casts. 
 “Rational therapy of asymptomatic 
bacteriuria in pregnant women may 
prevent associated risks such as 
pyelonephritis and pre-eclampsia.” 
 Of the 500 women screened, 433 
specimens showed significant bacteriuria. 
 
 [note: this study did not report the 
number of participants who developed 
PE/E)] 
Akiibinu, M. O., Kolawole, T. O., 
Ekun, O. A., & Akiibinu, S. O. (2013). 
Metabolic dysfunctions in Nigerian 
pre-eclamptics. Archives of 
Gynecology and Obstetrics, 288(5), 
1021–1026.  
Case-control 
 
 
32 pregnant women 
with pre-eclampsia 
(cases) 
5 months 
 
Pre-eclamptic women were recruited 
after 20 weeks. 
Total antioxidant potential (TAP), total 
plasma peroxides (TPP), total 
cholesterol (TC), total protein (TP), 
albumin, globulin, nitric oxide (NO), C-
reactive protein (CRP), total tri-
iodotyronine (TT3) and thyroid 
 Cases were defined as having 
hypertension (systolic BP = 169 + 26.0 
mmHg, diastolic = 102 + 11.0 mmHg), 
significant proteinuria (368 + 39 mg/24h, 
severe headache, abdominal pain and 
vomiting. 
 Weight, BMI, mean values of sBP, dBP 
urinary protein, TSH, T3-CHOL, TPP, OSI, 
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40 normal 
pregnancies 
(controls) 
stimulating hormone (TSH) were 
determined. 
Oxidative stress index (OSI) was 
calculated as the percent ratio of TPP 
and TAP. 
MDA and CRP in pre-eclamptics were 
significantly higher than in the controls. 
 Mean values of plasma TT3, albumin, TP 
TAP and NO were significantly lower 
among cases when compared with 
controls.  
 Globulin showed no significant difference 
between cases and controls 
 Results indicating that pre-eclamptics had 
hypothyroidism, hypercholesterolemia, 
oxidative stress and deranged 
inflammatory responses.  
 Conclusion: hypercholesterolemia, 
oxidative stress, deranged inflammatory 
responses and lower thyroid function are 
possible features of PE 
Akinloye, O., Oyewale, O. J., & 
Oguntibeju, O. O. (2010). Evaluation 
of trace elements in pregnant 
women with pre-eclampsia. AFRICAN 
JOURNAL OF BIOTECHNOLOGY, 
9(32), 5196–5202. 
 
Case control 
study* 
*the paper 
itself claims to 
be a ‘cross-
sectional 
randomized 
study’ 
Ladoke Akintola 
University of 
TechnologyTeaching 
Hospital, Osogbo, 
Osun State, Western 
Nigeria 
49 pre-eclamptic 
patients (cases) 
40 age-matched 
non pre-eclamptic 
women (controls) 
 
Blood collection was done using a 
sterile needle and syringe into 
appropriate tube, each sample was 
analyzed and zinc, copper, selenium, 
manganese and magnesium levels were 
determined  
 All elements evaluated (zinc, copper, 
selenium) were significantly lower in the 
PE group when compared to the control 
group.  
 Dietary supplementation of these 
elements may help prevent PE 
 Mean BMI, systolic blood pressure and 
diastolic blood pressure were all 
significantly higher among cases than 
controls 
 Mean serum concentrations of zinc, 
copper, selenium, manganese and 
magnesium were all significantly lower 
among cases than controls 
 Suggests that PE is associated with 
oxidative stress 
Anorlu, R. I., Iwuala, N. C., & Odum, 
C. U. (2005). Risk factors for pre-
eclampsia in Lagos, Nigeria. 
Australian and New Zealand Journal 
of Obstetrics and Gynaecology, 
45(4), 278–282 
Case-control  
Lagos University 
Teaching Hospital  
February 2001 to 
August 2002 
1803 women who 
delivered during 
study period 
137 of 
1803 had 
PE/E (128 
were 
analyzed)  
Incidence: 
7.6% 
Socio-demographic characteristics, pre-
pregnancy weight, medical history and 
previous obstetric history, and level of 
stress at home and at work was 
collected during face-to-face interviews 
 91 (71.1%) were primigravidae 
 Risk factors associated with increased 
risk of pre-eclampsia were: nulliparity (OR 
4.77; 95% CI 2.90–7.78), stressful work 
during pregnancy (OR 2.10; 95% CI 1.20–
3.71), stressful home environment (OR 
1.97; 95% CI 1.27–3.69), previous pre-
eclampsia (OR 11.68; CI 3.81–37.61), 
history of chronic hypertension (OR 2.21; 
95% CI 1.17–6.20), a body weight greater 
than 80 kg (OR 2.01; 95% CI 1.05– 3.87); 
and multiple pregnancy (OR 2.71; 95% CI 
1.27—6.13) 
 41 
 
Citation Study Design 
Location, 
Timeframe, and 
Sample size 
Prevalence
/ 
Incidence/ 
CFR 
Brief summary of Methods 
Main findings/ limitations 
Conclusions/ 
Recommendations 
Arinola, G., Arowojolu, A., Bamgboye, 
A., Akinwale, A., & Adeniyi, A. (2006). 
Serum concentrations of 
immunoglobulins and acute phase 
proteins in Nigerian women with 
preeclampsia. Reproductive Biology, 
6(3), 265–27 
 
Obstetrics and 
Gynaecology Clinic 
of the University 
College Hospital, 
Ibadan, Oyo State, 
Nigeria 
92 women 15-30 
years old 
 
Participants divided into three groups: 
--32 pregnant women in 3rd trimester 
with preeclampsia 
--36 pregnant women in 3rd trimester 
without preeclampsia 
--24 non-pregnant women with no 
history of abortion as controls 
Blood and urine samples were taken 
and analyzed for: immunoglobulin 
classes (IgA, IgG, and IgM) and acute 
phase proteins (alpha-2-macroglobulin, 
haptoglobin and transferrin). 
Mean of two readings for each 
specimen were taken as actual value 
 Diagnosis of PE was done based on: 
significant proteinuria (>100mg/day) and 
high blood pressure (>130/90 mmHg) on 
at least two occasions 6 hours apart or 
more.  
 Mean level of IgG was significantly lower 
in subjects with preeclampsia and 
significantly higher in patients with normal 
pregnancy when compared to non-
pregnant controls. 
 Mean level of IgA was significantly 
reduced in pre-eclamptic subjects vs. 
controls 
 Mean levels of transferrin and alpha-2-
macroglobulin were significantly lower 
and among PE group compared with other 
two groups. 
 Haptoglobin was significantly higher in 
women with PE compared to normal 
pregnancy, but both pregnant groups had 
lower levels compared with non-pregnant 
women. 
Atiba, A. S., Abbiyesuku, F. M., 
’Niran-atiba, T. A., Oparinde, D. P., 
Ajose, O. A., & Akindele, R. A. (2014). 
Free radical attack on membrane 
lipid and antioxidant vitamins in the 
course of pre-eclamptic pregnancy. 
Ethiopian Journal of Health 
Sciences, 24(1), 35–42. 
Longitudinal 
prospective 
cohort 
Ladoke Akintola 
University of 
Technology 
Teaching Hospital, 
Osogbo and 
Egbedore Local 
Government Health 
Centre, Awo, Osun 
state, Nigeria 
May 2011–January 
2012 
118 pre-eclamptic 
and 115 apparently 
normal pregnant 
women were 
recruited 
 
100 women for each of the three study 
groups (PE, normal pregnancy (NP), 
nonpregnant (NoP)) participated in 
baseline and follow up eight weeks 
later. 
Venous blood was collected from 
pregnant participants and nonpregnant 
controls. Plasma was separated and 
used for malondialdehyde (MDA) and 
vitamins C and E analysis. 
 Pre-eclamptic women were defined as 
having elevated BP of 140/90 mmHg on 
two consecutive recordings 4 to 6 hours 
apart, minimum proteinuria of 300gm in 
24 hour urine sample or 1+ on dipstick.  
 Highest levels of MDA were in PE patients 
and lowest in NoP patients; MDA among 
PE patients was also higher than NP 
during the second and third trimesters. 
 No change in plasma levels of vitamins C 
and E was found as pregnancy advances 
 Studies needed to identify the specific 
antioxidant to counteract lipid 
peroxidation (free radical injury) which 
may help reduce PE. 
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Age matched non 
pregnant women 
Attahir, A., Sufiyan, M. B., Salihu, A., 
& Rabiu,  a M. (2010). Association 
between Maternal Socio – economic 
Status , Polygamy and Risk of Pre – 
eclampsia in Rural Areas of Northern 
Nigeria. Journal of Family and 
Reproductive Health, 4(1), 47–52. 
 
Case control 
Primary Health 
Centers in Katsina, 
Adamawa and Borno 
states 
Two groups of 50 
each: 
A--Pregnant non-
hypertensive women 
B—women with pre-
eclampsia  
 
BP was measured and questionnaire 
was administered to each patient to 
assess the association between various 
social factors and risk of PE 
 If PE progresses to eclampsia, 
characterized by malignant hypertension 
and epileptiform convulsions, caesarian 
section is required. 
 Known risk factors: nulliparity, history of 
pre–eclampsia in previous pregnancy, 
extremes of maternal age, multi fetal 
gestation, chronic hypertension, diabetes 
mellitus, chronic kidney disease, vascular 
or connective tissue disease, 
thrombophilia, high Body Mass Index 
(BMI), and obesity. 
 Family history of hypertension, diabetes or 
kidney disease was more common among 
women with PE 
 Seclusion and polygamy were not found to 
have an effect on risk of developing PE 
 The women with PE were more likely to be 
uneducated, lack income, which could 
lead to low ANC attendance among this 
population 
Awodu, O. A., Shokunbi, W. A., & 
Ejele, O. A. (2003). Lupus 
anticoagulant in Nigerian women 
with preeclampsia. West African 
Journal of Medicine, 22(3), 240–
242. 
Case control 
University of Benin 
Teaching Hospital 
26 pregnant 
women, 18-45 years 
old with PE 
50 apparently 
healthy pregnant 
women, 18-45 years 
old 
 
Blood samples were collected and 
platelet poor plasma was prepared and 
preserved for testing/analysis. 
Kaolin clotting time (KCT) was done to 
test coagulation 
Lupus anticoagulant was determined to 
be present if the KCT ratio at 20% test 
plasma to KCT at 100% normal control 
plasma >  1.2 
 This study found 15.4% prevalence of 
lupus anticoagulant in women with PE 
which is statistically higher than the 
prevalence of LA in apparently healthy 
pregnancies. (it is controversial as to 
whether LA presence is causal or 
consequence of clinical manifestations 
with which it has been associated) 
 This study recommends that LA in PE in 
Nigeria is significant and all women 
should be screened for LA. 
Chigbu, C. O., Okezie, O. A., & Odugu, 
B. U. (2009). Women in southern 
Nigeria with change in paternity do 
not have increased incidence of pre-
eclampsia. Journal of Obstetrics and 
Gynaecology : The Journal of the 
Institute of Obstetrics and 
Prospective 
cohort 
Catholic Maternity 
Hospital, Moniaya, 
Ogoja, Cross River 
State, Nigeria 
September 2006—
August 2007 
 
Women attending ANC clinic of the 
hospital for their second pregnancy 
were recruited, sociodemographic and 
obstetric data was collected including 
paternity of index and previous 
pregnancies, outcome of previous 
 The “exposure” for this cohort study was 
change in paternity 
 PE was defined as hypertension 
(>140/90 mmHg on at least two 
occasions at least 6h apart or dBP of 
110mmHg at any time or an increase of 
30mmHg and 15mmHg in sBP and dBP 
respectively or mean arterial pressure of 
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Gynaecology, 29(2), 94–97.  779 women were 
recruited and 732 
were included in the 
final analysis due to 
loss to follow up 
pregnancy and duration of sexual 
cohabitation with present partner. 
 
Urine protein was measured using 
dipstick testing and ANC follow up was 
every four weeks until 28 weeks 
gestation and every two weeks after that 
until 37 weeks.  
greater than 105 mmHg) with proteinuria 
after 20 weeks of pregnancy 
 312 (group A) had change in paternity; 
420  had no change in paternity (group B) 
 The rate of PE was not significantly 
different between the two groups, within 
Group A, duration of cohabitation did not 
show significant difference between those 
who developed PE and those who did not. 
 “the findings of this study call for a re-
examination of the ‘change in paternity 
theory of pre-eclampsia’” 
Enaruna, N., Ande, A., & Okpere, E. 
(2013). Clinical significance of low 
serum magnesium in pregnant 
women attending the University of 
Benin Teaching Hospital. Nigerian 
Journal of Clinical Practice, 16(4), 
448–53.  
Prospective 
cohort 
University of Benin 
Teaching Hospital, 
Benin City 
June—December 
2011 
160 patients  
 
Participants (included antenatal women 
recruited in 2nd trimester and followed 
up until 1 week postpartum) had blood 
drawn at recruitment to measure serum 
magnesium and were followed up until 
delivery when repeat serum magnesium 
assay was done 
 Primary outcome measure was 
prevalence of hypomagnesemia in 
pregnancy 
 Magnesium deficiency was detected in 
16.25% of the patients and was 
significantly correlated with occurrence of 
PE, leg cramps, and preterm birth.  
 Recommends magnesium 
supplementation (or eating magnesium-
rich diet) 
Familoni, O. B., Adefuye, P. O., & 
Olunuga, T. O. (2004). Pattern and 
factors affecting the outcome of 
pregnancy in hypertensive patients. 
Journal of the National Medical 
Association, 96(12), 1626–1631. 
 
Retrospective 
cohort 
Olabisi Onabanjo 
University Teaching 
Hospital, Sagamu 
 
January 1997—
December 2002 
 
2,393 deliveries 
HDP 
incidence: 
5.3% 
Medical records of pregnant patients 
were analyzed, 127 were identified as 
having a hypertensive disorder of 
pregnancy (HDP). 
 
Based on hypertension type, patients 
were categories as “high-risk” or “low-
risk” the groups were compared 
 26.2% had gestational hypertension, 
19.7% had pre-eclampsia superimposed 
on chronic hypertension and 54.1% had 
PE/E.  
 Those with PE/E had the worst maternal 
and fetal outcomes (6.1% maternal 
mortality, 18.2% target organ damage, 
36.4% fetal mortality, 66.7% fetal 
respiratory distress) 
 62 (50.8%) were high-risk and 60 (49.2% 
were low-risk 
 High-risk group had higher rates of: 
illiteracy, maternal death, stroke, 
abruptio, fetal death, and caesarean 
section and lower rates of regular ANC. 
 Parity had no effect on whether the 
patient was high- or low-risk 
  
Glew, R. H., Cole, D. M., Mehla, G. S., 
El-Nafaty, A. U., Crossey, M. J., 
Case control Federal Medical 
Centre, Gombe and 
N/A Pregnant women were placed into one 
of four groups: Group 1: PE; Group 2: 
 PE was defined as BP 140/90 mmHg or 
greater and proteinuria (>190mg/g 
creatinine) 
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Tzamaloukas, A., & VanderJagt, D. J. 
(2005). Lysosomal enzymes in 
preeclamptic women in northern 
Nigeria. Clinica Chimica Acta; 
International Journal of Clinical 
Chemistry, 353(1-2), 95–101.  
 
 
Specialist Hospital, 
Gombe 
June-August 2001 
Group 1: 41 women 
Group 2: 31 women 
Group 3: 44 women 
Group 4: 52 women 
hypertensive aproteinuric; group 
3:normotensive proteinuric; group 4: 
healthy pregnant women (controls) 
Urine specimens were collected and 
underwent biochemical analyses. 
Results were statistically analyzed  
 The goal was to assess whether lysosomal 
enzyme concentrations in women with PE 
were due to the hypertension or 
proteinuria, or both. 
 This study found that low levels of β-
hexosaminidase in pre-eclamptic women 
is associated with proteinuria and not 
hypertension; it is not likely, therefore, 
that screening for lysosomal enzymes 
would be useful in predicting or 
monitoring PE.  
Glew, R. H., Melah, G., El-Nafaty, A. 
I., Brandt, Y., Morris, D., & 
VanderJagt, D. J. (2004). Plasma 
and urinary free amino acid 
concentrations in preeclamptic 
women in northern Nigeria. Clinica 
Chimica Acta; International Journal 
of Clinical Chemistry, 342(1-2), 
179–185.  
 
Case control 
Federal Medical 
Centre, Gombe and 
Specialist Hospital, 
Gombe 
37 pre-eclamptic 
women 
16 controls 
 
Urine and blood samples were taken 
and analyzed for amino acids. 
Statistical analyses were performed to 
compare variables between patients 
with PE and controls 
 Defined “pre-eclamptic” as: cerebral or 
visual disturbances, epigastric pain, 
pulmonary edema or cyanosis, sBP > 
140mmHg or dBP >90 mmHg and 
proteinuria (190mg total protein/g 
creatinine or more) 
 Serum concentrations of common amino 
acids (including serum arginine) were not 
significantly different between study 
groups, except phenylalanine. 
 Phenylalanine concentration was 
significantly higher among PE group 
Guerrier, G., Oluyide, B., Keramarou, 
M., & Grais, R. F. (2013). Factors 
associated with severe preeclampsia 
and eclampsia in Jahun, Nigeria. 
International Journal of Women’s 
Health, 5(1), 509–513.  
Hospital-based 
case control 
study 
Jahun Hospital 
October 2010—May 
2011 
2,835 pregnant 
women 
1,257: normal 
pregnancy (controls) 
419: Severe PE/E 
(cases) 
 
16% had 
severe 
PE/E (175: 
severe PE, 
and 244: 
eclampsia) 
Participants were selected from the 
emergency obstetric program in the 
rural Jahun hospital, patients were 
interviewed and gave demographic 
information, medical history, social 
history, current history, use of traditional 
treatments, delivery details and 
neonatal outcome. 
 Eclampsia is the occurrence of seizure 
and/or altered level of consciousness not 
caused by epilepsy or other convulsive 
disorders, with signs of severe 
preeclampsia. 
 Severe PE : new hypertension with blood 
pressure of 160 mmHg systolic or 
diastolic BP of 110 mmHg or greater, 
after 20 weeks of gestation in a woman 
who was normotensive before 20 weeks, 
associated with proteinuria 
 Of 244 eclamptic cases, 194 were ante- 
and intra-partum, and 50 were admitted 
postpartum; 11% experienced no signs of 
severe hypertension (headache, blurred 
vision) 
 The groups were similar except for: the 
cases were younger (mean age 21 vs 
mean age 25 among controls), a higher 
 45 
 
Citation Study Design 
Location, 
Timeframe, and 
Sample size 
Prevalence
/ 
Incidence/ 
CFR 
Brief summary of Methods 
Main findings/ limitations 
Conclusions/ 
Recommendations 
proportion attended fewer than four ANC 
visits (79% vs 73%) 
 63% used traditional treatments during 
their pregnancy (herbal medicines to treat 
bleeding, ease abdominal pain, or for 
rupture of the amniotic sac) 
 Cases were statistically more likely to 
have cesarean section, longer hospital 
stay, stillbirth or neonatal death. 
 Use of herbal treatment was not found to 
increase the risk of developing severe 
PE/E. 
Idogun, E. S., Imarengiaye, C. O., & 
Momoh, S. M. (2007). Extracellular 
calcium and magnesium in 
preeclampsia and eclampsia. 
African Journal of Reproductive 
Health, 11(2), 89–94. 
 
Cross sectional 
University of Benin 
Teaching Hospital, 
Nigeria 
11 patients  
23 controls,  
N/A 
Patients were randomly selected from 
among hospital attendees, “patients” 
were women presenting with PE (or 
PE/E) in their third trimester who were 
going for caesarean section; those on 
MgSO4 and calcium lactate drugs were 
excluded. Controls were normotensive 
pregnant women, also going for CS. 
Blood was taken from participants, and 
plasma was harvested and analyzed for 
calcium, magnesium and electrolyte and 
urea estimations; cerebrospinal fluid 
(CSF) was taken during lumbar puncture 
for spinal anaesthesia and calcium and 
magnesium estimations were made. 
 Plasma calcium was significantly higher in 
controls vs. patients but there was no 
significant difference between groups for 
plasma magnesium levels.  
 Calcium CSF and magnesium CSF were 
significantly lower in patients than in 
controls  
 Lower levels of magnesium and calcium 
may have an effect on PE/E 
Ikechukwu, I. C., Ojareva, O. I. A., 
Ibhagbemien, A. J., Okhoaretor, O. F., 
Oluwatomi, O. B., Akhalufo, O. S., … 
Chigaekwu, M. N. (2012). Blood 
lead, calcium, and phosphorus in 
women with preeclampsia in Edo 
State, Nigeria. Archives of 
Environmental & Occupational 
Health, 67(3), 163–169. 
Cohort 
Irrua Specialist 
Teaching Hospital 
Irrua, Edo State, 
Nigeria 
 
November 2006—
September 2008 
 
Women aged 20-35 attending ANC clinic 
at the hospital. Women with history of 
any chronic disease and glycosuria were 
excluded. 
 
Medical histories were taken and 
recorded in duplicate by doctors who 
were unaware of the goal of the study.  
 PE was defined as SBP > 140 mmHG 
and/or DBP > 90 mmHg and proteinuria 
during at least two visits after 22nd week 
of gestation. 
 150 normal pregnant women and 59 with 
preeclampsia 
 Blood lead levels were significantly higher 
in women with PE than normal pregnant 
women and serum calcium and inorganic 
phosphorus were significantly lower than 
in normal pregnant women. 
 A possible explanation for the increase in 
blood lead in PE women vs normal 
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283 pregnant 
women, 74 excluded 
for noncompliance 
209 nonpregnant 
controls 
 
BP was measured, protein and sugar 
levels tested in urine. Blood samples 
were taken from each participant at 
delivery and analyzed for calcium and 
phosphorus determination and blood 
lead determination.  
pregnant women is a possible increase in 
maternal bone lead mobilization. 
 Elevated blood lead levels may contribute 
to the development of PE 
Ikpen, M. A., Eigbefoh, J., Eifediyi, R. 
A., Isabu, P. A., Okogbenin, S., 
Okogbo, F. O., … Ekwedigwe, K. C. 
(2012). Determination of antioxidant 
status of pre-eclamptic and 
normotensive sub-rural Nigerian 
pregnant women at the Irrua 
Specialist Teaching Hospital, Irrua, 
Edo State. The Journal of Maternal-
Fetal & Neonatal Medicine, 25(10), 
2046–2050. 
prospective 
case—control 
study 
 
 
 
 
Antenatal clinics, 
antenatal and 
labour wards, 
Accident and 
Emergency unit of 
Irrua Specialist 
Teaching Hosptal, 
Irrua, Edo State. 
 
 
 
Eighty cases and 80 matched controls 
were recruited into the study.  
Cases: booked pregnant women with PE  
Controls: gestational age and parity 
matched normotensive pregnant women 
Blood samples were taken from all 
participants and analyzed for vitamins C 
and E.  
 Two consecutive BP measurements of 
>140.90 mmHg 4 hours apart after 20th 
week and significant proteinuria (>2+) or 
1+ if the specific gravity was < 1.030 and 
pH was <8. 
 Plasma vitamin C and E levels were 
significantly lower in cases than in 
controls. 
 Role of antioxidants in pathogenesis of PE 
is inconclusive, but may be an opportunity 
to prevent PE 
Isezuo, S. A., & Ekele, B. A. (2004). 
Eclampsia and abnormal QTc. West 
African Journal of Medicine, 23(2), 
123–127. 
 
Prospective 
case control 
Usman Danfodiyo 
University Teaching 
Hospital, Sokoto, 
Nigeria 
August 2001 and 
July 2002 
30 patients 
 
30 consecutive patients with 
intrapartum eclampsia were included in 
the study.  
General information was obtained as 
well as medical history. BP was 
measured three times at rest and the 
average of the last two were taken as 
the BP. 
Electrocardiogram (ECG) was recorded 
during the intrapartum period to 
measure QT interval 
 Eclampsia is characterized by generalized 
convulsion, elevated BP and proteinuria 
with or without oedema occurring after 20 
weeks gestation. 
 QT interval is the “total time from the 
onset of ventricular depolarization to the 
completion of repolarization”  
 Cases had higher mean heart rate, higher 
frequency of sinus tachycardia and 
significantly higher QTc.  
 This study found that eclampsia is 
associated with hypocalcaemia, abnormal 
QTc and T-axis deviation; serum 
magnesium did not differ significantly 
between study groups 
Leone, S., Res, J. B., No, V., O, O. V., 
S, A. A., Adewumi, A., & Olalekan, A. 
(2009). Homocysteine Levels in 
Nigerian Women with Pre-eclampsia 
/ Eclampsia. Sierra Leone Journal of 
Biomedical Research, 1(1), 55–60. 
Case control 
 
 
 
Lagos University 
Teaching Hospital, 
Idi-Araba 
January—October 
2006 
 
“all participants were to strictly maintain 
the drug regimen prescribed for routine 
antenatal use only” 
Venous blood was collected and plasma 
levels of homocysteine were determined 
 Rising homocysteine level in eclamptics 
was significantly associated with blood 
pressure levels.  
 Plasma homocysteine levels in the 3rd 
trimester of pregnancy is significantly 
higher among eclamptic women than 
those who have a normal pregnancy. 
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100 primigravidae 
women (60 lost to 
follow up, or 
incomplete data) 
25 eclamptic 
women 
25 non pregnant 
women 
at registration, at 26 weeks and at 34 
weeks gestation for all participants.  
 Mean corpuscular volume, plasma 
homocysteine level and rising blood 
pressure during pregnancy may help 
predict development of PE/E. 
Nwobodo, E. I., Panti, A., & A, N. E. P. 
(2012). Adolescent maternal 
mortality in North-west Nigeria. West 
African Journal of Medicine, 31(4), 
224–226. 
Review of 
hospital case 
records 
Usmanu Danfodiyo 
University Teaching 
Hospital (UDUTH), 
Sokoto 
January 2000—
December 2009 
2,047 live births 
among adolescents 
 
Case reports of live births for women 
15-19 years old were collected and 
reviewed. Demographic and other 
health data were extracted and 
analyzed. 
 165 maternal deaths among adolescent 
mothers: MMR = 5415 per 100,000 live 
births 
 Main cause of death was eclampsia: 
53.9% 
 ANC allows for early detection of PIH 
which can prevent the progression to 
eclampsia 
Okafor, U. V, & Ezegwui, H. U. 
(2010). Cesarean delivery in 
preeclampsia and seasonal variation 
in a tropical rainforest belt. Journal 
of Postgraduate Medicine, 56(1), 
21–23.  
 
Retrospective 
record review 
University of Nigeria 
Teaching Hospital, 
Enugu 
July 1996—June 
2006 
6798 deliveries, 
1579 CS deliveries 
196 had toxemia of 
pregnancy (166: PE 
and 30: eclampsia) 
 
Records for patients presenting for CS 
with PE/E during rainy and dry seasons 
were reviewed, and demographics and 
obstetric history and outcome were 
extracted and analyzed. 
 The primary objective of this study was to 
assess whether or not seasonality in a 
tropical rainforest belt had an effect on 
the presentation of preeclamptics 
undergoing cesarean section. 
 Among preeclampsia, 115 had CS during 
rainy season, 52 during dry season. 
 Among those with eclampsia, 26 
presented during rainy season and 4 
during dry season  
 This study found a “systemic seasonal 
variability in the need for cesarean 
delivery for preeclamptics with a peak 
during the rainy season”  
Olayemi, O., Strobino, D., Adedapo, 
K., Aimakhu, C., Odukogbe, A.-T., & 
Salako, B. (2010). Influence of 
previous abortions and new 
paternity on the risk of hypertension 
in nulliparous parturients in Ibadan: 
Prospective 
cohort 
University College 
Hospital (UCH) and 
Adeoyo Maternity 
Hospital (AMH), 
Ibadan 
Hypertensi
on in 
pregnancy 
incidence: 
33% 
Nulliparous women were recruited 
before 20 weeks gestation. For the 
baseline data, participants were 
interviewed about: sociobiological 
variables, history of previous abortions, 
sexual history, and family history of 
 At AMH, 76.5% of the participants 
reported a prior abortion, but only 20.4% 
reported same paternity abortion 
 At UCH, 64.9% reported prior abortion, 
and 31.5% reported same paternity 
abortion 
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a cohort study. The Journal of 
Obstetrics and Gynaecology 
Research, 36(5), 965–969. 
2000 patients 
(1000 at each site) 
hypertension and BP and urine protein 
were also measured. 
Within 48 hours of delivering the final 
interview was conducted, BP measured 
and urine tested. 
 “There was no statistical difference in the 
incidence of hypertension among 
participants with previous abortion (32.98 
vs 33.10 P=0.962)” 
 Nor was there a statistical difference in 
the development of hypertension 
regarding change in paternity; 30.12% of 
women reporting same paternity 
abortions and 34.10% without same 
paternity abortions developed 
hypertension (p=0.164) 
 The authors suggest researching 
presentation of human leukocyte antigen 
(HLA) from semen prior to conception to 
reduce incidence of eclampsia. 
Olayemi, O., Strobino, D., Aimakhu, 
C., Adedapo, K., Kehinde, A., 
Odukogbe, A.-T., & Salako, B. 
(2010). Influence of duration of 
sexual cohabitation on the risk of 
hypertension in nulliparous 
parturients in Ibadan: A cohort study. 
The Australian & New Zealand 
Journal of Obstetrics & Gynaecology, 
50(1), 40–44. 
Prospective 
cohort 
University College 
Hospital (UCH) and 
Adeoyo Maternity 
Hospital (AMH),  and 
Oluyoro Catholic 
Hospital (OCHH), 
Ibadan 
AMH: 900 women 
UCH: 950 women 
OCH: 780 
Gestational 
hypertensi
on 
incidence: 
28.93% 
PE 
incidence 
4.13% 
Nulliparous women were recruited 
before 20 weeks gestation. For the 
baseline data, participants were 
interviewed about: sociobiological 
variables, history of previous abortions, 
sexual history, and family history of 
hypertension and BP and urine protein 
were also measured. 
Within 48 hours of delivering the final 
interview was conducted, BP measured 
and urine tested. 
 29.64% reported having had previous 
abortion, and 25.92% were same 
paternity abortions 
 This study found that incidence of 
hypertension was higher among those 
who had had abortions (29.40%) than 
those who had not (28.52%) 
 Change in paternity did not have a 
significant impact on incidence of 
hypertension 
 Multivariate analysis found that length of 
sexual cohabitation was protective 
against hypertension (4% decline in risk of 
developing hypertension for every month 
increase in cohabitation). 
 This multivariate model controlling for 
age, BMI, educational attainment and 
family history of hypertension found that 
same paternity abortions were protective 
(HR 0.46, CI 0.22—0.96) but previous 
abortion alone was not. 
 The early timing of previous abortions 
(first trimester) would account for no 
observe protective feature of abortions in 
this study (when other studies have 
shown abortions to be protective 
Olusanya, B. O. (2011). Perinatal 
outcomes of multiple births in 
southwest Nigeria. Journal of Health, 
Retrospective 
cross-sectional 
review of 
Island Maternity 
Hospital, Lagos 
 Participants were included in this study 
from a prospectively recruited cohort of 
 This study’s primary objective was 
determine perinatal outcomes that may 
influence neurodevelopment adversely 
among multiple gestations; the relevance 
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Population, and Nutrition, 29(6), 
639–647. 
hospital 
records 
May 2005—
December 2007 
newborns under a separate program on 
universal newborn hearing screening.  
This study defined “hypertensive 
disorders” as pre-eclampsia, eclampsia 
and pregnancy-induced hypertension 
for our study is that Olusanya’s study 
indicated that multiple gestation is 
associated with an increased risk of 
hypertensive disorders. 
 This study found that mothers with 
multiple gestations (twins or triplets in 
this case, no higher-order births occurred 
during the study period) were significantly 
more likely to have had hypertensive 
disorders. 
 268/4,416 (6%) of singleton births were 
associated with hypertensive disorders 
compared to: 26/157 (16.5%) multiple 
gestations  
Onah, H. (2002). Prognostic value of 
absolute versus relative rise of blood 
pressure in pregnancy. African 
Journal of Reproductive Health, 6(1), 
32–40. 
cohort 
Department of 
Obstetrics and 
Gynaecology, 
University of Nigeria 
Teaching Hospital, 
Enugu 
December 17, 
1997—March 31, 
1999 
515 women (7% 
incomplete: 478 
participants) 
 
Longitudinal measurement of BP, 
anthropometric data and MMR in study 
population (heathy ANC subjects). 
Participants were recruited prior to 16 
weeks gestation. Fundal height, weight, 
height, BP, and presence or absence of 
proteinuria were recorded 
Participants were categorized into 
groups: 
A: relative diastolic blood pressure 
(DBP) rise from the averaged 16-20 
weeks readings until delivery < 
15mmHg and absolute DBP<90mmHg 
B: relative DBP rise > 15mmHg and 
absolute DBP < 90mmHg 
C: absolute DBP> 90mmHg no matter 
the relative rise in BP 
Analysis was also done with groups 
based on systolic BP (using 140mmHg 
as the threshold rate and 30mmHg as 
the relative rise amount) 
 478 of the 515 women completed the 
study. 
 Diagnosing hypertension from a relative 
rise in DBP of 15mmHg included 48% of 
subjects who had normal pregnancies. 
These relative rises in BP could indicate 
that closer surveillance is required. 
 This study found that maternal and fetal 
outcomes were not significantly affected 
by the relative rise in DBP (as long as DBP 
<90mmHg) 
 Strict eligibility criteria meant many were 
excluded (women booked after 16 weeks, 
delivered preterm, etc) 
 The data in this study suggest that 
absolute blood pressure (140/90 mmHg) 
is a better predictor of feto-maternal 
outcome than relative rise measurements 
in systolic or diastolic pressures.  
  
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Osungbade, K., Oginni, S., Olumide, 
A., K, O., Oginni, S., & Olumide, A. 
(2008). Content of antenatal care 
services in secondary health care 
facilities in Nigeria: implication for 
quality of maternal health care. 
INTERNATIONAL JOURNAL FOR 
QUALITY IN HEALTH CARE, 20(5), 
346–351.  
Cross-sectional 
Osun state 
N/A 
390 ANC clients 
 
Antenatal care exit interview forms from 
the Safe Motherhood Needs 
Assessment package was used to 
collect information from 390 pregnant 
women leaving ANC visits. 
 All of the women in this study had their 
blood pressure checked which is an 
important screening tool for detecting 
hypertension and toxaemia (now called 
PE) 
 At the hospitals, 48.6% of the 284 women 
and 28.3% of 106 at Health Centers had 
their urine checked for protein levels 
 This study concluded that the screening 
services and care were reasonably 
capable of addressing pre-eclampsia and 
early detection of some fetal problems but 
they were insufficient for detecting long-
standing pre-eclampsia and other 
conditions (detecting and treating severe 
anemia and preventing complications of 
malaria in pregnancy). 
Owolabi, A., AO, F., Kuti, O., Adeyemi, 
A., Faturoti, S., & Obiajuwa, P. 
(2008). Maternal complications and 
perinatal outcomes in booked and 
unbooked Nigerian mothers. 
Singapore Medical Journal, 49(7), 
526–531. 
Prospective 
case control 
Wesley Guild 
Hospital Unit, Ilesa, 
Nigeria (Obafemi 
Awolowo University 
Teaching Hospitals 
Complex) 
August 2004—May 
2006 
1,154 deliveries 
 
Outcomes of pregnancies booked for 
ANC were compared to outcomes of 
women who were unbooked 
 29% (n=336) were unbooked 
 Unbooked mothers were more likely to be 
younger, unmarried, have lower education 
and social status, higher proportion of 
multipara, experience antepartum 
haemorrhage, anemia and PE/E 
 7.9% of unbooked women developed 
PE/E compared to 2.1% of booked 
mothers (OR 1.71, 1.15—2.55) 
Salako, B. L., Olayemi, O., Odukogbe, 
A.-T. A., Adedapo, K. S., Aimakhu, C. 
O., Alu, F. E., & Ola, B. (2003). 
Microalbuminuria in pregnancy as a 
predictor of preeclampsia and 
eclampsia. West African Journal of 
Medicine, 22(4), 295–300. 
Cohort 
University College 
Hospital (UCH) 
Ibadan 
93 healthy 
normotensive 
pregnant women ( 
 
During initial booking, BP and urinalysis 
was conducted and 100 women who 
were normotensive were recruited and 
had urinalysis completed. 
PE: BP of 140/90 mmHg or more or a 
rise of 30mmHg in systolic BP or 
15mmHg in diastolic BP (measured two 
times, six hours apart, at rest) 
associated with proteinuria. 
 Ninety-three delivered at UCH, two had 
spontaneous abortion and five delivered 
elsewhere. 
 At booking 61.3% (57 patients) had 
normal albumin excretion and 22 (23.7%) 
had microalbuminuria and 12 (15%) had 
gross microalbuminuria.  
 This study found that there was a 
statistically significant difference in 
incidence of PE with an increase in 
albumin excretion.  
 Microabuminuria was found to predict 
preeclampsia with high sensitivity but with 
low positive predictive value 
(overestimated the number of cases) 
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Salako, B., Odukogbe, A., Olayemi, 
O., Adedapo, K., & Aimakhu, C. 
(2003). Serum albumin, creatinine, 
uric acid and hypertensive disorders 
of pregnancy. East African Medical 
Journal, 80(8), 424–428. 
Cohort 
University College 
Hospital (UCH) 
Ibadan 
23 healthy 
normotensive 
primigravidae 
singleton pregnant 
women 
 
59 women were recruited into the study 
when they booked for ANC prior to 20 
weeks gestation at the facility and were 
included in analysis if they delivered at 
the facility as well. These women were 
followed throughout their pregnancies. 
All participants gave complete clinical 
history, had BP measured and urinalysis 
done. 
Analysis of serum samples was 
performed as well (at a lab) 
 Of the 59 women recruited, two had 
abortions, 13 did not attend the minimum 
required number of prenatal clinic visits 
and 21 did not deliver at UCH. 
 23 completed the study; five (21.7%) had 
PE, two (8.7%) had pregnancy-induced 
hypertension and 16 (69.6%) remained 
normotensive. 
 Oedema and proteinuria were mild in all 
cases of PE, one of the cases of PE died. 
 This study found that there was no 
significant difference in uric acid and 
creatinine levels between the groups, but 
mean serum albumin concentration was 
significantly higher in the PE group. 
 Based on the findings of this study: serum 
uric acid and creatinine concentrations 
early in pregnancy are not useful to 
predict subsequent development of PE/E 
 Mean serum albumin levels early in 
pregnancy could be useful in predicting 
subsequent PE—further research is 
needed. To define the value of estimation. 
Vanderjagt DJ, Patel RJ, El-Nafaty 
AU, Melah GS, Crossey MJ, Glew RH. 
High-density lipoprotein and 
homocysteine levels correlate 
inversely in preeclamptic women in 
northern Nigeria. Acta Obstet 
Gynecol Scand. Denmark; 2004 
Jun;83(6):536–42.  
Case control 
Federal Medical 
Center or the 
Specialist Hospital, 
Gombe 
June—August 2001 
43 cases with PE/E 
130 controls 
N/A 
Participants were recruited while 
attending the facilities. The cases were 
diagnosed with PE/E if they had systolic 
BP greater than 140 mmHg, diastolic BP 
greater than 90mmHg, proteinuria in 
excess 190 mg total protein/g 
creatinine, and edema. Blood samples 
were taken from all participants and 
serum cholesterol concentration, serum 
HDL-cholesterol concentration, and 
serum triacylglycerol concentration were 
measured. 
 Mean serum total homocysteine 
concentration was greater among the 
women with PE/E than compared to the 
controls. 
 HDL-cholesterol concentration was found 
to be higher among the healthy women vs. 
those with PE/E 
 There was not a difference between the 
two groups for LDL-cholesterol and 
triacylglycerols.  
 Conclusion: this study found a significant 
negative correlation between the level 
homocysteine and the concentration of 
HDL-cholesterol in women with PE/E in 
northern Nigeria 
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Appendix V:  
SUMMARY TABLES OF OTHER HEALTH OUTCOMES ASSOCIATED WITH PE/E 
Citation Study Design 
Location, Timeframe, 
and Sample size 
Brief summary of Methods 
Main findings/ limitations 
Conclusions/ 
Recommendations 
ADEBAMI, O. J., OYEDEJI, G. A., OWA, J. A., & 
OYELAMI, O. A. (2007). Maternal factors in the 
etiology of fetal malnutrition in Nigeria. 
Pediatrics International, 49(2), 150–155.  
Prospective  
Neonatal and 
Maternity Units of the 
Wesley Guild Hospital 
Ilesa, Nigeria, a unit 
of Obafemi Awolowo 
University Teaching 
Hospitals Complex, 
Ile-Ife 
January – August 
2001 
473 consecutive, 
singleton, live birth, 
term (37-42 weeks 
gestation) neonates” 
Maternal prenatal records were 
reviewed, additional history 
collected from mother. Babies were 
classified into ‘babies with FM’ and 
‘babies without FM’ and the two 
groups were compared. 
 
 
 The study found that 27% of babies with FM were 
born to mothers with PIH/eclampsia compared to 
3.6% of babies without FM from mothers with 
PIH/eclampsia 
 “Hypertension and pre-eclampsia induce fibrinoid 
degeneration of arteriolar media with resultant 
intimal thickening and decreased luminal diameter. 
It causes permeability of essential nutrient across 
the placental barrier to the fetal and has, therefore, 
been implicated as a causative factor of FM” 
Adekanle, D., & Akinbile, T. (2012). 
Eclampsia and Pregnancy Outcome at 
Lautech Teaching Hospital, Osogbo, 
SouthWest, Nigeria. Clinics in Mother 
and Child Health, 9(1). 
Descriptive, 
cross-
sectional 
retrospective 
review 
Ladoke Akintola 
University of 
Technology Teaching 
Hospital, Osogbo, 
South West, Nigeria 
January 1, 2005—
December 31, 2010 
Review of case notes of women 
who had eclampsia 
Eclampsia defined as: “systolic 
blood pressure of > 140mmHg, 
diastolic blood pressure of 90 
mmHg, proteinuria of at least 1 
plus and convulsions in patients 
with no background history of 
seizure disorder were retrieved. 
 
 MMR was 1,981 per 100,000 live births 
 83 cases of eclampsia of 3952 deliveries, 
incidence = 2.1%, CFR: 8.3 
 Eclampsia accounted for 9.9% of maternal deaths 
(n=7) 
 Almost half of referrals (48.2%) were from private 
health facilitates and 2.4% were from TBAs 
 54.2% had antepartum eclampsia, intrapartum and 
postpartum eclamptic were each 22.9% 
 48.2% were booked in private health facilities and 
21.7 were booked in primary health facilities and 
then referred to this tertiary center. 
 71.1% of the cases were treated with MgSO4 and 
experienced  CFR of 8.3% 
 Most common maternal morbidity recorded was 
acute renal failure 
 54.2% of patients had caesarean section which 
was significantly associated with neonatal survival 
 Documented improvements in maternal and 
neonatal outcome due to use of MgSO4 rather 
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than diazepam, unavailability of MgSO4 supplies—
often due to cost—is likely a contributor to poor 
outcome 
Adeyemo, W. L., Rabiu, K. A., Okoturo, T. 
M., Adebanjo, A. A., Adewunmi, A. A., & 
Adeyemi, M. O. (2012). Orofacial injuries 
associated with eclampsia in patients 
presenting at a Nigerian Tertiary 
Hospital. Journal of Obstetrics and 
Gynaecology, January 20(32), 54–57.  
Prospective 
case review 
Lagos State 
University Teaching 
Hospital 
December 2008—
November 2009 
107 patients 
presented with 
eclampsia 
For women arriving at the facility 
with eclampsia, a proforma was 
designed to collect: age, parity, 
history of ANC, # of eclamptic fits, 
presence/absence of orofacial 
injuries and morbidity/mortality 
associated with eclampsia. In 
cases of orofacial injury, further 
details were collected as to the 
nature and cause of the injury 
 45 patients (42%) with eclampsia presented with 
orofacial injuries. Injuries were most often on the 
tongue and/or lips 
 Injury in most cases (n=16) was caused by 
relatives forcing hard objects into patient’s mouth 
or biting down during convulsions. 
 Six patients were injured due to a fall.  
 98% were not booked for ANC at this facility and 
were only referred after developing eclampsia 
 Patients who received ANC from TBAs and at 
churches were significantly more likely to have 
orofacial injuries 
Alhassan, M., Anyiam, C., Bosan, I., 
Danbauchi, S., David, S., & Isa, M. 
(2008). Role of pre-eclamptic toxaemia 
or eclampsia in hypertensive women 
attending cardiac clinic of Ahmadu Bello 
University Teaching Hospital Zaria, 
Nigeria. Annals of African Medicine, 
7(3), 133–137. 
 
Cross-
sectional 
Cardiac Clinic of 
Ahmadu Bello 
University Teaching 
Hospital, Zaria, 
Nigeria 
50 consecutive adult 
female hypertensive 
patients 
all patients provided demographic 
and clinical characterization from 
history and physical examination 
49 of the 50 patients recruited 
were studied. 
 Those who had PE in a previous pregnancy 
developed hypertension an average of 8.42 + 7.69 
years after the pregnancy and for those without PE, 
12.76 + 8.90 years. (no statistically significant 
difference) 
 Of the 49 participants, 32.7% had previous PE 
 Of those who had previous PE, 43.8% had 
complications of hypertension including: 
hypertensive heart disease, hypertensive heart 
failure, cerebrovascular accident, and peripartum 
cardiac failure. 
Faponle, A., & Makinde, O. (2007). 
Caesarean section: Intra-operative blood 
loss and its restitution. East African 
Medical Journal, 84(1), 31–34. 
 
Prospective 
study 
Obafemi Awolowo 
University Teaching 
Hospitals Complex, 
Ile-Ife, Nigeria 
January 1, 2005—
December 2005 
641 patients who 
underwent caesarean 
section 
The following was collected for all 
caesarean sections at the facility 
during the study period: 
Demographics, American Society of 
Anaesthesiologists grading, 
coexisting conditions, presence of 
clinical anaemia, indication for 
Caesarean section, pre-operative 
packed cell volume, surgical 
details. 
 PE/E were cited as indication for 9.4% (n=60) of 
the caesarean sections  
 Pre-eclampsia “carried the expected increased 
transfusion and major blood loss risk” 
Geidam, A. D., Audu, B. M., Kawuwa, B. M., & 
Obed, J. Y. (2009). Rising trend and indications 
of caesarean section at the university of 
Retrospective 
review 
University of 
Maiduguri Teaching 
Hospital 
Retrospective analysis of 
caesarean sections performed.  
 1,192 caesarean sections were performed during 
the study period, 79.4% of which were emergency 
C/S 
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Brief summary of Methods 
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Maiduguri teaching hospital, Nigeria. Annals of 
African Medicine, 8(2), 127–132. 
http://doi.org/10.4103/1596-3519.56242 
January 2000 to 
December 2005 
10,097 deliveries 
 Eclampsia caused 7.2% and severe pregnancy-
induced hypertension caused 4.8% 
Igwegbe, A., & Udigwe, G. (2001). Teenage 
pregnancy: still an obstetric risk. Journal of 
Obstetrics and Gynaecology, 21(5), 478–481. 
Retrospective 
and 
comparative 
study 
 
 
Nnamdi Azikiwe 
University Teaching 
Hospital, Nnewi. 
June 1 1995—
November 31, 1997 
1465 deliveries 
Reviewed hospital records of 28 
teenage deliveries and 30 records 
of mothers aged 20-24 were 
randomly selected to be used as 
controls 
 32 teenage deliveries, 21.8 per 1000 deliveries 
 This study found no significant difference between 
the teenagers and the control group with regard to 
PE/E  
Makinde, O. N., Adegoke, O. A., Adediran, I. A., 
Ndububa, D. A., Adeyemi, A. B., Owolabi, A. T., 
… Salawu, L. (2009). HELLP syndrome: the 
experience at Ile-Ife, Nigeria. Journal of 
Obstetrics and Gynaecology : The Journal of the 
Institute of Obstetrics and Gynaecology, 29(3), 
195–199. 
http://doi.org/10.1080/0144361090275394
5 
(cohort) 
 
Obafemi Awolowo 
University Teaching 
Hospitals Complex, 
Ile-Ife, Nigeria 
January 1—December 
31, 2006 
34 consecutive cases 
of severe PE/E 
Cases of severe PE/E were 
recruited and bloodwork and other 
biochecmical studies done (platelet 
count, peripheral blood smear, 
serum bilirubin lactate 
dehydrogenase, and aspartate 
transaminases estimation) 
HELLP syndrome was diagnosed in 
those who developed: haemolysis, 
abnormal liver function and 
thrombocytopenia (platelet count 
<90,000mm3) were   
 Each patient was categorized into three categories: 
1) 12 cases Severe PE: hypertension after 20th week, 
dBP>110mmHg on admission, proteinuria 
>30mg/dl in random urine specimen or > 300mg 
in 24hr 
2) 10 cases Imminent eclampsia: all parameters in 
(1) plus headache, blurring of vision and upper 
abdominal pain 
3) 12 cases Eclampsia: all parameters in (1) and 
seizures. 
 Six (17.6%) of the cases developed HELLP 
syndrome. 4 had eclampsia, 1 had imminent 
eclampsia and 1 had pre-eclampsia 
 CFR: 11.8% The only fatalities were the four 
eclamptic patients who also had HELLP syndrome.  
 There were 38 infants delivered, and six (15.8%) 
perinatal deaths. 
Ndukwe, K., Ugboko, V., Ogunlola, I., Orji, E., & 
Makinde, O. (2004). Orofacial injuries in 
eclamptic Nigerians. African Journal of 
Reproductive Health, 8(3), 147–151. 
Retrospective 
case review 
Department of 
Obstetrics and 
Gynaecology Obafemi 
Awolowo University 
Teaching Hospital, 
Ile-Ife, Nigeria 
January 1994 to July 
2002 
173 patient records 
 
Cases from patients with eclampsia 
during the study period were 
identified, and data extracted and 
analyzed.  
 21 of the 173 cases (12.1%) sustained orofacial 
injuries (mostly lacerations and bruises to soft 
tissues including the tongue). Dislocation of the 
lower jaw (temporomandibular joint dislocation) 
occurred in one case. Two patients died due to 
complications related to uncontrolled bleeding, 
acute renal failure and septicemia. 
 “antibiotics were prescribed in all the cases as part 
of the treatment regimen for eclampsia”  
 Recommend a campaign to ensure ANC 
attendance and against the forceful insertion of 
unpadded objects into the mouth during seizure. 
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Okafor, U., & Efetie, E. (2006). Cerebrovascular 
accident with quadriplegia following 
postpartum eclampsia. ACTA 
ANAESTHESIOLOGICA SCANDINAVICA 
Case report 
National Hospital, 
Abuja 
One, 26 –year-old 
woman 
The patient diagnosed with 
postpartum eclampsia was referred 
from a peripheral hospital, she 
delivered a live baby vaginally and 
experienced a tonic/clonic seizure 
just after delivering and became 
unconscious. 
After seizing, her Glasgow Coma 
score was determined to be 3, 
meaning she was deeply 
unconscious. 
She had a fever (38˚C), mild pedal 
oedema, puffy eyes and ‘grunting 
respiration,” a BP of 130/80 
mmHg on presentation. 
 
 There had been no history of elevated BP during 
ANC. 
 Her case was managed with magnesium sulphate, 
IV 5% dextrose/salinje, 50% dextrose and Zinacef 
(antibiotic). 
 She remained in the ICU for 42 days and was 
discharged from the Hospital after 169 days. BP 
had normalized, but she was still quadriplegic. 
 This is the only known case of quadriplegia 
resulting from postpartum eclampsia in sub-
Saharan Africa.  
 This study reinforced the thought that neurological 
effects of PE/E are more common when eclampsia 
presents postpartum; this patient had cerebral 
oedema 
Okafor, U., & Efetie, E. (2009). Anaesthetic 
management of patients with pre-
eclampsia/eclampsia and perinatal outcome. 
Journal of Maternal- Fetal and Neonatal 
Medicine, 22(8), 688–692. 
Retrospective 
record review 
University of Nigeria 
Teaching Hospital 
(UNTH), Enugu. 
July 1998—June 
2008 
6798 total deliveries,  
285 cases PE/E,  
196 cases of PE/E 
delivered by CS 
Hospital records for patients with 
PE/E who had caesarean delivery 
were reviewed and demographics, 
obstetric outcomes, and type of 
anaesthesia administered was 
recorded and analyzed. 
 12.4% (n=196) of all CS were for patients with 
PE/E. (59: mild PE, 107: severe PE, 30: eclampsia) 
 This group experienced 38 perinatal deaths, 180 
per 1000 births (19 stillbirths and 19 early 
neonatal deaths). 
  157 were delivered under general anaesthesia; 34 
under spinal anaesthesia and 5 under epidural 
block.  
 79% of the perinatal deaths were delivered by 
general anaesthesia.  
 Indications for CS among PE/E patients included: 
severe PE/E with unfavorable cervix, fetal 
distress/intrauterine growth retardation, previous 
CS, failed induction/failed vacuum extraction, 
prolonged labor and others 
 25.6% of perinatal deaths occurred in cases of 
severe PE, 21.2% occurred in cases of eclampsia 
and only 4.9% occurred in cases of PE. 
 89% of neonatal deaths occurred <36 weeks; 52% 
were <32 weeks 
 The increase to 20% use of regional anaesthesia 
(vs 1.3% in an earlier study) did not seem to have 
an impact on perinatal death. 
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Okafor, U., & Okezie, O. (2005). Maternal and 
fetal outcome of anaesthesia of caesarean 
delivery in preeclampsia / eclampsia in Enugu, 
Nigeria: a retrospective observational study. 
International Journal of Obstetric Anesthesia, 
14(2), 108–113.  
Retrospective 
survey of 
hospital 
records 
University of Nigeria 
Teaching Hospital 
(UNTH), Enugu. 
July 1998—June 
2002 
3926 total deliveries,  
898 CS deliveries  
125 cases of PE/E 
delivered by CS 
176 of 3926 (4.5%) deliveries were 
complicated by PE/E  
CFR: 5.2% 
 This facility was using methyldopa to control 
hypertension in these patients and nifedipine and 
beta-blockers added at the physicians’ advice. 
Hydralazine was also used to manage hypertensive 
crises. 
 Due to cost and unavailability of MgSO4, diazepam 
is often used prophylactically and also to treat 
eclamptic fits 
 82.4% (n=103) of the cases of PE/E delivered by 
CS were emergency procedures. 
 Six maternal deaths all of whom received general 
anaesthesia. 
 General anaesthesia was used for 116 (92.8%) of 
the patients, spinal anaesthesia was used in the 
other nine cases. 
 13 stillbirths and 10 neonatal deaths 
 Recommend using spinal anaesthesia for better 
health outcomes and also reduced cost. 
Oladapo, OT, JO Sotunsa, and AO Sule-Odu. 
“The Rise in Caesarean Birth Rate in Sagamu, 
Nigeria: Reflection of Changes in Obstetric 
Practice.” Journal of Obstetrics and 
Gynaecology 24.4 (2004): 377–381. 
Retrospective 
comparative 
study 
Olabisi Onabanjo 
University Teaching 
Hospital, Sagamu 
Two periods: 
January 1, 1989—
December 31, 1991 
July 1, 2000—June 
30, 2003 
Data were collected from theatre 
records, labor ward records, and 
case files on deliveries during the 
two study periods.   
 This study found that hypertensive disorders in 
pregnancy (severe PE/E) was cited as the 
indication for CS in 20 (8.9%) of caesareans during 
from 1989—1991  
 This increased to 13.4% (n=44) of CS due to 
severe PE/E in 2000-2003.  
 This finding is in line with other papers that report 
better maternal and fetal outcomes when a woman 
with severe PE/E is delivered via caesarean. 
OLADAPO, O. T., ADEKANLE, D. A., & 
DUROJAIYE, B. O. (2007). Maternal risk factors 
associated with fetal death during antenatal 
care in low-resource tertiary hospitals. 
Australian and New Zealand Journal of 
Obstetrics and Gynaecology, 47(5), 383–388.  
 
Case control 
study 
Olabisi Onabanjo 
University Teaching 
Hospital, Sagamu, 
Ogun State (OOUTH)  
and Ladoke Akintola 
University of 
Technology Teaching 
Hospital, Osogbo, 
Osun state 
(LAUTECHTH) 
January 1, 2002 and 
December 31, 2006 
at OOUTH 
Cases: booked singleton 
pregnancies who experienced fetal 
death during ANC 
Controls: booked pregnancies who 
had live births 
Four controls selected for each 
case (two immediately before and 
two after each case). 
Cases and controls were 
compared. 
 After multivariate logistic regression analyses, the 
following were found as predictors for fetal death 
among women receiving ANC: pregnancy induced 
hypertension (adjusted OR: 8.24, CI 3.01—22.51), 
proteinuria (adj. OR 4.23, CI: 1.57—11.42) and 
perceived reduction of fetal movements (adj OR 
7.17, CI: 1.57—45.76). 
 % of cases and controls with: 
 proteinuria: Cases: 41.9%, controls, 11.0% 
 PIH: cases: 43.5%, controls: 7.6% 
 previous hypertension: cases: 10.9%, controls: 
2.2% 
 PE: cases 24.4%, controls: 0.0% 
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January 1, 2003—
December 31, 2006 
LAUTECHTH 
Cases: 46 
Controls: 184 
Olagbuji, B., Ezeanochie, M., Ande, A., & 
Okonkwo, C. (2012). Prevalence and 
risk factors for persistent hypertension 
after the puerperium in pregnancies 
complicated with hypertensive 
disorders. Journal of Obstetrics and 
Gynaecology : The Journal of the 
Institute of Obstetrics and Gynaecology, 
32(6), 529–532.  
 
Prospective 
cohort study 
University of Benin 
Teaching Hospital 
(UBTH), Benin City, 
Nigeria  
December 2009—
November 2010. 
198 women 
Women who were managed for 
new-onset gestational hypertensive 
disorders who had received ANC, 
intrapartum and postpartum care 
at the facility were recruited during 
the prenatal period.  
“new-onset gestational 
hypertensive disorders” = 
gestational hypertension, or PE/E 
after 20 weeks gestation in 
previously normotensive, non-
proteinuric women with no history 
of chronic hypertension. 
 “Persistent hypertension” was diagnosed if 
hypertension remained during the postpartum visit, 
six weeks after delivery. 
 51 (25.8%) were discovered to have persistent 
hypertension at the 6th week postnatal follow up 
visit.  
 Persistent hypertension was significantly higher 
among women with maternal age > 35 years old 
and also among HIV-positive women. 
 Serum uric acid and creatinine levels were also 
significantly higher among the women who 
developed persistent hypertension  
Olusanya, B. O., & Solanke, O. A. (2012). 
Perinatal outcomes associated with maternal 
hypertensive disorders of pregnancy in a 
developing country. Hypertension in Pregnancy, 
31(1), 120–130.  
Retrospective 
study 
Island Maternity 
Hospital (IMH), Lagos 
May 15, 2005—2007 
216 mothers with 
HDP 
Mothers with HDP were recruited 
and their cases reviewed for: fetal 
distress, prematurity (<37 weeks 
gestation), low birth weight 
(<2500g), fetal growth restriction, 
birth asphyxia, admission to special 
baby care unit, and lack of 
exclusive breastfeeding as well as 
maternal factors. 
 
Hypertensive disorders of 
pregnancy (HDP): chronic 
hypertension, pregnancy-induced 
hypertension, pre-eclampsia and 
eclampsia 
 216 HDP/ 3491 mother-infant pairs = 6.2% 
incidence of HDP 
 10 (4.6%) were chronic hypertension, 120 (55.6%): 
pregnancy-induced hypertension, 86 (39.8%): PE/E 
 After adjusting for maternal factors and some 
relevant infant confounders, this study saw that 
HDP increased the odds of preterm birth (OR 3.30), 
fetal growth restriction (OR 2.94), low birth weight 
(OR 4.68) and birth asphyxia (OR 2.99). 
 Recommends greater collaboration between 
obstetricians and pediatricians to address HDP and 
its effects beyond maternal and perinatal mortality.   
58 
Citation Study Design 
Location, Timeframe, 
and Sample size 
Brief summary of Methods 
Main findings/ limitations 
Conclusions/ 
Recommendations 
Olusanya, B. O., & Solanke, O. A. (2012). 
Maternal and neonatal profile of late-preterm 
survivors in a poorly resourced country. The 
Journal of Maternal-Fetal & Neonatal Medicine, 
25(4), 346–352.  
 
Cross-
sectional 
study 
Island Maternity 
Hospital, Lagos 
May 2005—
December 2007 
4176 Surviving late 
preterm and full-term 
live births 
Infants were recruited under 24 
hours after birth, before being 
discharged from the hospital. 
Late preterm was defined as: 340/7 
to 366/7 weeks gestation. 
Gestational age was based on 
number of days between LMP (last 
menstrual period) and delivery 
 89 (38.4% of women with hypertensive disorders: 
PE/E and PIH) had PE/E and 41 (46.1%) of them 
were late-preterm 
 Univariate analysis showed that having a 
hypertensive disorder was significantly associated 
with late-preterm delivery 
 Multivariate analysis revealed that late-preterm 
delivery was independently associated with 
hypertensive disorders (OR 3.66, CI 1.97—6.84). 
Onuh, S., & Aisien, A. (2004). Maternal and 
fetal outcome in eclamptic patients in Benin 
City, Nigeria. Journal of Obstetrics and 
Gynaecology, 24(7), 765–768.  
 
University of Benin 
Teaching Hospital 
1995—2002 
103 cases of 
eclampsia 
Patient data for cases of eclampsia 
was retrieved from case notes and 
summary sheets and analyzed. 
 Incidence of eclampsia: 1.32%; The incidence of 
eclampsia among nullipara was 2.4% which is 
significantly higher than the incidence among 
multipara (0.9%). CFR: 11.7% 
 Only 13, (12.6%) of the patients came for ANC at 
UBTH while 90 (87.4%) either were referred from 
other facilities or did not attend ANC (“unbooked”) 
 58.4% (n=59) of the patients were delivered by 
caesarean section.  
 Complications included: cerebrovascular accident 
(n=6), transient blindness (n=6), abruptio 
placentae (n=6), HELLP syndrome (n=4), Acute 
renal failure (n=3), disseminated intravascular 
coagulation (n=2), aspiration pneumonia (n=1); 
26.2% of cases experienced a complication 
 Fetal outcome: there were 117 births (14 sets of 
twins, and 1 set of triplets); 25 perinatal deaths (9 
stillbirths, and 16 early neonatal deaths) 
prematurity was the cause of death for 17 (68%) 
and birth asphyxia 6 (24%) and sepsis 2 (8%). 
  
Onyearugha, C. N., & Ugboma, H. A. A. (2012). 
Fetal outcome of antepartum and intrapartum 
eclampsia in Aba, southeastern Nigeria. 
Tropical Doctor, 42(3), 129–132.  
Retrospective 
review of 
hospital 
registers 
Department of 
Obstetrics and 
Gynaecology, Abia 
State University 
Teaching Hospital, 
Abia 
January 1, 2002—
December 31, 2007 
48 babies delivered 
to eclamptic mothers 
Relevant information (gestational 
age, birthweight five-minute Apgar 
score and mother’s age, booking 
status parity, number of fits and 
mode of delivery) was obtained 
from delivery registers for 48 
babies delivered to eclamptic 
mothers; data analyzed.  
 Hospital incidence of eclampsia- 0.80%; CFR: 
20.8% 
 Women only come to this facility for treatment as a 
last resort; tradition treatment for fitting is “crude 
oil pushed into their mouths and eyes” 
 13 babies were <1500g, 15 were 1500g-2499g, 
19 were 2500g—4000g, and 1 was >4000g 
 Five-minute Apgar sore: 29 (60%)= 0 [stillborn], 4 
(8.3%)= 1-3 [severely asphyxiated], 9 (18.8%)= 4-
6, 6 (12.5%) >7  
 Poor Apgar scores could be partly explained by 
asphyxiogenic effect in utero during maternal 
convulsions. 
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Onyiriuka, A. N., & Okolo, A. A. (2007). Neonatal 
morbidity pattern in infants born in Benin City 
to Nigerian mothers with hypertensive 
disorders in pregnancy. Nigerian Journal of 
Clinical Practice, 10(4), 294–299. 
 
Case control 
study 
University of Benin 
Teaching Hospital 
(UBTH) 
 
January 1, 1992—
June 30, 1994 
 
Cases: 256 live 
newborns of 
hypertensive mothers 
 
Controls: 804 infants 
of normotensive 
mothers 
For each hypertensive mother 
recruited, three normotensive 
pregnant mothers were recruited 
as controls. All participants came 
for clinical visits every 2 weeks and 
had BP measured and urine tested  
HDP= documented history of 
hypertension (140/90 mmHg) 
before pregnancy, an increase in 
either SBP (by 30mmHg) or DBP (by 
15mmHg) above the booking BP, 
an intrapartum blood pressure = 
140.90 mmHg obtained on at least 
two occasions not less than six 
hours apart during delivery 
 Comparing the outcomes of the infants born to 
hypertensive vs. normotensive women, this study 
found that 39.5% vs 17.9% were low birth weight, 
29.3% vs. 12.% were preterm 
 Caesarean delivery rate was significantly higher 
among hypertensive women. 
 This study concludes that “pregnancies 
complicated by hypertension are associated with 
an increase in neonatal morbidity” and that these 
infants are a high-risk group that need close 
attention and treatment of these specific 
outcomes. 
Osinubi, A., Ajayi, G., & Adegbola, O. (2009). 
Effect of normal and pre-eclamptic pregnancies 
on plasma cholinesterase in Nigerian women. 
African Journal of Endocrinology and 
Metabolism, 8(1), 1–3. 
Case control 
study 
Antenatal Clinic and 
Prenatal Diagnostic 
and Therapy Center, 
College of Medicine 
of the University of 
Lagos/Lagos 
University Teaching 
Hospital 
30 women: mild PE 
27 women: severe PE 
30: normal 
pregnancy  
30 healthy non-
pregnant women  
Patients were recruited and 
categorized into four groups: 
healthy non pregnant, healthy 
pregnant, mild PE and severe PE 
Mild PE: pregnancy-induced sBP 
>160mmHg or diastolic BP > 
110mmHg with proteinuria 2+ 
Severe PE: any two of the following 
signs were present: (1) systolic 
blood pressure >160 mmHg or 
diastolic blood pressure >110 
mmHg; (2) proteinuria (>3+ on 
dipstick [500 mg/dL]); (3) facial 
oedema. 
 Plasma cholinesterase concentrations:  
Healthy, non-pregnant (controls) 3594 + 422 m/L 
Healthy pregnant: 2135 + 330 [postpartum: 3212 
+ 346. Mild PE: 1781 +330 [postpartum: 3157 + 
75] 
Severe PE: 1630 + 326 [postpartum: 2864 + 700] 
 This study found that pregnancy reduced plasma 
cholinesterase concentrations when compared to 
healthy non-pregnant women; PE further reduced 
concentrations when compared to normal pregnant 
women.  
 Reduced plasma cholinesterase activity leads to 
prolonged succinylcholine effect. 
 It was also noted, that cases of severe PE did not 
see concentrations of serum cholinesterase return 
to normal within six weeks after delivery.  
 Recommendations: cases of severe PE should be 
monitored beyond six weeks postpartum, consider 
using peripheral nerve stimulator when 
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Serum cholinesterase 
concentrations were measured by 
collecting blood and separating the 
plasma for cholinesterase assays 
between 28—41 weeks for 
pregnant women and 6 weeks 
postpartum 
 
 
succinylcholine is administered in PE/E, further 
research targeting cholinesterase activity as 
diagnostic tool and prognostic marker in PE/E 
pregnancies. 
 
Ozumba, B. C., & Anya, S. E. (2002). Maternal 
deaths associated with cesarean section in 
Enugu, Nigeria. International Journal of 
Gynaecology and Obstetrics: The Official Organ 
of the International Federation of Gynaecology 
and Obstetrics, 76(3), 307–309. 
 
University of Nigeria 
Teaching Hospital, 
Enugu 
January 1994—
December 1999 
 
1,684 cesarean 
section deliveries 
 
 Overall CS rate of 25.6%  
 Hypertensive disorders of pregnancy (HDP) was 
cited as indication for 27% of CS (behind 
prolonged/ obstructed labor, 31%). 
 There were 26 deaths following CS, 23% of which 
were associated with HDP 
Waziri-Erameh, M. J., Omoti,  a E., & Edema, O. 
T. (2003). Bilateral total loss of vision following 
eclampsia--a case report. African Journal of 
Reproductive Health, 7(2), 106–108. 
Case report Benin City 
31 year old patient, para-5 who 
suffered bi-lateral total loss of 
vision for four weeks. She had been 
successfully treated for eclampsia 
and lost vision during the 
convulsion, this progressively 
became worse and she was 
referred for ophthalmological 
consultation 
 Eclampsia was treated using Hydrallazine to 
reduce the blood pressure and diazepam to stop 
the convulsions. 
 Upon referral, she had a blood pressure of 130.90, 
which may indicate that she had underlying 
hypertension during pregnancy 
 Steroids were given and within a few weeks, her 
vision was restored.  
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Appendix V:  
SUMMARY TABLES OF PROGRAM DESCRIPTIONS AND LITERATURE REVIEWS 
Citation Paper Type Summary 
Abalos, E., Cuesta, C., Grosso, A., Chou, D., & 
Say, L. (2013). Global and regional estimates of 
preeclampsia and eclampsia: a systematic 
review. European Journal of Obstetrics & 
Gynecology and Reproductive Biology, 170(1), 
1–7. 
Systematic Review 
11 datasets found on PE/E in Nigeria (4 on PE, 7 on E). Total population covered by these datasets = 54,144 
women. Crude incidence of PE among the four datasets = 4.6% and crude incidence of E among the 7 datasets 
= 4.0% 
Ameh, C., & van den Broek, N. (2015). Making It 
Happen: Training health-care providers in 
emergency obstetric and newborn care. Best 
Practice & Research Clinical Obstetrics & 
Gynaecology, 1–15. 
Program description 
The Making It Happen multi-country programme (implemented in Nigeria during Phase II) aims to build the 
capacity of health-care providers to recognize and manage complications during pregnancy, childbirth and the 
post-partum period through ‘skills-and-drills’ competency-based training in skilled birth attendance, emergency 
obstetric care and early newborn care (EmONC). 
Key interventions under MiH programme are:  
1) in-service training of healthcare providers working in maternity areas (including management of severe PE/E)  
2) quality improvement using audit methodology  
3) improved monitoring and evaluation. 
Ekele, B. A. (2009). Use of magnesium sulfate to 
manage pre-eclampsia and eclampsia in Nigeria: 
overcoming the odds. Annals of African 
Medicine, 8(2), 73–75. 
Editorial 
Even though MgSO4 has been shown to be the safest and most effective method for managing convulsions in 
pregnant women and to prevent recurrence, many providers and facilities have been unable to adjust to the new 
standard and still stock and use diazepam to manage eclampsia. Other barriers to using MgSO4 include: fear of 
toxicity (which is detectable and treatable using calcium gluconate), no local manufacturer making availability 
more difficult and more expensive, and the dosage itself.  
Garba, J., & Umar, S. (2013). etiology of 
maternal mortality using verbal autopsy at 
Sokoto, North-Western Nigeria. Etiologie de la 
mortalité maternelle en utilisant l’autopsie 
verbale à Sokoto, Nigeria du Nord-Ouest. African 
Journal of Primary Health Care and Family 
Medicine, 5(1), 6 p 
Descriptive, cross-
sectional study 
Interviews using a verbal autopsy questionnaire with relatives of a women 15-49 years old who had died of 
pregnancy-related condition in the preceding two years. Sixty-two maternal deaths were identified and 58 
questionnaires for the verbal autopsy were completed.  
Eclampsia was the cause of death for 18.97% (second most common after Haemorrhage, 48.28%) 
Among primipara, eclampsia was the cause of death for 29.2% 
Hlimi, T. (2015). Association of anemia, pre-
eclampsia and eclampsia with seasonality: A 
realist systematic review. Health & Place, 31(0), 
Systematic review Hlimi conducted a systematic literature review of studies that look at the effect of weather/rainfall/seasonality 
might have on the development of anemia and PE/E. This review included three studies from Nigeria, one was 
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Citation Paper Type Summary 
180–192.  
 
published in 1970, one in 1981 and one in 2009. The study from 2009 (Okafor et al.) is included in this current 
literature review on PE/E in Nigeria. 
 
Overall, Hlimi found that there are often observed seasonal patterns for anemia and PE/E and that PE/E might 
follow similar seasonal variation to malaria, but more research is needed. 
Lalonde, A., & Grellier, R. (2012). FIGO saving 
mothers and newborns initiative 2006–2011. 
International Journal of Gynecology & Obstetrics. 
Summary of FIGO 
funded projects 
under Safe 
Motherhood and 
Newborn Health 
(SMNH) Committee 
One of the projects described was implemented in Nigeria: Saving mothers and newborns in Edo, Amambra and 
Kaduna States; this project aimed to improve data collection and use, through improved birth register records, 
fatal outcome records and clinical audits. The project also trained providers on EmONC and strengthened 
capacity of national professional societies (midwifery and obstetric) through development of protocols and 
advocacy activities. Three achievements of the project were: supplying MgSO4 to all state hospitals by the 
Kaduna state government, reduced cost of MgSO4 by manufacturers and four obstetric protocols were 
introduced. 
McDonald, S., Lutsiv, O., Dzaja, N., & Duley, L. 
(2012). A systematic review of maternal and 
infant outcomes following magnesium sulfate for 
pre-eclampsia/eclampsia in real-world use. 
International Journal of Gynecology and 
Obstetrics, 118, 90–96.  
 
Systematic review 
A systematic review of studies conducted looking at the effectiveness of magnesium sulfate. The authors 
searched MEDLINE and EMBASE for studies published from January 7, 1990 to July 20, 2010 and included 
‘before-and-after’ studies, cohort studies, and serial cross-sectional studies which reported outcomes of women 
receiving MgSO4 compared to a group of women who did not. Studies looking at a sample <10 were excluded. 
Primary outcomes were: maternal death, infant death, eclampsia or recurrent seizure. Secondary outcomes 
included: pulmonary edema, pneumonia, cardiac arrest, coagulopathy, renal failure, liver failure, cerebral 
hemorrhage, respiratory depression or arrest, toxicity (calcium gluconate required to stop toxic effect of MgSO4), 
length of stay in ICUs. From 754 citations, 156 full text articles were reviewed and 150 were excluded for 
sample size, study design or failure to report outcomes of interest. 
The six studies included were all cohort studies, included 536 women with eclampsia treated with MgSO4 and 
698 who were treated with another anticonvulsant.  
The results from the six studies included, seem to indicate that the improvements demonstrated in RCTs are 
comparable to those observed in real-world use of MgSO4 and result in reduction in recurrent seizures, morbidity 
and mortality. 
Mohammed, S., Ahonsi, B., Oginni, A., Tukur, J., 
& Adoyi, G. (2015). Obstetric knowledge of 
nurse-educators in Nigeria: Levels, regional 
differentials and their implications for maternal 
health delivery. Health Education Journal.  
 
Cross-sectional 
survey 
This paper aimed to assess the knowledge of nurse-midwife educators on the major causes of maternal 
mortality in Nigeria by administering a survey. The authors found that 57.2% of 292 educators could diagnose 
pre-eclampsia. 86% knew about MgSO4 but only 16.8% knew about using calcium gluconate as an antidote to 
MgSO4 toxicity. Nearly two thirds (63.7%) were unable to describe the steps of active management of third stage 
labor. In addition to these, other knowledge gaps were identified relating to oxytocic use for hospital delivery, 
when to perform episiotomies, and causes of postpartum haemorrhage. 
The authors propose scale up of quality obstetric care by updating pre-service curricula in addition to in-service 
appraisals and continuing education on these issues. 
Okafor, U. (2009). Maternal and perinatal 
outcome after caesarean delivery in 
preeclampsia or eclampsia in Enugu, Nigeria: 
four years on. International Journal of Obstetric 
Correspondence 
This correspondence from Okafor provides a brief update on health outcomes following caesarean delivery of 
women with PE/E and their babies. Based on a retrospective review of hospital cases of PE/E deliveries via CS 
(1998—2002), the author previously recommended a multidisciplinary approach to management and increased 
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Citation Paper Type Summary 
Anesthesia. use of spinal anaesthesia. Here, the author looks at records from July 2002 to June 2006 to assess whether the 
outcomes have improved for women with PE/E undergoing CS. 
During the recent four year period, three eclamptics (2 spinal, 1 epidural), 17 severe PE (15 spinal, two epidural) 
and 10 mild PE (8 spinal, 2 epidural) were delivered via CS. 
Maternal outcomes were improved when compared to the prior study period; possibly due to the preference of 
spinal anaesthesia (general anaesthesia is known to be associated with higher rates of maternal mortality and 
morbidity). 
Perinatal mortality was unchanged. 
Definitions:  
Mild preeclampsia: BP between 140/90 and 160/110 mmHg on two occasions six hours or more apart, or a 
rise from midtrimester values of 3mmHg in systolic or 15mmHg in diastolic BP, more than ).3g/L proteinuria on 
two consecutive specimens and significant non-dependent oedema. 
Severe PE: BP persistently above 160/110 mmHg, proteinuria above 5g/24 hours and headache, blurred vision, 
epigastric pain and oliguria.  
Okereke, Ekechi, Babatunde Ahonsi, et al. 
“Benefits of Using Magnesium Sulphate 
(MgSO(4)) for Eclampsia Management and 
Maternal Mortality Reduction: Lessons from 
Kano State in Northern Nigeria.” BMC research 
notes 5 (2012). 
 
Project description 
In 2012, 33 heath workers in five facilities in Jigawa state were selected and recruited to be mentors for junior 
medical officers, nurses, midwives, CHOs and CHEWs to improve MNCH service delivery. In February of 2013, 
this study conducted interviews with stakeholders (mentors, mentees, facility managers and state government 
health officials) to assess perceptions about clinical mentoring as a strategy to improve MNCH service delivery. 
The clinical mentors and the healthcare workers in-charge of obstetrics saw changes regarding the introduction 
and updating of treatment guidelines for basic emergency health services including using magnesium sulphate 
to manage PE/E. This study concludes that clinical mentoring improved worker capacity to deliver quality MNCH 
services and that by integrating mentorship into the district health system, it has the potential to promote 
government ownership and sustainability.  
Olamijulo, J., Ogedengbe, O., & Giwa-Osagie, O. 
(2008). Availability and use of obstetric 
guidelines in Nigeria. International Journal of 
Gynaecology and Obstetrics, 102(3), 242–245 
Cross-sections 
survey 
This survey was meant to assess the availability and use of obstetric guidelines by asking Ob/Gyns (at SOGON 
Annual General Meeting and Scientific Conference) to respond to a self-administered questionnaire. One 
hundred and seventy-eight responses were completed, but only 176 were able to be analyzed. Most (83.5%) of 
the respondents had over ten years’ experience. The results showed that 55.9% of respondents reported that 
guidelines for severe PE/E were in place, but only 38.8% said that they were used regularly. 
Osungbade, K., & Ige, O. (2011). Public health 
perspectives of preeclampsia in developing 
countries: implication for health system 
strengthening. Journal of Pregnancy.  
Review Article 
Literature review of papers published on PE/E in developing countries between 2000 and 2010. Based on the 
papers identified that reported numbers for Nigeria, prevalence of PE ranged from 2-16.7%. 
Challenges identified include: managing PE, three delays to care, health policies. 
Recommend: risk assessment and clinical management, society and community interventions, and health 
system strengthening 
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Tukur, J. (2009). The use of magnesium 
sulphate for the treatment of severe pre-
eclampsia and eclampsia. Annals of African 
Medicine, 8(2), 76–80. 
Literature review 
Tukur discusses the severity of maternal mortality due to PE/E in Nigeria and describes key issues related to 
using magnesium sulphate He explains that while MgSO4 was introduced in 1925 to manage convulsions it 
wasn’t until 1995 that its efficacy was confirmed by the Collaborative Eclampsia Trial (Magpie Trial). Despite its 
now known efficacy, MgSO4 remains mostly unavailable in developing countries where it is most needed. Tukur 
goes on to describe the two predominant dosing regimens: Pritchard and Zuspan as well as the importance of 
monitoring for toxicity. Choice of regimen depends on various factors including expertise and availability of staff 
to administer the drug, (Pritchard is often preferred in low resource settings because it is a simple IM injection 
that can be administered by lower cadre providers and doesn’t require infusion pump). 
Pritchard involves administering a loading dose bolus of 4g of MgSO4 via IV over 5-10 minutes and is followed 
immediately by 10g (5g in each buttock) and subsequent maintenance doses of 5g in alternate buttocks every 
four hours. 
Zuspan involves an initial IV dose of 4g of MgSO4 over 5-10 minutes followed by 1-2g every hour by infusion 
pump(a gravity fed infusion set can be used) 
It is necessary to train providers on MgSo4 use and ensure that protocols for its use are in place. Ensuring the 
involvement of important stakeholders is essential to ensure availability and utilization of MgSO4 
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SUMMARY TABLES OF DESCRIPTIVE PAPERS ON HOSPITAL REPORTS 
Citation 
Study 
Design 
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Main findings/ limitations 
Conclusions/ 
Recommendations= 
Abe, E., & Omo-Aghoja, L. O. (2008). Maternal 
mortality at the Central Hospital, Benin City 
Nigeria: a ten year review. African Journal of 
Reproductive Health, 12(3), 17–26. 
Retrospecti
ve review 
of hospital 
records. 
Obstetric unit of Central 
Hospital, Benin City, 
Nigeria 
January 1, 1994 –
December 31, 2003 
28,186 deliveries 
N/A 
 146 maternal deaths over the 10 year period, overall maternal 
mortality ratio of 518/100,000 total deliveries. 
 PE/E was fourth leading direct cause of maternal mortality, 
contributing 15.6% of overall maternal deaths. 
 Training, retraining and continuing medical education on emergency 
obstetric care, making maternal health care free, and reducing 
poverty and increasing female education to reduce the burden of 
maternal mortality. 
Aboyeji, A., Ijaiya, M., & AAFawole. (2007). 
Maternal mortality in a Nigerian teaching 
hospital -- a continuing tragedy. Tropical Doctor, 
37(2), 83–85. 
Retrospecti
ve review 
of hospital 
records. 
University of Ilorin Teaching 
Hospital, Ilorin, Nigeria 
January 1, 1997—
December 31, 2002 
13,092 live births 
 
 108 maternal deaths during the period, overall maternal mortality 
ratio of 825/100,000 live births 
 Severe PE/E was most common cause of death (27.8%) 
 “The emergence of severe pre-eclampsia/eclampsia as the common 
most clinical cause of maternal death is not entirely surprising. […] it 
is also possible that this is so because more of the patients with the 
condition are elderly and they may have other medical conditions such 
as hypertension as an underlying disease. This will carry more 
mortality than the straightforward eclampsia associated with 
primigravidity.” 
 MMR may be overestimated since this is a referral center and often 
sees complicated, high risk cases. 
 Recommendations: train TBAs to recognize obstetric emergencies,  
Adamu, A., & Ekele, B. (2012). Pregnancy 
outcome in women with eclampsia at a tertiary 
centre in northern Nigeria. African Journal of 
Gynecology & Obstetrics, 119(S3), S531–S867. 
Retrospecti
ve analysis 
of 
demograph
ic and 
clinical 
data of 
patients 
with 
eclampsia 
Obstetrics & Gynecology 
department of Usmanu 
Danfodiyo University 
Teaching Hospital. 
 
January 2000—December 
2009. 
 
1035 eclamptics 
Incidence: 
1035/23,26
6 = 4.4% 
 
CFR = 18% 
 Maternal mortality Ratio = 2670/100,000; 26.7% of which were 
eclamptic deaths. 
 Intrapartum: 62.6% 
 Delivery method: spontaneous vaginal= 45.2%; instrumental 
deliveries= 28.7%, destructive operations= 6.5%, Caesarean section 
was performed in 19.6% of the cases, 6.1% of eclamptic women died 
undelivered. 
 Women were more likely to die if they had not received antenatal care. 
 Complications among women who died included: Aspiration 
pneumonitis, pulmonary edema, hyperpyrexia, cerebral edema, acute 
renal failure, disseminated intravascular coagulopathy, abruption 
placentae, HELLP syndrome, and anesthetic complication 
 Over half of the maternal deaths occurred in the first 24 hours after 
hospital admission.  
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 Fetal outcome: alive at discharge=59.2%; fresh stillbirth=18.3%’ 
macerated stillbirth= 14.7%; early neonatal death=7.7% 
Adamu, Y. M., Salihu, H. M., Sathiakumar, N., & 
Alexander, G. R. (2003). Maternal mortality in 
northern Nigeria: a population-based study. 
European Journal of Obstetrics and Gynecology 
and Reproductive Biology, 109(2), 153–159. 
 
Retrospecti
ve on vital 
statistics 
register 
Kano State, Research and 
Statistics Department of 
the Ministry of Health in 
Kano State 
Eclampsia 
causes 
31.3% of all 
maternal 
deaths 
 4154 maternal deaths out of 171,621 Maternal mortality ratio: 2420 
per 100,000 
 Eclampsia was found to be the most important cause of maternal 
deaths 
 “Phase I delay (delay in seeking appropriate treatment), in particular, 
appears to be the rate-determining step along the non-biologic 
pathway through which death precipitated by eclampsia occurs.” 
 Recommend training staff in detecting and referring women at risk for 
eclampsia (as well as anemia and ruptured uterus) during pregnancy.  
Adelaja, L. M., & Olufemi Taiwo, O. (2011). 
Maternal and fetal outcome of obstetric 
emergencies in a tertiary health institution in 
South-Western Nigeria. ISRN Obstetrics and 
Gynecology, 2011.  
Retrospecti
ve study of 
case 
records 
Olabisi Onabanjo University 
Teaching Hospital 
(OOUTH), Sagamu, Nigeria 
Jan 2005—December 
2007 
262 obstetric emergencies 
out of1420 deliveries 
Severe PIH: 
8.8% of 
obstetric 
emergencie
s 
Eclampsia: 
8.0% of 
obstetric 
emergencie
s 
 Obstetric emergencies accounted for 70.6 of the 17 maternal deaths 
 Prevention and effective management through ANC, personal financial 
planning for pregnancy, development of adequate blood banking 
system, regular training of doctors and nurses can go a long way to 
reduce maternal and perinatal mortality in Nigeria. 
Ade-Ojo, I., & Loto, O. (2008). Outcome of 
eclampsia at the Obafemi Awolowo University 
Teaching Hospital Complex, Ile-Ife. Nigerian 
Journal of Clinical Practice, 11(3), 279–284. 
Rerospecti
ve review 
of case 
records 
Obafemi Awolowo 
University Teachin Hospital 
Complex, Ile-Ife, Nigeria 
January 1, 1994—
December 31, 2003 
124 cases of eclampsia 
Incidence of 
elcampsia: 
0.91% 
 Eclampsia was highest among young adults <25 years of age, those 
women carrying their first pregnancy, those who were unbooked. 
 62.5% of cases occurred after 36 weeks gestation 
 Common symptoms included: headache (100%), hypertension (75%) 
and fever (20.2%) 
 Antepartum eclampsia (56.5%) 
 Maternal mortality = 8.0% and Perinatal mortality = 19.1% 
 Morbidities include: acute renal failure, pulmonary edema, and 
aspiration pneumonitis 
 55.3% (n=69) had emergency abdominal delivery 
 Recommendations include: strengthening essential obstetric care 
Adeoye, I. A., Onayade, A. A., & Fatusi, A. O. 
(2013). Incidence, determinants and perinatal 
outcomes of near miss maternal morbidity in Ile-
Ife Nigeria: a prospective case control study. 
BMC Pregnancy and Childbirth, 13(93), 8-10. 
Case-
control  
Maternity units of Obafemi 
Awolowo University 
teaching Hospitals 
Complex, Ile-Ife, Nigeria 
 
July 2006—June 2007 
*w/periods of interruption 
Hypertensiv
e disorders 
of 
pregnancy = 
37.3% 
(n=28) of 
near miss 
cases 
[severe 
 Maternal near miss was defined as “any woman who experienced a 
life-threatening complication and who nearly died but for the hospital 
care she received” and included cases of: haemorrhage, hypertensive 
disorders in pregnancy, dystocia, infection, severe anemia.  
 Majority of near miss cases were not booked for ANC at tertiary facility 
(70.7%) which was significantly different from proportion of controls 
not booked for ANC at tertiary level (27. 0%) 
 37.3% of near miss morbidities  caused by hypertensive disorders in 
pregnancy 
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75 near miss, 300 controls PE=19(25.3
%), 
eclampsia=
9(12.0%)] 
 Chronic hypertension found to have strongest association as a risk 
factor for near misses (7 fold increase in risk). 
 Key determinants of near miss: phase I delay, chronic hypertension, 
emergency caesarean section, and assisted vaginal delivery. 
Adinma, E. D. (2012). Pattern of clinical 
presentation of eclampsia at Nnamdi Azikiwe 
University Teaching Hospital, Nnewi, 
Southeastern Nigeria. Nigerian Journal of 
Medicine, 21(3), 313–316. 
Retrospecti
ve study of 
cases of 
eclampsia  
Nnamdi Azikiwe University 
Teaching Hospital, Nnewi, 
Southeastern Nigeria 
January 1, 2000—
December 31, 2009 
6,262 cases reviewed 
Prevalence 
of 0.91% 
 57 cases of eclampsia, but only 46 case files were complete and 
included in the analysis. 
 Antepartum eclampsia= 35 (76.1%); intrapartum = 7 (15.2%); 
postpartum = 4 (8.7%) 
 21 cases experienced three or more convulsions before treatment 
was started, 9 cases had two convulsions, and 16 experienced one 
convulsion prior to treatment. 
 Patients presented with: headache (74%), edema (71%), severe 
hypertension (dBP >110mmHg) (69%), Blurring of vision (65%) and 
unconsciousness (26%) 
 60.9% were nulliparous and 89% were unbooked 
Adinma, E. D. (2013). Maternal and perinatal 
outcome of eclampsia in tertiary health 
institution in Southeast Nigeria. Journal of 
Maternal-Fetal and Neonatal Medicine, 26(2), 
211–214. 
Retrospecti
ve study of 
cases of 
eclampsia  
Nnamdi Azikiwe University 
Teaching Hospital, Nnewi, 
Southeastern Nigeria 
January 1, 2000—
December 31, 2009 
6,262 cases reviewed 
Prevalence 
of 0.91% 
CFR: 8/46= 
17.4% 
 57 cases of eclampsia, but only 46 case files were complete and 
included in the analysis. 71.7% of which were delivered by caesarean 
section 
 Morbidities include: pulmonary edema (n=6), acute renal failure 
(n=4), coagulopathy (n=3) aspiration pneumonitis (n-2), 
cardiovascular accidents (n=2) and HELLP syndrome, septicemia and 
cerebral edema occurred in 1 each. 
 Eight maternal deaths 
 Perinatal outcomes: 46 women delivered 51 babies (1 set triplets and 
three sets twins). 82.5% were premature, and 70.6 had low birth 
weight 
 13 perinatal deaths (25.5%)  
Agida, E. T., Adeka, B. I., & Jibril, K. A. (2010). 
Pregnancy outcome in eclamptics at the 
University of Abuja Teaching Hospital, 
Gwagwalada, Abuja: a 3 year review. Nigerian 
Journal of Clinical Practice, 13(4), 394–398. 
 
Retrospecti
ve review 
of case 
notes 
University of Abuja 
Teaching Hospital, 
Gwagwalada, Abuja 
Case note review, of 
patients with eclampsia 
from May 1, 2005 and 
April 30, 2008 
4471 deliveries, 59 
eclampsia cases, 46 case 
notes available 
59 cases of 
eclampsia; 
incidence of 
13 per 
1,000 
deliveries 
CFR: 8.5% 
Stillbirth 
rate: 2 per 
1,000 
deliveries 
 At the time, this facility used the Zuspan regimen 
 Eclampsia was most common among 20-24 year olds (34.8%). 60.9% 
of eclampsia cases were in women 20-29 years old 
 60.9% were primigravidae 
 22 (47.8%) had proteinuria of 3+, 3 (6.5%) had no proteinuria 
 20 were managed with diazepam and 19 were managed with MgSO4; 
only three patients had recurrent seizures 
 39 were delivered by caesarean, 5 vaginally (1 of whom delivered 
elsewhere and was referred when she developed eclampsia 
postpartum), and 1 died undelivered.  
 Complications included: acute renal failure (6 patients) 3 of whom 
died (though 5 maternal deaths due to eclampsia were recorded, the 
case notes were only available for three).  
68 
Citation 
Study 
Design 
Location, Timeframe, and 
Sample size 
Prevalence/ 
Incidence/ 
CFR 
Main findings/ limitations 
Conclusions/ 
Recommendations= 
 37 babies were delivered alive, (6 of whom were <1500g; 14 were 
2500g> but >1500g; and 16 were >2500g) 8 stillbirths 
Alabi, O. O., Olarunfemi, G., & Onile, T. G. (2012). 
The trend in maternal mortality in an upgraded 
tertiary facility in North Central Nigeria. Nigerian 
Journal of Medicine : Journal of the National 
Association of Resident Doctors of Nigeria, 
21(3), 282–289. 
 
Retrospecti
ve review 
of case 
records 
Federal Medical Centre, 
Lokoja, Kogi 
Jan 1, 2005 – December 
31, 2009 
44 maternal deaths 
reviewed 
Hypertensiv
e disorders 
causes 
31.8% of 
maternal 
deaths 
 MMR during this period at the facility was 463 per 100,000 live births 
 PE/E accounted for 14 of the 44 maternal deaths 
 During the study period, MgSO4 was unavailable at the facility; since 
its introduction at the center in Oct 2009, no one has died from PE/E 
 
Bukar, M., Kunmanda, V., Moruppa, J., Ehalaiye, 
B., Takai, U., & Ndonya, D. (2013). Maternal 
mortality at federal medical centre yola, 
adamawa state: a five-year review. Annals of 
Medical and Health Sciences Research, 3(4), 
568–571. 
Retrospecti
ve study of 
maternal 
deaths 
Federal Medical Centre 
Yola.  
January 2007—December 
2011 
28 case files of maternal 
deaths 
N/A 
 54 maternal deaths among 8497 deliveries: MMR= 636 per 100,000 
deliveries; 33 files were retrieved and 28 were complete for analysis. 
 Leading cause of maternal death was PE/E (32.1% of 28)—all of those 
who died of PE/E had not attended ANC, were Muslim and Hausa or 
Fulani. 
Buowari, Y. (2013). Pattern and Outcome of 
Eclampsia Managed at a General Hospital in 
North-West Nigeria. Nigerian Health Journal. 
Retrospecti
ve study of 
eclampsia 
patients  
General Hospital Aliero, 
Kebbi state, Nigeria 
December 2004 to 
November 2006 
58 records 
 
 47 antepartum or intrapartum; 11 postpartum eclampsia 
 Of those 47, 31 (66%) were delivered by caesarean and 44 (75.86%) 
survived and were discharged 
 37 babies survived, 6 were fresh stillbirths and 4 were caveated 
stillbirths. 
 At the time of the cases, diazepam was the only anticonvulsant 
available 
Chigbu, B., Onwere, S., Kamanu, C., Aluka, C., 
Okoro, O., & E, A. (2009). Pregnancy outcome in 
booked and unbooked mothers in South Eastern 
Nigeria. East African Medical Journal, 86(6), 
267–271. 
Hospital 
based 
retrospecti
ve study 
Abia State University 
Teaching Hospital, Aba, 
Nigeria 
January 1, 2005—
December 31, 2007 
3,734 mothers who 
delivered 
Incidence 
(unbooked): 
7.9% 
Incidence 
(booked): 
2.0% 
Overall 
incidence: 
3.0% 
 Unbooked mothers had statistically higher incidence of PE/E (OR 
3.88; 95% CI 2.61-5.77) 
 Eclampsia caused 9 deaths among unbooked women and 6 among 
booked women 
 Unbooked mothers in this study were generally younger, with lower 
educational status and higher probability of being unmarried. 
Ebeigbe, P., & Aziken, M. (2010). Early onset 
pregnancy induced hypertension/eclampsia in 
Benin City, Nigeria. Nigerian Journal of Clinical 
Practice. 
Retrospecti
ve study of 
hospital 
cases 
University of Benin 
Teaching Hospital, Benin 
City, Nigeria 
 
 Early onset pregnancy induced hypertension/eclampsia contributed 
6.3% of all HDP cases (1 per 141 deliveries)  
 58.7% of HDP cases were delivered by caesarean section 
 Perinatal survival rate was 34.0%,  
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March 1, 2000 –February 
28, 2005 
 This study suggests that aggressive management (stabilization and 
early delivery) of early onset severe PE is associated with good 
outcomes for mother but poor perinatal outcomes. Conservative 
management should be only used in well-equipped facilities that have 
the resources and capacity for close monitoring and urgent response. 
Efetie, E. R., & Okafor, U. V. (2007). Maternal 
outcome in eclamptic patients in Abuja, Nigeria--
a 5 year review. Nigerian Journal of Clinical 
Practice, 10(4), 309–313. 
Retrospecti
ve analysis 
of medical 
records 
 
National Hospital, Abuja 
March 1, 2000—February 
28, 2005 
Incidence 
7.8 cases of 
eclampsia 
per 1000 
deliveries 
CFR= 28.3% 
 Eclampsia occurred most often in unbooked, nulliparous mothers, 
71.5% of cases were delivered by caesarean due to ‘unfavourable 
cervix’  
 58.7% of cases occurred antepartum, 26.1% were postpartum and 
15.2% were intrapartum 
 Diazepam was used to control fits, MgSO4 was only used in two 
cases. 
 Hydrallazine was used to control hypertensive (particularly in ICU) 
while Nifedipine and Methyldopa were used when BP was better 
controlled 
 19 developed complications including (HELLP syndrome, acute renal 
failure, disseminated intravascular coagulation, septicaemia, lobar 
pneumonia, pulmonary edema, cerebral hemorrhage, cerebral 
damage and quadriplegia.  
 13 maternal deaths, 46.2% due to HELLP syndrome 
Eke, A. C., Ezebialu, I. U., & Okafor, C. (2011). 
Presentation and outcome of eclampsia at a 
tertiary center in South East Nigeria--a 6-year 
review. Hypertension in Pregnancy, 30(2), 125–
132. 
Retrospecti
ve study of 
case notes 
Nnamdi Azikiwe University 
Teaching Hospital, Nnewi, 
Anambra state, Nigeria 
2004-2009 
212 case notes of 
eclampsia patients 
Prevalence= 
1.57% 
CFR 7.5% 
 24.5% of eclamptic patients were unbooked 
 Most commonly affected women were nulliparous teenagers (60.4%). 
Cesarean delivery accounts for 75.5% of all eclamptic deliveries  
 12 neonatal and 8 perinatal deaths 
Ekele, B., Bello, S., & Adamu, A. (2007). Clusters 
of eclampsia in a Nigerian teaching hospital. 
International Journal of Gynecology and 
Obstetrics, 96(1), 62–66. 
Retrospecti
ve cohort 
Usmanu Danfodiyo 
University Teaching 
Hospital, Sokoto, Nigeria 
Jan 1, 1995—December 
31, 2004 
Reviewed files of 15,318 
deliveries over the period  
Overall 
prevalence: 
4.29% 
Incidence at 
the 
beginning of 
the study 
period: 
0.39% 
(1995) and 
increased to 
7.0% (2004) 
 Cases were defined as “maternities that presented with fitting or fitted 
while on admission, had blood pressure equal to or greater than 
140/90 mmHg at least 2+ proteinuria with or without edema, and had 
no past history of epilepsy.” 
 26.3% were antepartum, 67.3% were intrapartum and 6.4 were 
postpartum. 95.4% patients were unbooked. 75.8% were primigravida 
 Incidence increased significantly over the study period with peaks 
identified in 1996, 2001 and 2004. (Each is twice about twice the 
expected/projected rate for that time.) 
 Factors that may have caused UDUTH to receive more cases of 
eclampsia: it is the only tertiary facility in the area and would receive 
more difficult cases and the facility’s participation in the Magpie Trial 
meaning they had MgSO4 and clinicians in nearby facilities were 
aware which might have encouraged selective referral of women PE/E 
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to UDUTH. Also many of the risk factors for PE/E are common in this 
area.  
El-Nafaty, A., Melah, G., Massa, A., Audu, B., & 
Nelda, M. (2004). The analysis of eclamptic 
morbidity and mortality in the Specialist Hospital 
Gombe, Nigeria. Journal of Obstetrics and 
Gynaecology, 24(2), 142–147.  
Retrospecti
ve case 
review 
Specialist Hospital Gombe 
January 1, 1997—
December 31, 1999 
302 cases of eclampsia 
Incidence of 
3.9% 
CFR= 11.6% 
 Eclampsia occurred intrapartum in 55% of the patients 
 90% of cases experienced headache, blurred vision, and epigastric 
pain prior to first seizure 
 dBP > 110 mmHg was recorded in 33.8% 
 66.9% were teenagers, 73.5% were primigravidae, spontaneous 
vaginal delivery occurred in 52.6% (40.4% were caesarean section) 
 111 perinatal deaths (36.8%) (108 were due to eclampsia, the other 
6 had congenital anomalies) 
 Of the 216 live births, 40% were preterm 
 Morbidities included: pyrexis (7.3%), postpartum hemorrhage (4.6%) 
abruption (2.7%), and others at lower frequency 
Fabamwo, A., Akinola, O., Tayo, A., Gbadegesin, 
A., Kushemiju, O., & Oyedele, Y. (2007). Socio-
Demographic Characteristics of Eclamptic 
Patients at a Tertiary Institution in Lagos Nigeria. 
Nigerian Medical Practitioner, 52(4). 
 
Retrospecti
ve review 
Department of Obstetrics 
and Gynaecology, Lagos 
State University Teaching 
Hospital, Ikeja, Lagos State 
January 1, 1999— 
December 31, 2003 
12,875 deliveries 
Incidence = 
1.66% 
eclampsia 
 65.4% of cases were nulliparous, incidence was highest for women 
under 30 
 Unbooked, young, nulliparous women were found to be most prone to 
developing eclampsia, recommend targeting this group to attend ANC 
regularly. 
Igberase, G., & Ebeigbe, P. (2006). Eclampsia: 
Ten-years of experience in a rural tertiary 
hospital in the Niger delta, Nigeria. Journal of 
Obstetrics and Gynaecology, 26(5), 414–417. 
Descriptive 
review of 
hospital 
cases 
Baptist Medical Centre 
(BMC), Eku, Delta State 
January 1, 1994—
December 31, 2003 
123 cases of eclampsia 
Incidence of 
eclampsia: 
2.3% 
 17 (13.8%) of women with eclampsia were unbooked. Teenagers 
accounted for 21.1$ of cases.  
 Most common symptoms were: headache (78%), blurring of vision 
(57.7%), vomiting (29.3%), epigastric pain (19.5%), and dizziness 
(55.3%) 
 68% of the patients began experiencing seizures antepartum, 23.6% 
intrapartum, and 8.2% postpartum 
Igberase, G., & Ebeigbe, P. (2007). Maternal 
mortality in a rural referral hospital in the Niger 
Delta, Nigeria. JOURNAL OF OBSTETRICS AND 
GYNAECOLOGY, 27(3), 275–278.  
Maternal 
death audit 
Baptist Medical Centre 
(BMC), Eku, Delta State 
January 1, 1994—
December 31, 2003 
5,153 deliveries, 115 
maternal deaths 
 
 
CFR: 15.4% 
 MMR= 2,232 per 100,000 live births (booked: 420 per 100,000; 
unbooked 4,123 per 100,000) 
 PE/E caused 20 (17.4%) of maternal deaths during this period, the 
third most significant cause after puerperal sepsis (33%) and 
abortions (22.6%). 
 Two thirds were delivers by CS, 25.2% by spontaneous vaginal delivery 
and 8.1% (n=10) by instrumental delivery. 
 Mean systolic BP at presentation was 174 + 29.7 mmHg and mean 
diastolic BP was 111.8 + 18.1 mmHg 
 19 maternal deaths 
 Perinatal mortality was 195 per 1,000 births 
 Recommend: community-based health education programs to 
encourage667777654 early ANC, train TBAs and integrate them into 
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primary healthcare team, improve referrals and capacity of tertiary 
institutions to provide intensive care for eclamptic patients.  
Ikechebelu, J., & Okoli, C. (2002). Review of 
eclampsia at the Nnamdi Azikiwe University 
teaching hospital, Nnewi (January 1996-
December 2000). Journal of Obstetrics and 
Gynaecology, 22(3), 287–290.  
Retrospecti
ve case 
review 
Nnamdi Azikiwe University 
Teaching Hospital, Nnewi 
January 1996—December 
2000 
43 cases of eclampsia  
Incidence of 
eclampsia: 
0.75% 
CFR 9.3% 
 65% were primigravidae, 83.7% were unbooked, 81.4% were under 
30 years of age, mean age was 23.5 years 
 24 (55.8%) had eclamptic fits antepartum, 11 (25.6%) intrapartum 
and 8 (18.6%) postpartum.  
 No fits occurred below BP of 150/90mmHg 
 100% were treated with diazepam; break-through seizures were 
controlled with diazepam, and IV paraldehyde was used in one patient 
who was not responding well to diazepam. 
 All 43 patients received Hydrallazine to control blood pressure 
 Rate of caesarean section was 85.7%,  
 Seven fetal deaths occurred (two due to low birth weight and asphyxia 
and the other five were stillborn before arriving at the facility)  
 Health education, ANC, women’s awareness of obstetric services, 
early diagnosis and treatment, protocols for management of fluid 
balance, antihypertensive, and anticonvulsive therapies are necessary 
to reduce morbidity, mortality and high rates of CS. 
Jido, T. (2012). Ecalmpsia: maternal and fetal 
outcome. African Health Sciences, 12(2), 148–
152. 
Prospectiv
e hospital 
case 
review 
Aminu Kano Teaching 
Hospital, Kano, Nigeria 
120 cases of eclampsia 
Incidence of 
eclampsia 
1.2% 
CFR: 11.7% 
 Maternal complications in eclamptic patients: prolonged 
unconsciousness: 13 (10.8%); acute renal failure: 6 (5.0%), 
cerebrovascular accident 5 (4.2%); HELLP syndrome: 5 (4.2%) and 
others including: pulmonary oedema/pneumonia, coagulopathy, 
abruptio placenta, cortical blindness, cardiomegaly, vesicovaginal 
fistula  
 14 maternal deaths due to eclampsia 
 Perinatal outcomes in eclamptic mothers: stillbirth: 27 (22.5%), birth 
asphyxia: 47 (39.1%); low birth weight: 31(25.8%); admission to 
nursery: 19 (15.0%) 
  
Kullima, A. A., Kawuwa, M. B. M., Audu, B. M., 
Geidam, A. D., & Mairiga, A. G. (2009). Trends in 
maternal mortality in a tertiary institution in 
Northern Nigeria. Annals of African Medicine, 
8(4), 221–224.  
 
Retrospecti
ve review 
hospital 
files 
Federal Medical Centre, 
Nguru 
January 1, 2003—
December 31, 2007 
112 case notes from 
maternal deaths 
N/A 
 MMR 2,849 per 100,000 deliveries 
 Eclampsia persistently was the leading cause of death (46.4% of all 
deaths during the period) 
 Grandmultiparas, illiteracy and lack of prompt ANC were significant 
contributors in this study 
Mairiga, A., & Saleh, W. (2009). Maternal 
mortality at the State Specialist Hospital Bauchi, 
Northern Nigeria. East African Medical Journal, 
86(1), 25–30. 
Prospectiv
e analysis 
of 
State Specialist Hospital, 
Bauchi, Nigeria 
N/A 
 MMR= 1,732 per 100,000 live births 
 81% of maternal deaths were in unbooked deliveries 
 Severe PE/E accounted for 31.9% (n-245) of maternal deaths 
(followed by obstetric haemorrhage and sepsis) 
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 maternal 
mortality 
January 1, 2001—
December 31, 2007 
767 maternal deaths 
 Updating management policy for eclampsia and focus on increasing 
quality of emergency obstetric care can help reduce maternal death 
as well as use of magnesium sulphate and training providers from 
referring facilities on how to use it. Improving blood banking and 
transfusions can also help women in this community survive. 
Makinde, O. N. (2011). The Contribution of 
Severe Pre-Eclampsia and Eclampsia to 
Perinatal Mortality in a Nigerian Teaching 
Hospital. In D. O. Ezechi (Ed.), Perinatal 
Mortality. 
cohort 
Obafemi Awolowo 
University Teaching 
Hospitals Complex, Ile-Ife, 
Nigeria 
January 1, 2006—January 
31, 2007 
39 cases of severe PE/E 
 
 Each patient was categorized into three categories: 
 16 (41.02%) Severe PE: hypertension after 20th week, 
dBP>110mmHg on admission, proteinuria >30mg/dl in random urine 
specimen or > 300mg in 24hr 
 11 (28.2%) Imminent eclampsia: all parameters in (1) plus headache, 
blurring of vision and upper abdominal pain 
 6 (15.4%) Eclampsia: all parameters in (1) and seizures. 
 Six perinatal deaths (13.95%) (among four cases), three early  
neonatal deaths were a set of triplets. Overall perinatal mortality rate 
attributable to a single disease entity (severe PE/E) was 5.84 per 
1000 births 
 The author recommends that in this setting, the Pre-eclampsia 
community Guidelines (PRECOG) would minimize incidence and 
complications of ‘SPEE” (severe PE/E) 
Mbachu, I. I., Udigwe, G. O., Okafor, C. I., 
Umeonunihu, O. S., Ezeama, C., Eleje, G. U., & 
GU, M. I. U. G. O. C. U. O. E. C. E. (2013). The 
pattern and obstetric outcome of hypertensive 
disorders of pregnancy in Nnewi, Nigeria. 
Nigerian Journal of Medicine, 22(2), 117–122. 
 
Descriptive 
retrospecti
ve review  
Nnamdi Azikiwe University 
Teaching Hospital, Nnewi, 
Nigeria 
January 2004—December 
2008 
4026 deliveries 
3.7% 
incidence of 
hypertensive 
disorders in 
pregnancy. 
CFR: 5.6% 
 148 women managed for hypertensive disorders in pregnancy; 138 
complete folders were available for analysis 
 64 (46.4%) had PE, 50 of whom had “severe” PE; 28 (20.3%) had 
eclampsia; 7(5.1%) had Chronic hypertension; 14 (10.1% had chronic 
hypertension with superimposed preeclampsia; 17 (12.3%) had 
unclassified hypertension. 
 Booking status and severity of disease were important determinants 
of maternal and neonatal outcome in this study 
  
Melah, G., Massa, A., & El-Nafaty, A. (2006). 
Pregnancy outcomes of women with eclampsia 
in Gombe, Nigeria. International Journal of 
Gynecology and Obstetrics, 92(3), 251–252. 
Review of 
hospital 
records 
Specialist Hospital Gombe 
January 1, 1997—
December 31, 2000 
11,985 deliveries 
Incidence of 
eclampsia: 
3.7% 
 MMR 2058 per 100,000 deliveries 
 438 cases of eclampsia, 67.8% were teenage mothers, 79.8% were 
primigravidas; 51.0% delivered vaginally 
 64.7% were live births and 35.3% stillbirths. Among women with 
eclampsia, perinatal mortality was 2023 per 100,000 live births (due 
to prematurity, intrauterine fetal death, and low birth weight)  
Nwagha, U. I., Nwachukwu, D., Dim, C., Ibekwe, 
P. C. P., & Onyebuchi, A. (2010). Maternal 
mortality trend in South East Nigeria: less than a 
decade to the millennium developmental goals. 
Journal of Women’s Health (2002), 19(2), 323–
327.  
Retrospecti
ve study 
Federal Medical Centre 
(FMC), Abakiliki and Ebonyi 
State University Teaching 
Hospital (EBSUTH), 
Abakiliki and two mission 
hospitals: Mile 4 Hospital, 
Ishieke and Mater 
 
 134 maternal deaths of 14, 884 live births: MMR= 902.7 per 
100,000 live births 
 30% of all deaths were 20-29 years old and 35.1% were grand 
multiparous; overall 12 maternal deaths (12.4%) from PE/E 
 Most common cause of death at FMC was PE/E (30%)(n=3) 
 EBSUTH saw 2 (6.5%) maternal deaths from PE/E, Mile 4 Hospital had 
2 (7.7%) and Mater Misericordiae Hospital had 5 (16.7%) maternal 
deaths from PE/E 
 73 
 
Citation 
Study 
Design 
Location, Timeframe, and 
Sample size 
Prevalence/ 
Incidence/ 
CFR 
Main findings/ limitations 
Conclusions/ 
Recommendations= 
Misericordiae Hospital, 
Afikpo 
January 2003—December 
2005 
14,884 live births 
Nwobodo, E., & Ahmed, Y. (2011). Maternal 
mortality associated with eclampsia in Sokoto, 
Nigeria. Orient Journal of Medicine2, 23. 
Retrospecti
ve hospital 
record 
review 
Usmanu Danfodiyo 
University Teaching 
Hospital, Sokoto 
January 2005—December 
2009. 
277 maternal deaths 
CFR: 31.7% 
 117 (42.2%) of maternal deaths were caused by eclampsia 
 CFR was slightly higher for women <20 years (36.2%), first delivery 
(33.8%), no formal education (32.4%) no prenatal care (32.3%), and 
Glasgow coma score of <5 at presentation (46.1%) (only Glasgow 
coma score had a significant difference) 
 24.7% of perinatal deaths were due to eclampsia (61.5% of which 
were from mothers who also died). 
 Educating women, promoting FP, ANC and delivery services, and 
health education on feature of severe PE are measures that can help 
reduce maternal death from eclampsia 
Okafor, U. V, & Aniebue, U. (2004). Admission 
pattern and outcome in critical care obstetric 
patients. International Journal of Obstetric 
Anesthesia, 13(3), 164–166.  
Retrospecti
ve review 
of hospital 
records 
University of Nigeria 
Teaching Hospital, Enugu. 
January 1997—December 
2002 
6,544 deliveries 
 
 816 patients admitted to ICU during period, rate of 2.8 per 1000 
deliveries. 
 Nine were preeclamptic or eclamptic (which made up 50% of the 
obstetric admissions) other obstetric admissions included: obstetric 
haemorrhage, gestational diabetes.  
 Four of the PE/E cases admitted to the ICU died (44%) due to 
cardiovascular collapse following multiple organ failure (n=3) and 
cerebral haemorrhage (n=1). 
 This and other studies show that PE/E and obstetric haemorrhage are 
the most common causes of obstetric admissions to the ICU 
 This study suggests that PE/E might benefit from preoperative 
admission to ICU and invasive monitoring could help reduce mortality 
Okafor, U. V, & Efetie, R. E. (2008). Critical care 
management of eclamptics: Challenges in an 
African setting. Tropical Doctor, 38(1), 11–13. 
 
Retrospecti
ve study of 
records  
ICU of the National 
Hospital, Abuja 
November 2001—April 
2005 
CFR: 29% 
 40 eclamptics presented at the ICU during the study period, but 
records for two were incomplete and not included in analysis; ICU 
admission rate of 8.2 per 1000 live births. 32 (84.2%) of these 
patients were unbooked for ANC. 
 4,857 deliveries, 4,854 live births, (5,051 total births, including 
multiple births).   
 20 (52.6%) had antepartum eclampsia, 12 (31.6%) had postpartum 
eclampsia, and six (15.8%) had intrapartum eclampsia 
 29 (76.3%) were delivered by caesarian section 
 Major complications included: HELLP syndrome, disseminated 
intravascular coagulation, acute renal failure, and quadriplegia. 
 MgSO4 was unavailable at the time, ant all expect for one of the 
patients received diazepam to control fitting. 
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 To lower BP, Hydrallazine was the preferred antihypertensive. 
 The main cause of death in this study was HELLP syndrome (n=5, 
45%) 
Okeh, U. (2009). Statistical analysis of the 
maternal death rate at the Ebonyi State 
University Teaching Hospital, Abakaliki, for the 
year ending 31 December 2007. African Journal 
of Primary Health Care and Family Medicine, 
1(1), 3 p.  
Retrospecti
ve review 
of case 
notes 
Ebonyi State University 
Teaching Hospital, 
Abakaliki 
January 1—December 31, 
2007 
1,646 deliveries 
 
 MMR=2735.6 per 100,000 deliveries 
 Severe PE/E accounted for 35.6 (n=16) maternal deaths 
(haemorrhage caused 28.9% and sepsis caused 13.3% of maternal 
deaths) 
 88.9% (n=40) of all maternal deaths were unbooked; improving ANC 
attendance an help prevent development of severe PE/E and reduce 
maternal death by detecting and managing pre-eclampsia early 
Okogbenin, S A et al. “Eclampsia in Irrua 
Specialist Teaching Hospital: A Five-Year 
Review.” Nigerian Journal of Clinical Practice 
13.2 (2010): 149–153.  
Retrospecti
ve review  
Irrua Specialist Teaching 
Hospital, Edo state 
5 year period 
78 cases of eclampsia 
 
 (no full text available, but was able to extract relevant details from 
Abstract) 
 Eclampsia accounted for 2.52% of admissions to the labor ward; case 
notes available for 74 cases. 
 All except four were unbooked and over half (54.29%) of those 
unbooked cases had not received any ANC. 
 Patients experienced: headache (74.32%), blurred vision (21.62%), 
restlessness (16.22%), nausea (10.81%) and vomiting (10.81%). 
 Perinatal mortality = 28.38%, maternal mortality= 22.97% 
Okusanya, BO et al. “Maternal Deaths: Initial 
Report of an on-Going Monitoring of Maternal 
Deaths at the Federal Medical Centre Katsina, 
Northwest Nigeria.” Journal of Maternal - Fetal 
and Neonatal Medicine 26.9 (2013): 885–888. 
Review of 
hospital 
reports on 
maternal 
death 
Department of Obstetrics 
and Gynaecology, College 
of Medicine, University of 
Lagos 
June 1, 2008—May 31, 
2012 
68 maternal deaths 
 
 MMR = 827 per 100,000 live births, PE/E was the second most 
common direct cause of maternal death (n=14, 18.9%) 
 Among teenagers (23.5% of deliveries), PE/E was the most common 
cause of maternal death, accounting for 37.5% 
  
Oladapo O, Adetoro O, Ekele B, Chama C, Etuk 
S, Aboyeji A, et al. When getting there is not 
enough: a nationwide cross-sectional study of 
998 maternal deaths and 1451 near-misses in 
public tertiary hospitals in a low-income country. 
BJOG An Int J Obstet Gynaecol [Internet]. 2015 
Prospectiv
e review of 
hospital 
cases 
Cross 
sectional 
Nigeria 
June 1, 2012—August 14, 
2013 
42 hospitals in six 
geopolitical zones 
 
2,449 SMO cases 
 
 Identified all cases of severe maternal outcome (SMO): maternal near-
miss (1451) or maternal death (998). 
 91, 724 live births, MMR at participating facilities was 1088 per 
100,000 live births, maternal near-miss was 15.8 per 1,000 live 
births, and SMO ratio was 26.7 per 1,000 live births. 
 Hypertensive disorders (chronic hypertension and PE/E) were the 
most common complication and caused 24% of SMOs 
 Eclampsia was the most frequent complication and accounted for 1/5 
maternal deaths. 
 About half women experiencing organ dysfunction due to hypertensive 
disorders in pregnancy, died—effort is needed to reduce maternal 
mortality by promptly managing organ dysfunction resulting from HDP. 
 Overall, the median time interval to initiating “definitive 
treatment/intervention’ was 60 minutes, but in 47.4% of SMO cases, 
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the delay was over an hour and in more than 1/5 cases it was over 
four hours 
 The research team identified deficiencies in management of almost 
half SMO cases (1215, 49.6%) 
 Contributors to substandard care included: late presentation to 
hospital, inability to pay/no insurance, unavailability of blood products 
Oladapo, O., Lamina, M., & Fakoya, T. (2006). 
Maternal deaths in Sagamu in the new 
millennium: a facility-based retrospective 
analysis. BMC Pregnancy and Childbirth, 6, 6. 
Retrospecti
ve 
descriptive 
analysis  
Olabisi Onabanjo University 
Teaching Hospital, 
Sagamu, Nigeria 
January 1, 2000—June 30, 
2005 
75 maternal deaths 
N/A 
 75 maternal deaths and 2509 live births; MMR= 2989.2 per 100,000 
live births 
 Hypertensive disorders in pregnancy (severe PE/E) caused 28% of the 
maternal deaths, (eclampsia: 24%, severe PE, 4%) 
 Nine women died from complications due to severe PE/E before 
delivery; these complications were: cerebrovascular accident (n=8) 
and acute renal failure (n=1). 
 Up to the end of the study period, MgSO4 had not been adopted for 
treating severe PE/E and was unavailable 
Olapade, F., & Lawoyin, T. (2008). Maternal 
mortality in a Nigerian maternity hospital. African 
Journal of Biomedical Research, 11(3), 267–
273.  
 
Retrospecti
ve case 
control 
Adeoyo Maternity Hospital, 
Ibadan, 
January 2003—December 
2004 
84 maternal deaths 
 
 MMR= 963 per 100,000 live births 
 14 (16.7%) maternal deaths caused by eclampsia; 64.2% of these 
were among women under 25 years old 
 71.4% of deaths due to eclampsia were in nulliparous women, 85% 
occurred within 24 hours of being admitted, 71.4% were unbooked, 
and more deaths due to eclampsia were seen during the rainy season 
Olatunji, A. O., & Sule Odu, A. O. (2006). 
Maternal mortality from eclampsia. Journal of 
Obstetrics and Gynaecology, 26(6), 542–543.  
 
Retrospecti
ve review 
Olabisi Onabanjo University 
Teaching Hospital, Sagamu 
1988—1997 
93 cases of eclampsia 
Incidence 
1.7% 
CF ratio: 0.2 
(20%, CFR) 
 5,423 deliveries over the study period and 92 maternal deaths, 19 of 
which were caused by eclampsia. 
 82 cases were antepartum, eight were intrapartum and three were 
postpartum, 94.7% of deaths were in antepartum cases. 
Olatunji, A., & Sule-Odu, A. (2007). Presentation 
and outcome of eclampsia at a Nigerian 
University Hospital. Nigerian Journal of Clinical 
Practice.  
Retrospecti
ve review 
Olabisi Onabanjo University 
Teaching Hospital, Sagamu 
January 1988—December 
1997 
93 cases of eclampsia 
Incidence 
1.7% 
CFR: 20.4% 
 93 cases of eclampsia, all patients received diazepam to control 
convulsions and hydralazine (antihypertensive) when needed.  
 96.8% were unbooked, 60.2% were delivered by caesarean section, 
and 78.5% were nulliparous 
 Nulliparous teenagers were the most at risk of dying from eclampsia 
n=38) 
 87 were antepartum, 4 were intrapartum and 2 were postpartum 
(*conflicts with previous paper published on these data, above) 
Olowonyo, T., Oshin, S., & Obasanjo-Bello, I. 
(2005). Registering in a health facility for 
delivery protects against maternal mortality in a 
developing country setting. Journal of Obstetrics 
Prospectiv
e cross- 
sectional 
study 
Primary, secondary and 
tertiary facilities and 123 
private facilities in Ogun 
State 
N/A 
 Using a one-page form, researchers collected the data elements they 
required to calculate various neonatal, perinatal, infant, under-five 
and maternal mortality rates. 
 MMR= 177.6 per 100,000 live births 
 Eclampsia accounted for 9 of the 37 maternal deaths 
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and Gynaecology, 25(7), 638–641. 
 
November 2003—July 
2004 
37 maternal deaths 
 8 of the 9 deaths caused by eclampsia were unbooked/unregistered 
patients 
  
Omo-Aghoja, L., Aisien, O., Akuse, J., & 
Okonofua, F. (2010). Maternal mortality and 
emergency obstetric care in Benin City South-
south Nigeria. Journal of Clinical Medicine and 
Research, 2(4), 55–60. 
 
Retrospecti
ve review 
of hospital 
records 
University of Benin 
Teaching Hospital, Benin 
City, Edo state 
January 1, 2005—
December 31, 2007 
3,681 deliveries 
CFR: 15.9% 
 84 maternal deaths, MMR= 2,282 per 100,000 deliveries, 
 113 cases of eclampsia were managed 
 18 (21.4%)(*there was a typo in the table, it says 12.4%) of the 
maternal deaths were due to “severe pregnancy induced 
hypertension/eclampsia” 
 Recommends improved emergency obstetric services 
Onah, H., Okaro, J., Umeh, U., & Chigbu, C. 
(2005). Maternal mortality in health institutions 
with emergency obstetric care facilities in Enugu 
State, Nigeria. Journal of Obstetrics and 
Gynaecology, 25(6), 569–574. 
Retrospecti
ve 
maternal 
death 
analysis 
Enugu State 
December 1, 2003—April 
30, 2004 
141 maternal deaths 
 
 Five facilities were included: University of Nigeria Teaching Hospital 
(UNTH), the Mother of Christ Specialist Hospital (MOCSH), Parklane 
Specialist Hospital (PSH), Bishop Shanahan Hospital (BSH), and 
Ntasiobi Ndi No N’afufu Hospital 
 Overall MMR= 772 per 100,000 (UNTH was the worst with an MMR of 
2,283 per 100,000 and MOCSH had only 192 per 100,000) 
 Only complete folders were retrieved for 89 (63.1%) of the maternal 
deaths. 
 PE/E caused 15 of the 89 maternal deaths (16.9%) 
Onakewhor, J. U. E., & Gharoro, E. P. (2008). 
Changing trends in maternal mortality in a 
developing country. Nigerian Journal of Clinical 
Practice, 11(2), 111–120. 
Retropectiv
e review of 
case notes 
Mission hospital, Benin City 
January 1, 1996—
December 31, 2000 
32 maternal deaths 
N/A 
 32deaths out of 7,055 deliveries, MMR= 454 per 100,000 
 34.4% (n=11) of maternal deaths were due to eclampsia; this was the 
most significant cause of maternal death followed by sepsis and PPH 
at 18.8% each 
 This study presents some case scenarios of maternal deaths, two 
related to PE/E: 
 --One woman, 32 years old, para 2, with PE arrived at the UBTH after 
being referred from a private maternity home, after two convulsions, 
she died before she could deliver 
 --A 25 year old woman with severe PE (BP 181/130mmHg) declined 
admission, went home to update her husband and returned later but 
died shortly after re-admission 
Onwuhafua, P. I. (2002). Dying undelivered. 
Journal of Obstetrics and Gynaecology : The 
Journal of the Institute of Obstetrics and 
Gynaecology, 22(2), 155–158. 
Retrospecti
ve review 
of hospital 
records 
Ahmadu Bello University 
Teaching Hospital, Kaduna 
January 1, 1990—
December 31, 1997 
15 women who died 
undelivered 
 
 53 maternal deaths out of 10,572 deliveries; MMR= 501 per 
100,000 
 Incidence of dying undelivered = 141 per 100,000 deliveries 
 Severe PE/E contributed six (40%) of the undelivered deaths, followed 
by ruptured uterus (n=4, 26.7%) 
 Two of the eclampsia patients were grandmultiparae, poor, and 
illiterate. 
 Seven of the fetuses survived and six of them were in patients with 
eclampsia. 
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 Recommendations include: health education for would-be clients, 
improve content of ANC, improve obstetric emergency capability at 
facility, establish materno-fetal medicine unit and awareness and 
policy relating to postmortem caesarean section 
Onwuhafua, P. I., Onwuhafua, A., & Adze, J. 
(2000). The challenge of reducing maternal 
mortality in Nigeria. INTERNATIONAL JOURNAL 
OF GYNECOLOGY & OBSTETRICS, 71(3), 211–
213. 
Retrospecti
ve review 
of hospital 
records 
Ahmadu Bello University 
Teaching Hospital, Kaduna 
1990—1997 
53 obstetric deaths 
16 abortion deaths 
 
 MMR= 652 per 100,000 (including abortion deaths) 
 Nulliparity and unbooked had the highest rates of maternal mortality. 
 Eclampsia contributed 17 maternal deaths (36.95%) 
Onwuhafua, P. I., Onwuhafua, A., Adze, J., & 
Mairami, Z. (2001). Eclampsia in Kaduna State 
of Nigeria--a proposal for a better outcome. 
Nigerian Journal of Medicine : Journal of the 
National Association of Resident Doctors of 
Nigeria, 10(2), 81–84. 
 
Retrospecti
ve review 
of hospital 
records 
Ahmadu Bello University 
Teaching Hospital, Kaduna 
1990—1997 
45 cases of eclampsia 
Incidence of 
eclampsia= 
0.42% 
CFR: 
42.22% 
 Antepartum eclampsia occurred in 60% of cases, 31.3% had 
intrapartum and 8.7% postpartum  
 The most common symptoms were: headache (100%), hypertension 
(88.88%) and fever (42.22%). 
 Diazepam successfully controlled fits in 66.6% of patients 
 19 maternal and 20 perinatal deaths 
 Recommendations include: standard plan for managing eclampsia 
and distributed as guides to all hospitals, ANC and delivery services 
must improve and provide quality surveillance of women and 
identification of women at risk of eclampsia, intensive care facilities 
are needed to treat women experiencing acute renal and 
cardiopulmonary complications. 
Orji, E., Ogunlola, I., & Onwudiegwu, U. (2002). 
Brought-in maternal deaths in south-west 
Nigeria. Journal of Obstetrics and Gynaecology, 
22(4), 385–388. 
Prospectiv
e review at 
hospital 
Ife State Hospital, Ile-Ife 
and Wesley Guild Hospital, 
Ilesa (part of the Obafemi 
Awolowo University 
Teaching Hospitals 
Complex) 
1995—1999 
24 brought-in maternal 
deaths 
 
 Eclampsia was determined to be the probable cause of death in 8 
(33.3%) of the brought-in maternal deaths  
 Common reasons for late presentation to the hospital include: inability 
to obtain transit (41.7%), inability of health care staff to detect 
problems early enough (33.3%), inability of referring hospital to 
perform emergency C-section (25%), unavailability of blood for 
transfusion( 25%), unwillingness of drivers to travel at night (25%), 
and no money to pay for hospital fees (16.7%) 
 One woman had suffered from eclampsia at 38 weeks gestation and it 
took her husband some time to collect the money for transit and 
hospital fees. She was carried on a motorcycle for 10km to the closest 
place to get on a vehicle to the facility. She had to wait for the vehicle 
to arrive and died on the way before arriving at the hospital. 
Sule-Odu, A. (2000). Maternal deaths in 
Sagamu, Nigeria. International Journal of 
Gynecology and Obstetrics, 69(1), 47–49. 
Review of 
hospital 
records 
Ogun State University 
Teaching Hospital, Sagamu 
1988—1997 
 
 MMR= 1936.1 per 100,000 = 103 maternal deaths out of 5320 
deliveries, 86.4% of which were due to obstetric causes 
 Eclampsia accounted for13 (12.6%) of all maternal deaths and 
pregnancy induced hypertension caused 5 (4.9%) 
  Blood banking, improved access to healthcare services and 
empowering women can reduce maternal deaths. 
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103 maternal deaths 
Tukur, J., Umar, B. A., & Rabi’u, A. (2007). 
Pattern of eclampsia in a tertiary health facility 
situated in a semi-rural town in northern Nigeria. 
Annals of African Medicine, 6(4), 164–167.  
 
Retrospecti
ve review 
of case 
records 
Federal Medical Centre, 
Birnin Kudu, Jigawa State 
207 cases of eclampsia 
Incidence of 
eclampsia: 
9.42% 
 Eclampsia contributed to 43.1% (n=22) of all maternal deaths and 27 
(13%) perinatal deaths 
 56% of patients experienced delay before reaching hospital. 
 58.5% were <20 years old, 78.3% were primigravida, and 51.7% were 
delivered by cesarean section 
 Eclampsia manifested antepartum in 32.9% (n=69), intrapartum in 
54.1% (n=112) and postpartum in 12% (27). 
 Recommends health education for community members to increase 
awareness of the importance of ANC 
Ujah, I. A. O., Aisien, O. A., Mutihir, J. T., 
Vanderjagt, D. J., Glew, R. H., & Uguru, V. E. 
(2005). Maternal mortality among adolescent 
women in Jos, north-central, Nigeria. Journal of 
Obstetrics and Gynaecology, 25(1), 3–6. 
Retrospecti
ve case file 
review 
Jos University Teaching 
Hospital, Jos, Plateau State 
January 1991—December 
2001 
4,564 adolescent 
deliveries 
N/A 
 Adolescent= 10-19 years old 
 25 maternal deaths among study population, Adolescent MMR= 547 
per 100,000 deliveries 
 Eclampsia and Sepsis each caused 5 deaths, accounting for 26.3% 
each of the overall adolescent maternal deaths. 
Ujah, I., Aisien, O., Mutihir, J., Vanderjagt, D., 
Glew, R., & Uguru, V. (2005). Factors 
contributing to maternal mortality in north-
central Nigeria: a seventeen-year review. African 
Journal of Reproductive Health, 9(3), 27–40. 
Review of 
case files  
Jos University Teaching 
Hospital, Jos, Plateau State 
1985—2001 
267 maternal deaths 
 
 267 maternal deaths out of 38,768: MMR 740 per 100,000 
deliveries 
 Eclampsia accounted for 75 (23.6%) of all maternal deaths. 
Eclampsia ranked third most common direct cause of maternal death 
after Haemorrhage (34.6%) and sepsis (28.3%) 
 An indirect cause of maternal mortality was acute renal failure (8%) 
which is a complication of eclampsia. 
  
Yakasai, I., & Gaya, S. (2011). Maternal and 
fetal outcome in patients with eclampsia at 
Murtala Muhammad specialist Hospital Kano, 
Nigeria. Annals of African Medicine. 
Case 
record 
review 
Murtala Muhammad 
Specialist Hospital (MMSH) 
Kano 
April 2008—May 2009 
688 cases of eclampsia 
Prevalence 
of 
eclampsia: 
5% 
CFR= 5.2% 
 127 women died out of 13,943 deliveries ; MMR= 904 per 100,000 
 Eclampsia contributed 28.57% of all maternal deaths. 
 Perinatal mortality among eclamptics was 132 per 1000 eclamptic 
deliveries. 6.2% were fresh stillbirths, 3.5% were macerated stillbirths, 
and 3.5% were not delivered. 
 50.14% of the patients were teenagers (10-19 years old) 
 82.3% were primigravidae, 48.5% received some ANC (mostly from 
primary health centers) 
 44.9% developed convulsions antepartum 
 83.3% presented within 12 hours of the first convulsion and 
outcomes are made worse by delay in presentation.  
 
